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ABSTRACT OF DISSERTATION 
 
 
 
ENGINEERING NOVEL TERPENE PRODUCTION PLATFORMS  
IN THE YEAST SACCHAROMYCES CEREVISIAE 
 
The chemical diversity and biological activities of terpene and terpenoids have served in 
the development of new flavors, fragrances, medicines and pesticides. While terpenes 
are made predominantly by plants and microbes in small amounts and as components of 
complex mixtures, chemical synthesis of terpenes remains technically challenging, costly 
and inefficient. In this dissertation, methods to create new yeast lines possessing a 
dispensable mevalonate biosynthetic pathway wherein carbon flux can be diverted to 
build any chemical class of terpene product are described. The ability of this line to 
generate diterpenes was next investigated.  Using a 5.5 L fed bath fermentation system, 
about 569 mg/L kaurene and approximately 207 mg/L abietadiene plus 136 mg/L 
additional isomers were achieved. To engineer more highly modified diterpenes that 
might have greater industrial, agricultural or medicinal applications, yeast engineered for 
kaurenoic acid production reached 514 mg/L with byproducts kaurene and kaurenal 
accumulating to 71.7mg/L and 20.1mg/L, respectively, in fed batch fermentation 
conditions. Further genetic modifications yielded additional yeast lines engineered for 
monoterpene, ZXM, and triterpene, ZXB, production.  ZXM, for instance, engineered 
with a mutant prenyltransferease designed for GPP biosynthesis and a bi-functional 
monoterpene/sesquiterpene synthase gene from strawberry (FaNES1) accumulated 
84.76 mg/L linalool (monoterpene) and 20.54 mg/L nerolidol (sesquiterpene).  In 
contrast, ZXB engineered for triterpene biosynthesis accumulated 297.7 mg/L squalene 
under shake flask conditions. 
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 1 
Chapter 1: Background and Introduction 
 
1.1. Natural products 
Plants, microorganisms and animals produce a large variety of organic chemical 
compounds, some of which are used universally for growth and metabolism and others 
seem to play specialized roles in the life cycle of the organism (Maimone & Baran, 
2007). As such, two large classes of natural products are widely recognized. Primary 
metabolites are those essential for live in all eukaryotic organisms, while specialized 
metabolites appear to give species specific advantages for occupying distinct 
environmental niches.  The distinctive role specialized metabolites play in an organism’s 
natural history, for example how these metabolites provide protection against microbial 
challenge, have also not escaped attention for their possible utility in a wide range of 
applications. For example, many of the currently used drugs are derived from or inspired 
by plant-derived specialized chemicals and are commonly referred to as Natural 
Products (Newman & Cragg, 2012). Capturing the all the possible chemical and 
structural diversity of Natural Products has recently been identified as a major objective 
within the scientific community in large part because of the wide array of applications 
Natural Products have and the resulting economic implications.  
1.2. Terpenoids 
Terpenes and terpenoids are a large and diverse family of Natural Products with more 
than 55,000 having been identified (Maimone & Baran, 2007). However, based on the 
biosynthetic mechanisms responsible for terpenes, chemists have predicted that only a 
small fraction of all the possible terpene compounds have been discovered (Bouvier et 
al., 2005). Terpenes are derived from a five-carbon isoprene building block with different 
combinations of the isoprene units generating different classes of the terpene products. 
The classification and biosynthesis of terpenoids are based on the number of five-carbon 
 
 
 
 2 
units they contain as illustrated in Fig.1.1. Monoterpenes (consisting of 10 carbons), 
sesquiterpenes (15 carbon derivatives), and diterpenes (20 carbon derivatives), arise 
from the corresponding intermediates geranyl diphosphate (GPP), farnesyl diphosphate 
(FPP), and geranylgeranyl diphosphate (GGPP). These intermediates in turn arise by 
the sequential head to tail condensation of C5 units. Higher order terpenes like triterpene 
(30 carbons) are formed from two farnesyl units condensed head-to-head (Buchanan et 
al., 2002). 
Monoterpenes are well known as the volatile essence of flowers and such mixtures can 
account for up to 5% of plant dry weight (Buchanan et al., 2002). Menthol and camphor 
are common monoterpenes found in diverse plant families and whose structural 
complexity in terms of stereo- and regio-chemistry are emphasized in Fig. 1.2. Besides 
providing pleasing fragrances, monoterpenes have been shown to function as signal 
molecules in defense mechanisms against pathogens (Hick et al., 1999). Monoterpenes 
have commercial values as flavors, fragrances, essential oils, and as anticancer and 
antimicrobial drugs (Burke et al., 1997). Sesquiterpenes (C15) are also found in 
essential oils, and many sesquiterpenes possess antibiotic activities, prompting 
suggestions that they are produced by plants as phytoalexins through a defense 
mechanism (Bailey, 1982). Diterpenes (C20) include gibberellins (plant hormones), 
vitamin A, as well as pharmaceutical important metabolites such as taxol, an exceptional 
anticancer regent (Barkovich & Liao, 2001). Triterpenes (C30) include the 
brassinosteroids, phytosterols important for lipid membrane composition, and 
components of surface waxes, such as oleanolic acid of grapes. Squalene, the major 
content of shark liver oil, is a linear triterpene and common ingredient in cosmetic 
products (Huang et al., 2009), has special utility as a lubricant for high performance 
machinery, and is a common adjuvant in many pharmaceutical formulations (Bhilwade et 
al., 2010, Huang et al., 2009, Reddy & Couvreur, 2009). Tetraterpenes (C40) include 
carotenoid accessory pigments, like lycopene, which assist and support the light 
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reactions of photosynthesis. Longer chain terpenes, so-called polyterpenes, contain 
more than 8 isoprene units and include examples like ubiquinone and rubber (Buchanan 
et al., 2002). 
1.3. Terpenoid metabolic pathways 
There are two pathways for terpene biosynthesis in plant cells. One is the mevalonate 
pathway pathway (MVA) which is well established and discovered in the 1960s (Bouvier 
et al., 2005). The other is the mevalonate independent pathway, or more properly 
referred to as the methylerythritol-phosphate pathway (MEP), which was more recently 
discovered (Bouvier et al., 2005). The MEP pathway was first discovered in prokaryote 
cells, and then confirmed to exist in plant cells (Barkovich & Liao, 2001). Interestingly, 
plants utilize these two pathways to meet different terpene biosynthetic needs.  
Sesquiterpenes, sterols, triterpenes and oligoterpenes (side chain of dolichols) are 
synthesized in the cytosol via the MVA pathway, while monoterpenes, diterpenes, 
teraterpenes, and polyterpenoids are synthesized in chloroplasts via the MEP pathway 
using pyruvate and glyceraldehydes-3-phosphate as the primary precursors (Fig. 1.2). 
 
 
 
 
 
Table 1.1. Biological activities and commercial applications of typical terpenoids. 
Class Biologic activities Commercial applications Examples 
Monoterpenoids Signal molecules and used as 
defense mechanisms against 
pathogens 
Flavors, fragrances, cleaning 
products, anticancer, 
antibacterial, antioxidant, 
essential oil, biofuel 
Limonene, menthol, camphor, 
linalool 
Sesquiterpenoids Antibiotic, antitumor ,antiviral, 
immuno-suppressive, and 
hormonal activities, defensive 
agents or pheromones 
Flavors, fragrances, 
pharmaceuticals (antibacterial, 
antifungal), insecticides, 
biofuels 
Nootkatone, artemisinin, 
patchoulol, nerolidol, farnesol, 
capsidol, farnesene, bisabolene 
Diterpenoids Hormonal activities, growth 
regulator, antitumor, 
antimicrobial and anti-
inflammatory properties 
Anticancer agents, feedstock 
for industrial chemical 
applications  
 
Gibberellins,phytol, taxol, 
kaurene, abietadiene, 
kaurenoic acid, abietic acid 
Triterpenoids Memberane component, 
steroid hormones 
Biologic markers, biofuel, skin 
moisturizers in cosmetics, 
immunologic adjuvant in 
vaccines. 
Sterols, hopanoids, squalene, 
botryococcene.  
Tetraterpenoids 
 
Antioxidants, photosynthetic 
components, pigments, and 
nutritional elements (vitamins) 
Food additives, colorants, 
antioxidants 
Lycopene, beta-carotene 
4
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Figure 1.1. Classification and biosynthesis of isoprenoids. Isoprenoids are 
biosynthesized from the basic five carbon units IPP and DMAPP. 
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Figure 1.2. Schematic outline of the two terpene biosynthetic pathways that operate in 
plants (the MVA and MEP pathways) (Chappell, 2002), their intracellular locations, and 
examples of the chemical compounds derived from each.  
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1.4. The mevalonate pathway in Saccharomyces cerevisiae 
The principal product of the mevalonate pathway is sterols, for example cholesterol in 
animal cells, stigmasterol and campesterol in plant cells, and ergosterol in fungi, which 
all play essential roles in establishing the structural integrity of membranes, establishing 
permeability and fluidity, and also serving as signal compounds in cellular 
communication (Buchanan et al., 2002). In Sacchromyces cerevisiae, only the 
mevalonate pathway is known to operate and no components of the MEP pathway have 
been found (Maury et al., 2005). Figure 1.3 shows the intermediates and the related 
genes involved in the yeast mevalonate pathway (Maury et al., 2005). Two molecules of 
acetyl-CoA are condensed by acetoacetyl-CoA thiolase, which is encoded by ERG10, to 
synthesize acetoacetyl-CoA. A second condensation reaction between acetoacetyl-CoA 
and acetyl-CoA is then catalyzed by HMG-CoA synthase encoded by ERG13 to yield 3-
hydroxy-3methyglutaryl-CoA (HMG-CoA). 
HMG-CoA is reduced by HMG-CoA reductase to yield mevalonate. This reaction is 
catalyzed by HMG-CoA reductase, which is encoded by 2 separate loci in yeast. Both 
loci appear to compensate for a knockout loss of the other gene. The C5 position of 
mevalonate is phosphorylated by mevalonate kinase, encoded by ERG12. Then a 
second kinase, phosphomevalonate kinase, encoded by ERG8, catalyzes the 
successive phosphorylation to yield diphosphomevalonate. In the next step the 
diphosphomevalonate is converted into IPP (isopentenyl diphosphate) by mevalonate 
diphosphate decarboxylase, encoded by ERG19. IPP isomerase, encoded by IDI1 
converts IPP into DMAPP (dimethylallyl diphosphate). The condensation of the C5 
buidling blocks of IPP and DMAPP into FPP is catalyzed by FPP synthase, which is 
encoded by ERG20. FPP can then be used as substrate for sterol and other isoprenoid 
biosynthetic needs. 
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Recent studies have discovered that FPP is also available in yeast mitochondria, as 
evidenced by increasing novel sesquiterpene production three-times by targeting a 
sesquiterpene synthase to the mitochondria compartment compared with targeting this 
same enzyme to the cytosol (Farhi et al., 2011). The origin of FPP in mitochondria could 
be the IPP and DMAPP arising in cytosol being imported and converted in the 
mitochondria to FPP. Alternatively, a hypothetical leucine metabolism model for the 
formation of terpene in S. cerevisiae is also a possibility. The leucine catabolism 
pathway (MCC pathway) is known to occur in the mitochondria of other eukaryotic  
mammalian and plant cells (Anderson et al., 1998),  in mitochondria leucine metabolite 
to form 3-Hydroxy-3-methylglutaryl-CoA, which can be catalyzed by HMGR to produce 
mevalonic acid, and then produce IPP and DMAPP through MVA pathway as shown in 
Fig 1.4 (Carrau et al., 2005). Interestingly, a yeast line engineered with a chimeric 
diterpene synthase targeted to the cytoplasm along with prenyltransferases streamlined 
for GGPP biosynthesis, yielded 2-3 times more diterpene when the expression vector 
also provided a leu2 auxotrophic selection marker gene. The interpretation provided by 
the authors was that the extra leucine produced by the auxotrophic selection marker 
gene provided another source for IPP via the leucine catabolic pathway (Fig. 1.4). (Zhou 
et al., 2012).   
1.5. The prenyltransferase and terpene synthase reaction 
Prenyltransferases generate allylic diphosphate esters GPP, FPP, and GGPP. These 
compounds can undergo a variety of reactions, which include cyclization reactions 
catalyzed by terpene synthases, yielding diverse terpenes based on regio- and stereo-
chemical constraints built into the reactions. Prenyltransferases and terpene syntahases 
utilize electrophilic reaction mechanisms to mediate the catalytic reactions (Ohnuma et 
al., 1996) and typically share a conserved aspartate-rich DDXXD motif thought important 
for the initial substrate binding and metal-dependent ionization step leading to the first 
reaction carbocation intermediates. In the prenyltranferase reactions, the allylic 
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diphosphate ester can be ionized to form a carbocation, then condensed with a second 
IPP in another round of elongation.  
One of the simpler monoterpene synthase reactions is catalyzed by limonene synthase, 
an enzyme and reaction that has served as a model for all other terpene cyclization 
reactions as illlustrated in Fig. 1.5. The ionization of GPP, assisted by divalent metal 
ions, provides for a delocalized carbocation and relocation of the diphosphate anion pair 
to C3, which leads to the allelic isomer LPP (linalyl diphosphate). Rotation about the C2-
C3 single bond and a second ionization of LPP promotes the formation of another 
carbocation intermediate that can cyclize to form the final product limonene. 
 
 
 
 
 
 
Figure 1.3. The mevalonate pathway for ergosterol biosynthesis in yeast (S. cerevisiae). 
The enzymes encoded by the different genes are: ERG10: acetoacetyl-CoAthiolase; ERG13: HMG-CoA synthase; HMG1, 
HMG2: HMG-CoA reductases; ERG12: mevalonate kinase; ERG8: phosphomevalonate kinase; ERG19: diphosphomevalonate 
decarboxylase; IDI1: IPP, DMAPP isomerase; ERG20: FPP synthase; ERG9: squalene synthase; ERG1: squalene epoxidase; 
ERG7: lanosterol synthase. 
1
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Figure 1.4. The proposed alternative HMG-CoA formation pathway through 
leucinecatabolism pathway, adapted from (Carrau et al., 2005, Zhou et al., 2012). 
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Figure 1.5. Limonene synthase model for terpene cyclization.  
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1.6. Metabolic engineering 
Metabolic engineering aims to make genetic modifications in a way to optimize cellular 
metabolism of microbial or eukaryotic host cells to produce desired novel and specific 
molecules that are of utility as chemical precursors, pharmaceuticals, fine chemicals, 
fuels, and food ingredients. Many of the target compounds are normally difficult to 
produce by organic chemical synthesis and metabolic engineering takes advantage of 
the specificity of enzyme-mediated biosynthesis to generate stereo-chemically pure 
products from cheap raw materials. 
1.7. Terpene engineering 
Terpenes can be obtained by isolation from natural source, metabolic engineering native 
host, chemical synthesis and fermentation of metabolically engineered cell cultures of 
bacteria and yeast. Terpenes are usually made by plants and microbes in small amounts 
and as complex mixtures, making the isolation of single entity molecules difficult. 
Chemical synthesis of terpenoids is often prohibitively expensive and inefficient because 
of difficulties in retaining specific configurations around stereo-centers and obtaining 
absolute purity. Metabolic engineering of terpenes in plant and microbes have hence 
challenged scientists to aim towards the accumulation of specific, high-value target 
molecules.  
An especially exciting example of microbial engineering for terpenes is the production of 
the antimalarial drug Artemisinin precursor amorphadiene in engineered yeast with 
yields in excess of 100 mg/L (Ro et al., 2006) (Table 1.3) and 105 mg/L in E. coli (Martin 
et al., 2003) (Table 1.2). Further optimization of a two-phase fermentation of 
amorphadiene producing E. coli strain dramatically increased sesquiterpene production 
to 500 mg/L (Newman et al., 2006) (Table 1.2). By tethering the enzymes of the MEV 
pathway (AtoB, HMGS, HMGR) to a synthetic protein scaffold, a further 77-fold 
enhancement of mevalonate production was observed, indicating the importance of 
controlling/directing carbon flux through this metabolic pathway in E. coli (Dueber et al., 
2009). Additional optimization of fermentation conditions including nitrogen delivery, 
medium and feeding control strategy led to amorphadiene production >25 g/L in fed-
batch bioreactor fermentation (Tsuruta et al., 2009). Amorphadiene or artemisinic acid 
engineering in yeast have also been advanced significantly in the past few years. By 
using the leu2d selection marker to maintaining high plamid copy number in the yeast 
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strains of Ro et al. (2006), accumulation of amorphadiene and artemisinic acid up to 780 
mg/L and 250 mg/L, respectively, in shake flask cultures have been reported (Ro et al., 
2008). In other sesquiterpene engineering studies, the Chappell laboratory reported 
another yeast strain engineered for high level FPP production had the capacity to divert 
upwards of 50% of this pool to sesquiterpene biosynthesis at yields of 80 mg/L 
(Takahashi et al., 2007) (Table 1.3).  
Taxadiene is a diterpene hydrocarbon and the key intermediate in the biosynthesis of 
paclitaxel, which is widely used in cancer chemotherapy. Metabolic engineering of 
taxadiene synthase has resulted in 1.3 mg/L in E. coli (Huang et al., 2001) (Table 1.2 ) 
and 1 mg/L in yeast (Dejong et al., 2006) (Table 1.3). Recently, advance improvement in 
taxadiene engineering achieved 1g/L in E. coli (Ajikumar et al., 2010) under fed-batch 
fermentation through a muiltivariate-modular approach for optimize balancing and 
channeling the flux of IPP and DMAPP toward taxidiene biosynthesis (Table 1.2 ). More 
recent approaches in the production level of diterpenes are shown in Table 1.3. By 
overexpression of fusion enzymes to increase the association of relative enzymes and 
channeling intermediates to efficient desired products, 238.8 mg/L geranylgeraniol were 
produced in yeast shake flask cultures (Tokuhiro et al., 2009). Using similar strategies 
for miltiradiene, the precursor to the Chinese herb medicine tanshionones, up to ~480 
mg/L in optimized yeast fermentation was attained (Zhou et al., 2012, Dai et al., 2012).  
Monoterpene engineering in E. coli was developed with 5 mg/L (Reiling et al., 2004) and 
5 mg/L in yeast (Fischer et al., 2011). Compared with sesquiterpene engineering level in 
microbial hosts, monoterpene level is quite low, which may reflect limitations of 
intermediates like GPP. 
Concurrent to the microbial genetic engineering, significant progress has also been 
achieved in the metabolic engineering of terpene metabolism in plants. Work in the 
Chappell lab has revealed that the redirection of cytosolic or plastidic isoprenoid 
precursors through over-expression an avian farnesyl diphosphate synthase and an 
appropriate terpene synthase elevates sesquiterpene production in planta more than 
1,000 times higher, with amorphadiene accumulating to 25 µg/g FW and patchoulol to 30 
µg/g FW (Wu et al., 2006) (Table 1.4). When a strawberry linalool/nerolidol synthase 
was over-expressed in Arabidopsis, total terpene levels of 1.5 µg/g FW were observed, 
and large amounts of linalool were released as volatiles from the transgenic plant, with 
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the highest level reaching 13.3 µg per plant per day (Aharoni et al., 2003) (Table 1.4). 
The recent studies in Chappell lab have revealed that targeting FPP synthase and 
squalene synthase to the chloroplast compartment of secretory trichomes resulted in 
upwards of 1,760 µg/g FW, or approximately 1% of the dry weight, in greenhouse grown 
tobacco plants (Wu et al., 2012).  
The yeast Saccharomyces cerevisiae has several properties make it having tremendous 
advantages as a host cell to metabolic engineering terpene compounds. As a eukaryote, 
yeast is a suitable host organism for the high-level production of soluble cytosolic 
proteins as well as complicated protein or organic molecules with furthe modification 
such as glycosylation, which make yeast more advantage than bacteria (Mendoza-Vega 
et al., 1994). Yeast can also be grown rapidly and reach high cell density on simple 
media. And genetic manipulations are more readily performed than with  other eukaryote 
hosts. Furthermore, having the native ergosterol biosynthesis pathway with important 
terpene biosynthesis intermediates and precursors, yeast has more advantage for 
terpene engineering.  
I have illustrated here why terpene compounds have attracted so much attention, and 
outlined the latest achievements of engineering terpeneoids in bacteria, yeast and plant 
organisms, and as well as the advantages of yeast as host cell factory for engineering 
highly desired, single entity valuable terpene compounds. The current metabolic 
engineering efforts for terpene production in yeast have mostly focused on producing 
specific compounds, especially the sesquiterpene amorphadiene. In our stratagies, we 
have proposed that the yeast baseline FPP pool can be improved by building a yeast 
line having a dispensable MVA biosynthetic pathway and complete erg9 knock out 
instead of using a suppressor promoter to conditional inhibiting ERG9 gene, as 
described in Chapter 2. And theoretically, the flux of carbon to farnesyl diphosphate 
could be utilized and diverted for the biosynthesis of any class of terpene products. With 
further modifications through molecular and genetic manipulations of this new yeast 
system, we successfully built all classes of terpenes in our newly developed yeast 
system: for diterpenes as described in Chapter 3, monoterpenes in Chapter 4, and 
triterpenes in Chapter 5. Hence, a general novel yeast platform suitable for producing all 
classes of terpene have been built to provide yeast strains suitable for manufacturing of 
single entity, high-value terpene compounds.  
 
 
 
 
Table 1.2. Summary of Terpene Production in E. coli with Different Approaches for Improving the Production Yield. 
Literature Isoprenoid produced  Class Approach Production 
yield 
(Carter et al., 
2003) 
Limonene, carveol 
carvone 
Monoterpene Inducible overexpression of heterologous GPP 
synthase and IPP isomerase genes and feeding 
of precursor. 
5mg/L limonene, 
No carveol or 
carvone detect 
(Reiling et al., 
2004) 
Carene Monoterpene Inducible overexpression of heterologous DXS, 
IDI, and variant of IspA (FPP synthase) that 
produce GPP.  
0.42 
µg/OD600/L/h 
(Martin et al., 
2003) 
Amorpha-4,11-diene Sesquiterpene Expression of the genes from S. cerevisiae 
encoding the mevalonate pathway and 
amorpha-4, 11-synthase. 
112 mg/L 
(Newman et al., 
2006) 
Amorpha-4,11-diene Sesquiterpene Optimization of two-phase partitioning 
bioreactor for fermentation of amorpha-4, 11 
diene producing strain of Martin et al. (2003).  
500mg/L 
 
(Chang et al., 
2007))  
8-hydroxycadinene and 
artemisinic acid 
Sesquiterpene Expression of plant cytochrome P450s followed 
by optimization in strain of Martin et al. (2003) 
105 mg/L and 
105 mg/L 
(Pfleger et al., 
2006) 
 Mevalonate Upstream 
pathway 
optimization 
Developed a method for tuning the expression 
of multiple genes within operons by generating 
libraries of tunable intergenic regions (TIGRS) 
by using of mRNA secondary structures to 
control production of the first three enzyme in 
the mevalonate pathway (AtoB, HmgS,HmgR), 
strain of Martin et al. (2003). 
7-fold increase 
of mevalonate 
(Dueber et al., 
2009) 
Mevalonate Upstream 
pathway 
Increase carbon flux through the metabolic 
pathway by tethering the enzymes in the 
77-fold increase 
in mevalonate 
1
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optimization pathway (AtoB, HMGS, HMGR) to a synthetic 
protein scaffold (GBD, SH3, PDZ binding 
domains) in strain of Martin et al. (2003). 
(Tsuruta et al., 
2009) 
Amorpha-4,11-diene Sesquiterpene Optimization of nitrogen delivery and 
fermentation conditions of strain of Dueber et 
al. (2009).  
>25 g/L in fed-
bath bioreactor 
fermentation 
(Huang et al., 
2001) 
Taxadiene Diterpene Overproduction of DXP synthase, IDI, GGPP 
synthase and taxadiene synthase. 
1.3 mg/L 
 
(Ajikumar et al., 
2010) 
Taxadiene 
Taxadien-5α-ol 
Diterpene Muiltivariate-modular approach for optimize 
balancing and channeling the overflow flux from 
IPP DMAPP toward Taxol biosynthesis. 
1g/L Taxadiene  
and 60mg/L 
Taxadien-5α-ol 
fed bath 
fermentation 
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1
7
 
 
 
 
 
Table 1.3. Summary of Terpene Engineering in yeast (S. cerevisiae) with Different Approaches for Improving the Production Yield. 
Literature Isoprenoid 
produced  
Class Approach Production yield 
(Carrau et al., 
2005) 
Linalool, α-terpieneol, 
citronellol 
Monoterpene Wine yeast under high concentration of 
assimilable nitrogen fermentation. 
<5 µg/L 
(Oswald et al., 
2007) 
Geraniol, linalool Monoterpene Expression of geraniol synthase in yeast 
mutants defective in ERG20 gene (FPP 
synthase) K197E. 
0.5-1 mg/L 
(Fischer et al., 
2011) 
Geraniol  Monoterpene Expression of geraniol synthase in a set of 
yeast mutants defectivein ERG20 gene (FPP 
synthase) at position K197. 
5 mg/L 
(Jackson et al., 
2003) 
8-epi-cedrol Sesquiterpene Over production of epi-cedrol synthase, yeast 
FPP synthase ERG20 and HMGR. 
0.37 mg/L 
(Lindahl et al., 
2006) 
Amorpha-4,11-diene Sesquiterpene Expression of heterologous gene encoding 
amorpha-4,11-diene synthase on high-copy 
plasmid and integration in the chromosome. 
0.6 mg/L by 
plasmid and 0.1 
mg/L by genome 
integration 
transformant 
(Ro et al., 2006) Amorpha-4,11-diene and 
artemisinic acid 
Sesquiterpene Expression of heterologous ADS genes 
combined with overexpression of tHMG gene, 
down regulating the ERG9 gene by substitution 
of ERG9 promoter for MET3 promoter, 
overexpression of upc2-1, integration of 
additional tHMGR, overexpression of ERG20. 
Co-expression CPR and P450 and 
amorphadiene oxidase CYP71AV1 in high 
153 mg/L 
amorphadiene, 
and 32 mg/L  
artemisinic acid in 
shake flasks. 115 
mg/L artemisinic 
acid in bioreactor 
fermentation. 
1
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amorphadiene production yeast line. 
(Shiba et al., 
2007)  
Amorpha-4,11-diene Sesquiterpene Overexpressing native ALD6 and mutated Acs 
from Salmonella enterica in the strains from Ro 
et al. (2006) to generate the pyruvate 
dehydrogenase bypass in yeast. 
120 mg /L 
(Ro et al., 2008) Amorpha-4,11-diene, 
artemisinic acid 
Sesquiterpene Using Leu2d selection marker vector to 
hetrologous expression ADS and 
amorphadiene synthase to maintain plasmid 
stable in yeast and appropriate medium along 
with optimizing fermentation conditions. 
Amorphadiene 
780mg/L in shake 
flask. Artemisinic 
acid 250mg/L in 
shake flask and 
1g/L in bioreactor. 
(Asadollahi et al., 
2008) 
Valencene, cubebol and 
patchoulol 
Sesquiterpene Downregulating the ERG9 gene by substitution 
of ERG9 promoter for MET3 promoter and 
expression of heterologous terpene synthase 
genes. 
3,000 µg/L, 1,600 
µg/L and 11,500 
µg/L (nonspecific 
synthases results 
in a mix of 
isoprenoids) 
(Takahashi et al., 
2007) 
5-epi-aristolochene, 
Valencene, 
premnaspirodiene and 
hydroxylation of 5-epi-
aristolochene 
Sesquiterpene Expression of TEAS, CVS, HPS in erg9 
knockout yeast. Co-expression of TEAS, EAH 
and P450 reductase to hydroxylated of 5-epi-
aristolochene. 
80 mg/L 5-epi-
aristolochene 50 
mg/L valencene , 
90 mg/L 
premnaspirodiene 
and 120 mg/L 
hydroxylated 
aristolochene. 
(Dejong et al., 
2006) 
Taxadiene and taxadien-
5α-ol 
Diterpene Heterologous expression of five sequential 
paclitaxel pathway genes. 
taxadiene 1 mg/L 
and (taxadien-5α-
ol) ~25 µg/L 
Table 1.3 (continued) 
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(Tokuhiro et al., 
2009) 
Geranylgaraniol/ 
Squalene 
Diterpene/ 
triterpene 
Overexpression HMG1 leads squalene 
accumulation. Overexpression BTS1-DPP1 
fusion gene along with HMG1 shift production 
from squalene to GGOH. Additional BTS1-
ERG20 fusion gene increases the GGOH 
production. 
Squalene 191 
mg/L, GGOH 
228.8 mg/L in 
shake flask. 3 g/L 
GGOH in 
fermentor. 
(Zhou et al., 
2012) 
Miltiradiene Diterpene Overexpression of tHMGR1, BTS1-ERG20 
fusion and SmKSL-SmCPS fusion along with 
complementary leu2 auxotrophic marker and 
convert yeast from haploid to diploid.  
12 mg/L in shake 
flask, 365 mg/L in 
bioreactor. 
(Dai et al., 2012) Miltiradiene Diterpene Overexpression of SmCPS and SmKSL along 
with fusion BTS1-ERG20 in yeast. Switch 
auxotrophic marker to antibiotic maker on the 
episomal expression vector increase 
miltilrafiene production. 
8.8 mg/L or 62 
mg/L by 
auxotrophic 
vector or 
antibiotic vector in 
shake flask, 488 
mg/L in 
bioreactor. 
(Niehaus et al., 
2011) 
Botryococcene Triterpene  Overexpression of fusion gen SSL1-SSL3 
(Squalene synthase like gene) in erg9 knock 
out yeast line. 
70 mg/L 
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Table 1.4. Summary of Terpene Engineering in Plants with Different Approaches for Improving the Production Yield. 
Literature Isoprenoid 
produced  
Engineere 
species 
Class Approach Production yield 
(Ohara et al., 
2003) 
Limonene  Tobacco Monoterpene Limonene synthase of perilla 
frutescens were in traduced 
into tobacco to target in either 
plastid, cytosol or the 
endoplasmic reticulum (ER) 
Plastid localized 143 ng/g 
FW  
390ng/(plant*month) ,Cytosol 
localized 40ng/g FW 
515ng/(plant*month) ER 
localized 0ng/g FW 
(Aharoni et 
al., 2003) 
Linalool and 
nerolidol 
Arabidopsis Monoterpene Overexpression of a dual 
linalool/nerolidol synthase 
(FaNES1) in plastids. 
Total terpenoid 1,500 ng/g 
FW Linalool 13,300 ng/day 
Nerolidol 160 ng/day 
(Lücker et al., 
2001) 
S-linalyl-β-
Dglucopyranoside 
 
Petunia Monoterpene Petunia hybrid was 
transformed with a Clarkia 
breweri S-linalool synthase. 
 
5,000 ng/g FW 14.7 ng/(g 
day) 
(Lücker et al., 
2004) 
β-pinene, 
limonene, and γ-
terpinene 
Tobacco Monoterpene Tobacco plants were 
engineered with three 
monoterpene synthase β-
pinene, limonene, and γ-
terpinene synthase directed to 
the plastids. 
β-pinene 378 ng/(g·day) 
γ-terpinene 630 ng/(g·day) 
Limonene 1,206 ng/(g·day) 
(Wu et al., 
2006)  
Limonene 
Amorpha-4,11-
diene 
Patchoulol 
Tobacco Monoterpene/ 
susquiterpene 
Redirection of cytosolic or 
plastidic isoprenoid 
precursors. overexpression 
geranyl diphosphate synthase 
and limonene synthase. 
Limonene: 500 ng/g FW 
Amorpha-4,11-diene: 25,000 
ng/g FW; Patchoulol 30,000 
ng/g FW 
Table 1.4 (continued) 
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Overexpreesion chicken FPP 
synthase and amorpha-4, 11-
diene synthase. 
(Wallaart et 
al., 2001) 
Amorpha-4,11-
diene 
Tobacco Sesquiterpene Introducing amorpha-4, 11-
diene synthase in cytosol. 
1.7 ng/g FW 
(Zhang et al., 
2011) 
Amorpha-4,11-
diene, artemisinic 
alchol, 
dihydroartmisinic 
alcohol 
Tobacco Sesquiterpene Hetrologous expression of 
amorphadiene synthase and 
CYP71AV1. And additional 
expression of artemisinic 
aldehyde double bond 
reductase with or without 
aldehyde dehydrogenase A 
Amorphadiene 4,000 ng/g 
DW 
(Besumbes et 
al., 2004) 
Taxadiene Arobidopsis Diterpene Plastid target taxadiene 
synthase was constutive 
induced. 
24 ng/g FW 
(Wu et al., 
2012) 
Squalene Tobacco Triterpene Directing FPS and SQS 
(squalene synthase) to the 
secretory trichome cytoplasm 
or choloroplast. 
1760 µg/g FW of trichome 
plastidic transgenic plant. 
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Chapter 2: Building a Terpene Production Platform In Yeast 
 
2.1. Summary 
Terpene natural products have attracted keen interest since the 15th century when they 
served as highly desired trade items by the new world explorers. In more recent times, 
the chemical diversity and biological activities of this intriguing class of compounds have 
served in the development of new flavors, fragrances, medicines and pesticides. While 
terpenes are made predominantly by plants and microbes, they tend to accumulate in 
small amounts and as components of complex mixtures. Chemical synthesis of terpenes 
remains technically challenging, costly and inefficient. Hence, there are many on-going 
efforts to create robust and efficient biological production platforms for this important 
class of molecules. The methods described here generate new yeast strains possessing 
a dispensable mevalonate biosynthetic pathway wherein carbon flux can be diverted to 
build any chemical class of terpene product desired. First, a genetic screen was 
developed to select for mutant yeast capable of taking up exogenous sterol under 
aerobic conditions and eliminating the need for innate ergosterol biosynthesis. This was 
followed by the introduction of a knockout mutation in the endogenous yeast squalene 
synthase (ERG9) gene. Thus, yeast lines with a disabled downstream sterol biosynthetic 
pathway were created and these lines were viable if they were propagated in the 
presence of an exogenous sterol source. More importantly, these new yeast lines were 
evaluated for their ability to accumulate high levels of farnesol (FOH), the 
dephosphorylated form of farnesyl diphosphate (FPP), and a key intermediate in terpene 
biosynthesis. Theoretically, the flux of carbon to farnesyl diphosphate could be utilized 
for the biosynthesis of any class of terpene products. 
These new yeast lines were derived from the parental strain BY4741. The yeast was first 
subjected to EMS mutagenesis, followed by selection for growth in the presence of 
nystatin, squalestatin, and exogenous cholesterol. This screen selected for mutant yeast 
lines having a dispensable mevalonate pathway and uncharacterized sterol uptake 
enhancement (SUE) mutations supporting aerobic uptake of exogenous sterol. These 
mutants were next screened for high-level accumulation of farnesol as an indication of 
carbon flux to FPP, a key intermediate in terpene metabolism. To further improve the 
availability of FPP for other biosynthetic designs in these mutants, insertional mutation 
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into the ERG9 gene, which encodes for squalene synthase, were created. A series of 
these yeast strains were then screened for those that accumulated farnesol to levels 
over 100 mg/L under shake flask culturing conditions. The utility of these new yeast lines 
for novel terpene production was then qualified and quantified by introducing into the 
yeast a constitutive expressed Hyoscyamus muticus premnaspirodiene synthase (HPS) 
gene, which encodes for a well characterized sesquiterpene synthase. One of yeast 
lines, ZX178-08, accumulated premnaspirodiene up to 116 ± 23.6 mg/ L with FOH levels 
of 23.6 ± 14.5 mg/L. In comparison, the parental line BY4741 engineered with the H. 
muticus synthase gene accumulated 10-times less premnaspirodiene, 10.94 ± 3.12 
mg/L, with no FOH accumulation detected. Co-expression the HPS gene with a gene 
encoding for a putative rate-limiting enzyme in the early steps of the mevalonate 
biosynthetic pathway, an amino-terminal truncated form of the hamster 3-hydroxyl-3-
methyl-glutaryl Co-enzyme A reductase gene, improved premnaspirodiene accumulation 
approximately 50%, up to 170.23 ± 30.44 mg/L. 
2.2. Background 
2.2.1. Terpene physiologic and practical uses  
Terpene natural products play important physiological roles in plants, microbes and to 
some extent in insects, and also have many practical uses as fragrances, flavors, 
medicines for mankind with tremendous commercial value that have served to attract 
considerable interest since the 15th century (Buckingham, 2003). Terpenes are a very 
large class of structurally diverse compounds made in all kingdoms of life (Crowley et al., 
1998) and are perhaps the most extensively described class of natural products as 
evident by well over 100,000 different terpenes reported in the literature. Terpenes are 
also widely recognized for their diverse utility and applications. For example, many 
terpenes have been identified on the basis of their activity in herbal medicines, and 
many such terpenes and their derivatives have been developed into promising and 
potent pharmaceutical drugs in use today. Artemisinin is a sesquiterpene isolated from 
the plant Artemisia annua that has been developed as a key pharmacological agent for 
the control of malaria (Tu, 2011), with annual global demand around 130-150 tons 
(CHAI, 2009). Likewise, taxol is a diterpene widely recognized for its application as a 
chemotherapeutic agent, was first isolated from the bark and needles of several Taxus 
plant species (Wall & Wani, 1995), now widely used to treat patients with lung, ovarian, 
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breast and brain cancers, and reached annual sales in the US of $1.6 billion in 2000 
(Wikipedia).  
The structure complexity of terpenes gives them their broad utilities. Menthol is a 
monoterpene obtained from mint family plants and is a popular ingredient in many foods 
and consumer products (Bedoukian, 1983). Patchouli, another sesquiterpene, is a 
popular aromatic found in colognes, perfumes and many other household cleaning 
products (Wu et al., 2006). The world demand for patchouli is approximately 1200 to 
1500 tons/year with a projected increasing demand of 10% -15% per year (Vel & 
Nugrohowardhani, 2012). Triterpenes such as squalene, obtained from various plant 
sources and the livers of deep sea sharks, has utility as a nutraceutical product, is used 
extensively in many types of cosmetics, has special utility as a lubricant for high 
performance machinery, and is an adjuvant in some pharmaceutical formulations 
(Bhilwade et al., 2010, Huang et al., 2009, Reddy & Couvreur, 2009).  
2.2.2. Terpene production is limited from natural source 
Although there is often a high demand for specific terpenes, the actual amount of each 
terpene from natural sources is limited. Terpene are generally made natively by plants 
and microbes in small amounts and components of complex mixtures that vary with 
growth and environmental conditions, making it difficult to reproducibly obtain large 
amounts of any one terpene constituent (Wu et al., 2006). For instance, taxol was 
produced directly from the bark of Pacific yew from late 60’s to early 90’s, and the 
harvest process killed the trees. Approximately six 100-year old Pacific Yew trees were 
required to extract enough taxol compound for one cancer patient therapy (Chang & 
Keasling, 2006). Now paclitaxel, a taxol equivalent, is manufactured with plant cell 
culture fermentation (Tabata, 2004, Phyton-Biotech). Even though the whole 
biosynthetic pathway of paclitaxel is not clear, efforts to improve the biosynthesis of 
intermediates, precursors, and derivatives through metabolic engineering techniques to 
provide alternative sources to feed the worldwide market demand are the next 
challenges. 
Chemical synthesis of terpenes is often costly, and inefficient (Nicolaou et al., 1994). 
Chemical synthesis also suffers from generating enantiomeric mixtures, which adds 
another layer of complications and difficulties for down-stream processing if one 
particular stereochemical form of a terpene is desired. Given such difficulties, there are 
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many on-going efforts to create robust, reliable and efficient biological systems for the 
production of distinct classes of terpenes, and more so for the generation of 
stereochemically pure forms of terpenes (Keasling, 2009, Martin et al., 2003, Asadollahi 
et al., 2008, Asadollahi et al., 2010, Kirby et al., 2008, Seki et al., 2008, Fischer et al., 
2011, Takahashi et al., 2007). Metabolic engineering and synthetic biology techniques 
provide powerful tools for developing terpene production platforms. In plants there are 
two independent terpene metabolic biosynthesis pathways, which increase the 
opportunities for redirecting metabolic flux to desired high valued products. The MVA 
(mevalonate) and MEP (methylerythritol-phosphate) pathways both synthesize the basic 
five carbon building units IPP (isopentenyl diphosphate) and its isomer DMAPP 
(dimethylallyl diphosphate) necessary for the assembly of all classes of terpenes. The 
MVA pathway, however, operates in the cytoplasm, while the MEP pathway operates in 
plastids, which allows for a division of labor for the biosynthesis of specific classes of 
terpenes and unique opportunities for engineering strategies (Wu et al. 2006). This is in 
contrast to fungi or bacteria, which possess only one pathway, the MEP pathway in E. 
coli and the MVA pathway in yeast. Saccharomyces cerevisiae is a unicellullar 
eukaryotic organism widely used as a model system to study fundamental aspects of cell 
physiology, biochemistry and molecular genetics, and is commonly used in 
fermentations for biotechnology applications. The precursors of all classes of terpene 
biosynthesis (GPP, FPP, GGPP, and squalene) are natively synthesized in yeast via the 
resident MVA biosynthetic pathway, which originally suggested that yeast might offer a 
unique advantage as a production host for terpenes.  
2.2.3. Research progress of metabolic engineering sesquiterpene in S. cerevisiae 
Sesquiterpene are produced upon cyclization or ionization of farnesyl diphosphate 
(FPP), a 15 carbon intermediate in the MVA pathway. However wild type yeast does not 
biosynthesis any sesquiterpenes natively. Instead, all the FPP generated in vivo is 
channeled to the production of sterols (predominately ergosterol), dolichols, ubiqunione 
and prenylated proteins. Nonetheless, several studies have successfully engineered 
sesquiterpene production in S. cerevisiae based on the manipulation of native genes in 
sterol biosynthesis pathway, overexpression of a truncated, soluble form of 3-hydroxy-3-
methyl-glutaryl-coenzyme A reductase (tHMGR), selection for a global transcription 
factor, upc2-1, regulation sterol synthesis, overexpression of the yeast farnesyl 
diphosphate synthase gene, ERG20, and down-regulation the yeast resident squalene 
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synthase gene, ERG9 (Ro et al., 2006). HGMR is a rate-limiting enzyme in sterol 
biosynthesis, catalyzing the formation of mevalonic acid from HMG-CoA (Coenzyme et 
al. 1985). S. cerevisiae have two functional HMGR genes, HMGR1 and HMGR2. The N-
terminus of the encoded HMGR proteins anchors these proteins to the ER (endoplasmic 
reticulum) membrane, while the C-terminal contains the enzymatic active sites and is 
oriented for exposure to the cytoplasm (Liscum et al., 1985). These two enzymes are 
highly regulated by downstream intermediates which impose feedback control and 
degradation of the HMGR proteins. Over-expression of an N-terminal truncated version 
of HMGR, leaving the catalytically active C-terminal region, dramatically increased 
squalene accumulation (Dai et al., 2012, Polakowski et al., 1998). Likewise, a single 
point mutation in the transcription factor upc2-1 increased sterol uptake from the culture 
media 5-fold compared to wild type yeast under aerobic conditions (Crowley et al., 
1998), and upregulated several genes in the yeast sterol biosynthetic pathway (Ro et al., 
2006). Addition of tHMGR over-expression to these lines also improved amorphadiene 
production 5-fold. Down regulation of ERG9 by substituting a suppressible promoter for 
the native promoter also increased amorphadiene production an additional 2-fold, and 
when combined with overexpression of upc2-1 improved the amorphadiene production 
to 105 mg/L. Adding an extra tHMGR further improved production to 149 mg/L, with 
overexpression of ERG20 enhancing production to well above 150 mg/L (Ro et al., 
2006). Within these various yeast strains, changing the selection marker from Leu2 to 
Leu2d (a promoter deletion mutation leaving only 29-bp of the Leu2 promoter region in 
the Leu2 expression cassette) on the expression plasmid also harboring the 
sesquiterpene synthase, improved plasmid stability and maintained high copy number in 
S. cerevisiae, and subsequently boosted the amorphadiene production to 800 mg/L in 
non-selection media with shake flask cultures (Ro et al., 2008). Westfalla et al., (2012) 
reasoned that amorphadiene production in S. cerevisiae strain CEN.PK2 could be 
enhanced because this strain has better characterized physiology and significantly 
higher sporulation efficiency. Amorphadiene production reached 300 mg/L in CEN.PK2 
with similar modifications to strain BY4742, which accumulated 80 mg/L. When extra 
copies of the Erg10, 13, 12, 8, and IDI genes were integrated into the genome of 
CEN.PK2 with galactose inducible promoters to drive high level expression, along with 
over-expression cassette for the upc2-1 gene (a gene encoding for a transcription factor 
effecting expression of the innate mevalonate biosynthetic pathway and anoxia 
metabolism) and three copies of an HMGR gene encoding for a soluble form of the 
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enzyme, amorphadiene accumulation increased up to 1200 mg/L in shake flask cultures. 
A further deletion of the Gal80p gene, the gene encoding for a negative-regulator of 
galactose regulation of gene expression, from the strain eliminated the need to add 
expensive sugar galactose for induction of amorphadiene production. Finally the 
restricted ethanol-pulse feeding and glucose feeding through the fermentation process, 
resulted in over 40 g/L of amorphadiene accumulating (Westfall et al., 2012). As 
observed in plants, targeting terpene biosynthesis to non-native compartments within 
yeast has also proven to enhance terpene accumulation. When Farhi et al. (2011) 
targeted FPP synthase and either valencene synthase or amorphadiene synthase, two 
sesquiterpene synthases, to the mitochondria of yeast, sesquiterpene accumulation was 
improved 8- and 20-fold relative to when the enzymes were directed to the cytoplasm.  
Given the already impressive work done to engineer yeast as a terpene production 
platform, the current effort was directed towards the development of additional yeast 
strains that arise from a combination of unbiased, conventional genetic screens as well 
as directed engineering efforts. Our hope was that such an effort would afford yeast 
strains amendable to further optimization for all classes of terpenes, but initially 
demonstrated for sesquiterpene production as described here. 
2.3. Results 
2.3.1. Overall strategy to generate new yeast strains for terpene production  
Figure 2.1 outlines the approach used to generate yeast strains providing robust terpene 
biosynthesis from universal precursors that could be utilized for the production of many 
different classes of terpenes. The strategy takes advantage of the native mevalonate 
(MVA) pathway that operates normally in yeast for the biosynthesis of ergosterol, the 
dominant sterol found in yeast. Ergosterol is the main product of the yeast mevalonate 
pathway, is an important membrane component, and is essential for yeast growth. If the 
ergosterol biosynthetic pathway is blocked or inhibited, yeast cells die. In fact, this is the 
basis for many pharmacological drugs to control fungal infections in man (Maertens, 
2004) and agricultural chemicals to control fungal infection in plants (Casida, 2009). To 
further complicate matters, wild type yeast can only take up exogenously supplied sterol 
from their environment under anaerobic conditions.  
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In order to be able to efficiently channel terpene biosynthetic intermediates from the 
ergosterol biosynthetic pathway, a SUE (sterol uptake enhancement) mutation 
supporting the aerobic uptake and utilization of exogenous sterol was first created 
(Bourot & Karst, 1995, Shianna et al., 2001). A SUE mutation is thus a yeast line that 
can meet all its sterol needs by an exogenous source of sterol, and therefore making the 
endogenous ergosterol biosynthetic pathway dispensable. The SUE mutation was then 
complemented by the introduction of a knockout mutation in the ERG9 gene (squalene 
synthase) (Zhang et al., 1993), resulting in a yeast line where the MVA pathway was still 
operational up to the biosynthesis of FPP and hence, intermediates in the pathway 
(DMAPP, IPP and FPP) could be diverted to the biosynthesis of other non-essential 
terpene components. In order to follow and select for the desired mutant lines, the yeast 
lines could be monitored for farnesol (FOH) accumulation, the dephosphorylated form of 
farnesyl diphosphate. If the MVA pathway in the yeast line continued to operate as 
proposed, then one would expect carbon flux to FPP to continue. But, because the 
downstream utilization of FPP by squalene synthase was abolished, then the 
accumulating FPP would be subject to the endogenous phosphatase activity for its 
conversion to FOH, which could be used as an initial screen for monitoring development 
of the mutant yeast line. Further engineering of such a yeast line could then take 
advantage of the FPP, DMAPP and IPP pools for their diversion to the biosynthesis of 
monoterpenes (10 carbon compounds), sesquiterpenes (15 carbon compounds), 
diterpenes (20 carbon compounds) and triterpenes (30 carbon compounds).  
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Figure 2.1. Overall approach for generating a yeast line that would have a dispensable 
sterol biosynthetic pathway, which would provide opportunities for diverting 
intermediates (DMAPP, IPP and FPP) from the mevalonate (MVA) pathway for the 
biosynthesis of other terpene compounds. 
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2.3.2. Steps in the development of yeast with a dispensable mevalonate pathway 
To generate the new yeast line with high-level FPP pool accumulating suitable for 
terpene engineering, we subjected the parental wild type yeast line to three phases 
selection. Phase I selected for aerobic sterol uptake mutants induced by EMS 
mutagenesis, phase II screened those mutants for those accumulating high levels of 
FOH, and phase III selected for site-specific erg9 knock out mutants. Figure 2.2 
illustrates these 3 phases in the development of the desired yeast line. In phase I, 
chemical mutagenesis is used to introduce SUE mutations (Bourot & Karst, 1995, 
Shianna et al., 2001), which are identified by selecting for yeast cells that do not have a 
functioning ergosterol biosynthetic pathway and can only grow in the presence of 
exogenous cholesterol. The SUE mutation was created by subjecting wild type yeast 
strain BY4741 to EMS mutagenesis to introduce random mutations in the whole 
genome, followed by selection on plates containing three important selection agents: 
nystatin; cholesterol; and squalestatin. Nystatin binds to ergosterol in the cell membrane 
causing non-selective membrane permeability and leads to cell death (Silva et al., 2006). 
Nystatin thus selects against cells that have ergosterol in their membranes. However, 
yeast have an absolute requirement for sterols in order for their membranes to function 
properly. Hence, by having the mutagenized yeast plated in the presence of cholesterol, 
which nystatin cannot bind to, only yeast that can take up the exogenous cholesterol 
under aerobic conditions and properly incorporate the cholesterol into their membranes 
survive. Squalestatin is a potent inhibitor of squalene synthase and eliminates the 
yeast’s ability to synthesize ergosterol (Bergstrom et al., 1995), thus assuring that the 
surviving yeast have a dispensable mevalonate pathway.  
In phase II, yeast lines demonstrating an absolute requirement for exogenous sterols for 
growth were chemical profiled by GC-MS (Figure 2.3). Aliquots of those yeast lines 
exhibiting normal growth characteristics, and having growth rates comparable to wild 
type yeast, were extracted and their chemical constituents separated by gas 
chromatography and identified by their mass fragmentation patterns. The parental line 
BY4741 does not accumulate detectable amounts of FOH under these conditions. Eight 
mutant lines accumulating 50 or more mg/L of FOH (as shown in Figure 2.3) were 
selected for phase III knockout mutagenesis of the squalene synthase gene, ERG9. 
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The objective in phase III was to obtain a knockout mutation of the ERG9 (squalene 
synthase) gene, thus assuring the dispensable nature of the endogenous mevalonate 
pathway for ergosterol biosynthesis, thus eliminating the need for the addition of 
squalestatin to the culture medium. Site specific recombination was afford by appending 
5’ and 3’ regions surrounding the native ERG9 gene onto a hygromycin selection marker 
gene (see supplementary materials and methods information), then introducing this 
linear gene construct into selected yeast lines from the phase II screening under 
conditions to promote site-specific, double recombination with the native ERR9 gene. 
The knockout mutants were then selected by plating the cells in the presence of 
ergosterol and hygromycin. Recombination as depicted in Figure 2.2 should result in the 
coding region of the ERG9 gene being displaced or substituted by the hygromycin 
resistance marker gene. Replica of the obtained single colonies on plates plus and 
minus ergosterol revealed positive erg9 knock out colonies can only grow on plates with 
sterol supplementation, but cannot grow on plates without sterol supplementation. 
Further confirmation of such a substituted erg9 knockout event was obtained by 
screening the genomic DNA of the selected sterol-dependent yeast colonies for the 
hygromycin marker gene in proximity to genomic DNA sequences normally found 3’ to 
the ERG9 coding region. Using genomic DNA isolated from hygromycin resistant 
colonies as template with a hygromycin specific primer (HphF) and a primer specific to a 
genomic DNA sequence found 3’ to the ERG9 gene (ERG9 450DwR), a PCR 
amplification product of approximately 1,538 bp would be expected and is evident in the 
colonies so tested in Figure 2.4 A. 
Independent colonies from each of the erg9 knockout lines were then re-evaluated for 
their growth in liquid media and the dispensable nature of their mevalonate pathway by 
checking for their accumulation of FOH (Figure 2.5). These new yeast lines with erg9 
knockout and dispensable sterol pathway accumulate significant amount FOH, the 
dephosphorylated form of farnesyl diphosphate, in comparison with parental yeast line 
BY4741, which have no detectable level of farnesol (Figure 2.4 B). Nine yeast lines 
accumulating more than 60 mg/L farnesol in test tube scale culture were selected for 
qualification of terpene production capacity. 
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Figure 2.2. Generation of new yeast strains for terpene production.  
BY4741 haploid wild type yeast was mutagenized with EMS 
Plated onto YPD media containing:  
Nystatin - selects for ergosterol biosynthesis mutants 
Squalestatin – inhibits squalene synthase, mimic of erg9 mutation 
Cholesterol – restores growth, supplants ergosterol 
Picked 200 colonies 
Replica plated all 200 colonies onto YPD+squalestatin and YPD+squalestatin+ergosterol plates 
Screened for colonies that only grew in the presence of ergosterol 
134 colonies grew on both plates, only 66 demonstrated ergosterol dependent growth 
Grew the 66 positive colonies in liquid YPD+squalestatin+ergosterol media and  
screened for farnesol accumulation 
20 colonies did not accumulate FOH 
46 colonies accumulated 1-60 mg FOH/L 
9 colonies accumulated more than 50 mg FOH/L 
Introduce ERG9 Knockout mutations in the 8 of the 9 selected lines,  
First, verify for no growth without ergosterol addition to the media, 
 follow-up with PCR confirmation of erg9 KO, 
 then screened for FOH accumulation by 8 independent colonies from each line. 
Eleven of 64 independent lines accumulated more than 70 mg/L FOH in small scale test tube culture. 
 
A 
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A) Three phases in selection of yeast lines dependent upon exogenous sterols for 
aerobic growth and having a dispensable mevalonate biosynthetic pathway. B) Steps in 
the development of yeast having a dispensable mevalonate biosynthetic pathway and 
the number of colonies screened at each stage. 
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Figure 2.3. Quantitation of FOH levels in yeast lines demonstrated to have an 
exogenous sterol requirement for growth. 
Yeast lines were grown as test tube shake cultures with 3 ml of YPD media containing 
40 µg/ml of ergosterol and 40 µg/ml of squalestatin for 6 days prior to sampling the 
cultures. One ml aliquots of cultures were mixed vigorously with 1 ml of acetone, then 
allowed to stand for 15 min. One ml of hexane containing a cedrene external standard 
was then added, vortexed, centrifuged in a clinical centrifuge for 5 min, and the upper 
hexane phase removed and concentrated to 100 µl under a nitrogen stream. One µl 
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aliquots of the hexane extracts were then subjected to GC-MS and FOH levels 
quantified relative to the external standard. 
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Figure 2.4. PCR and metabolites confirmation of erg9 knockout mutation. 
A) PCR confirmation for the erg9 knockout mutation. DNA isolated from 4 independent 
colonies selected for substitution of the hygromycin resistance gene for the ERG9 gene 
was used as PCR template with a hygromycin specific primer and a primer specific for 
the genomic DNA surrounding the ERG9 locus. If the HPH gene did insert and replace 
the ERG9 gene, the expected amplification product would be 1,538 bp. B) Metabolite 
confirmation of erg9 knock out mutation. FOH accumulation in a yeast line (178-08) 
selected for a dispensable mevalonate biosynthetic pathway plus erg9 knock out in 
comparison to that accumulating in the parental line (BY4741) used to generate the new 
mutant yeast lines. GC-MS chromatograph of hexane extracts prepared from the wild 
type and engineered yeast lines. No farnesol accumulated in parental yeast BY4741. 
Over 100 mg of FOH/L accumulated in the newly developed yeast line ZX178-08, as 
quantified on the basis of a cedrene external standard. 
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Figure 2.5. Quantitation of FOH levels in sue, erg9 mutant lines of yeast demonstrated 
to have an exogenous sterol requirement for growth and resistance to hygromycin. 
Cultures were grown in 3 ml test tube cultures of SCE media supplemented with 
histidine, leucine, uracil, tryptophan and methionine for 6 days before extracting and 
quantifying their FOH levels by GC-MS as described in Figure 2.3. 
0 10 20 30 40 50 60 70 80 90 100 
zx19-01 
zx19-02 
zx19-03 
zx19-04 
zx19-05 
zx19-06 
zx19-07 
zx19-08 
zx22-01 
zx22-02 
zx22-03 
zx22-04 
zx22-05 
zx22-06 
zx22-07 
zx22-08 
zx23-01 
zx23-02 
zx23-03 
zx23-04 
zx23-05 
zx23-06 
zx23-07 
zx23-08 
zx24-01 
zx24-02 
zx24-03 
zx24-04 
zx24-05 
zx24-06 
zx24-07 
zx24-08 
zx27-01 
zx27-02 
zx27-03 
zx27-04 
zx27-05 
zx27-06 
zx27-07 
zx27-08 
zx31-01 
zx31-02 
zx31-03 
zx31-04 
zx31-05 
zx31-06 
zx31-07 
zx31-08 
zx97-01 
zx97-02 
zx97-03 
zx97-04 
zx97-05 
zx97-06 
zx97-07 
zx97-08 
zx178-01 
zx178-02 
zx178-03 
zx178-04 
zx178-05 
zx178-06 
zx178-07 
zx178-08 
Z
X
1
9
 
Z
X
2
2
 
Z
X
2
3
 
Z
X
2
4
 
Z
X
2
7
 
Z
X
3
1
 
Z
X
9
7
 
Z
X
1
7
8
 
FOH product  (mg/L) 
Y
e
a
s
t 
L
in
e
 
 
 
39 
 
2.3.3. Qualification of a new mutant yeast strain for its utility to produce a desired 
terpene compound  
Nine of the yeast lines harboring a SUE mutation and having the native ERG9 gene 
deleted were evaluated indirectly for the available of terpene biosynthetic intermediates, 
and specifically FPP, to support sesquiterpene biosynthesis in comparison to the 
parental strain BY4741 (Figure 2.6). Hyoscyamus premnaspirodiene synthase (HPS), a 
catalytically active sesquiterpene synthase first isolated from Hyoscyamus muticus, was 
chosen for this evaluation because HPS has been characterized for its expression in 
bacteria (Mathis et al., 1997) and in yeast (Takahashi et al., 2007). An appropriate HPS 
gene expression vector was engineered into the indicated yeast lines and the 
subsequent transformants screened for premnaspirodiene accumulation when the yeast 
were grown as 30 mL shake flask cultures with SCE media containing leucine, 
tryptophan, uracil, and methionine for 12 days at 23°C. Yeast line ZX178-08 
accumulated the highest level of premnaspirodiene, up to 116 ± 23.64 mg/L, with FOH 
levels of 23.6 ± 14.5 mg/L. In comparison, the parental line BY4741 accumulated 10 
times less premnaspirodiene, 10.94 ± 3.12 mg/L, with no farnesol accumulation 
detected. The control line ZX178-08 without HPS gene expression produced farnesol 
101.36 ± 16.84 mg/L, which was less than the premnaspirodiene plus FOH (~140 mg/L) 
produced in ZX178-08 strain expressing the HPS gene. This indicated that the 
production of terpene in this new yeast line is related with the specific catalytic terpene 
synthase activity and, because the FPP is known to act as a feedback signal that 
controls ubiquitination and therefore degradation of HMGR2 (Gardner & Hampton, 1999, 
Hampton & Bhakta, 1997). HMGR is a putative rate-limiting step control carbon flux in 
the mevalonate pathway (Coenzyme et al. 1985), the FPP level could also be self 
regulating. When part of the FPP pool is diverted to a sesquiterpene production, more 
FPP is produced, which might explain how Zx178-08 with HPS produces more total FPP 
than ZX178-08 alone.   
HMGR catalyzes a key regulatory step controlling sterol biosynthesis metabolism, the 
reaction of conversion of 3-hydroxy-3-methylglutaryl coenzyme A to mevalonate. In 
addition to being subject to regulation at the protein turnover level as noted above, the 5' 
end of HMG CoA Reductase gene also contains sequences responsible for sterol-
mediated inhibition of transcription (Osborne et al., 1985). Hence, to engineer elevated 
HMGR enzyme activity into yeast and further enhance terpene production, a truncated 
and full-length version of the hamster HMGCoA reductase were co-expressed with HPS 
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gene in the new developed yeast line ZX178-08. The truncated hamster HMGR 
(tHMGR) was produced by removing the regulatory and N-terminal, membrane-spanning 
domains, which was previously shown when constitutively expressed in tobacco led to a 
3- to 6-fold increase in the total HMGR enzyme activity and a 3- to 10-fold increase in 
the total sterol accumulation (Chappell et al., 1995). Co-expression HPS gene plus full 
length HMGR gene, resulted in improved sesquiterpene production to 132±11.5mg/L 
with 31.21±7.2 mg/L FOH. When the HPS gene and tHMGR gene were co-expressed, 
premnaspirodiene production further improved to 170.23±30.44 mg/L with 21.88±3.82 
mg/L farnesol. Figure 2.6 B and C compare cell culture growth and premnaspirodiene 
production by yeast strains developed for enhanced levels of FPP plus truncated HMGR 
(Figure 2.6 B) or full length HMGR (Figure 2.6 C) over-expression over 12 days time 
course. 
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Figure 2.6. Comparison of terpene accumulation levels in yeast lines (ZX series) 
developed as terpene production platforms. 
Each of the ZX cell lines as well as the wild type parental line (BY4741) were 
independently transformed with an expression vector harboring the Hyoscyamus 
premnaspirodiene synthase gene or co-expression along with truncated hamster HMGR 
or full length (intact) HMGR. The yeast lines were then grown for 12 days prior to 
chemically profiling for their cell constituents by GC-MS and quantifying the levels of 
premnaspirodiene and farnesol found in each culture. (A). Comparison of cell culture 
growth and premnaspirodiene production by yeast strains developed for enhanced levels 
of FPP plus truncated  HMGR (B) or full length HMGR (C) over-expression over 12 days  
time course.   
HPS+HMGR full in ZX17808
Day
0 2 4 6 8 10 12 14
T
e
rp
e
n
e
 p
ro
d
u
c
t 
(m
g
/L
)
0
20
40
60
80
100
120
140
160
180
200
O
D
6
0
0
0
5
10
15
20
FOH
Prem
OD
C 
 
 
 
43 
 
2.4. Discussion 
Terpenes are a highly diverse class of natural products with important biological 
activities and commercially value. Nonetheless, the development of single entity terpene 
products has been hampered by the high cost and low efficiency of extraction from its 
natural sources, and the complexities associated with thier chemical synthesis. Many 
labs have focused on taking advantage of the native sterol biosynthesis pathway in 
yeast for the development of a terpene production platform (Asadollahi et al., 2008, 
Martin et al., 2001, Ro et al., 2008, Ro et al., 2006, Takahashi et al., 2007, Westfall et 
al., 2012). Yeast, as a fermentable organism, lends itself to the notion of building a cell 
factory for production of stereochemically distinct terpenes without limitations of 
availability.  
In this present study, we first developed new yeast strains with a dispensible sterol 
biosynthetic pathway. In phase I, chemical mutagenesis was used to isolate SUE 
mutations to obtain yeast that could take up exogenously supplied sterol from the 
medium under aerobic condition. In phase II, high FOH accumulating lines were 
identified via a GS-MS screen when the individual lines were grown in the presence of 
squalestatin, an inhibitor of squalene synthase. Because FOH is derived from the 
dephosphorylationof FPP, these high FOH accumulating lines were inferred to have high 
levels of FPP accumulation. Since nearly all of the FPP is normally used for the 
biosynthesis of sterols, blocking the flux of FPP to sterols would conceptually increase 
the accessible FPP, as well as earlier precursors, for other enzymes redirecting carbon 
flux to the building of other desired end products. Subsequently in phase III, an erg9 
(yeast squalene synthase) knock out mutation was introduced, replacing the need for 
using exogenous squalestatin to inhibit squalene synthase. 
If our engineering design was correct, then we would expect enhanced levels of FPP to 
be available for sesquiterpene biosynthesis. We chose to test this possibility by over-
expressing the gene encoding for premnaspirodiene synthase, HPS, a robust 
sesquiterpene synthase. Premnaspriodiene accumulation in the selected yeast line 
ZX178-08 was approximately 10-fold greater than when the HPS gene was expressed in 
the original yeast strain BY4741. We also evaluated if it were possible to push more 
carbon down the mevalonate pathway to FPP by over-expressing the putative rate-
limiting enzyme HMGR (Coenzyme et al. 1985). When a truncated form of the hamster 
HMGR enzyme was expressed from a high copy plasmid under the control of the strong 
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constitutive GPD promoter, a further increase in premnaspirodiene accumulation of 50% 
in shake flask cultures was observed. The increased premnaspirodiene production levels 
are two-fold higher than our previous efforts with yeast lines having a different genetic 
background (Takahashi et al., 2007). The current results suggest that we might be able 
to make further improvements in these yeast lines in terms of terpene production by 
integrating the truncated HMGR gene in multiple copies across the yeast genome, 
perhaps targeted to rDNA loci or Ty repetitive elements (Romanos et al., 2004). Such a 
line would have the advantage of not having to be grown under selection pressure for an 
autonomous plasmid, which could represent a significant cost savings as well as result 
in better growth characteristics of the yeast cultures.  
Engineering yeast for sesquiterpene production has also been an objective of the 
Keasling research group at the University of California, Berkeley, targeting a means for 
the biosynthesis and accumulation of artemisinin, a therapeutic reagent for the treatment 
of malaria. The basic strategy of this group is summarized in Figure 2.7 A and consists 
of the following modifications: 1) to limit carbon flux to downstream biosynthetic 
processes, the native squalene synthase gene promoter was replaced with a methionine 
suppressible promoter, pMet3; 2) To increase the upstream carbon flux to FPP 
biosynthesis, high level over-expression of the ERG10, 13, 12, 8, 20, tHMGR, and IDI 
genes were achieved by either using conventional over-expression gene cassettes or by 
up-regulating the UPC-2 transcription factor (green highlighted genes are up-regulated 
by upc2-1); 3) To further increase the pool of isoprenoid intermediates that could be 
channeled to sesquiterpene production, a defective leu-2d selection marker was used to 
increase the copy number of the corresponding plasmid with hopes this would translate 
into additional copies of the associated terpene biosynthetic genes being expressed;  
and 4) Optimization of medium components leading to enhanced growth and 
fermentation production of sesquiterpenes (Ro et al., 2008, Ro et al., 2006, Westfall et 
al., 2012).   
The greatest difference between the yeast lines developed here in comparison to the 
amorphadiene production lines developed by the Keasling group is the generation of the 
dispensable sterol biosynthetic pathway and the complete shut down of carbon flux to 
the downstream sterol biosynthetic pathway by knocking out the ERG9 gene as shown 
in Figure. 2.7 B. In the yeast engineered for amorphadiene accumulation, the native 
ERG9 promoter was replaced with the MET3 promoter, which allowed for the 
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suppression of squalene synthase gene expression by exogenous application of 
methionine at the late stages of culture growth. Moreover, the methionine suppression 
mechanism is dependent on the methionine concentration and the metabolic state of the 
cell culture. Yeast consume methionine, so expression of the ERG9 gene can occur if 
the methionine levels drop below a key threshold level. Accurate monitoring of the 
methionine concentration and the ability to readily add methionine are essential for this 
control mechanism of squalene synthase. In contrast, the ZX yeast strains described 
here contain a complete knockout of the ERG9 gene, hence a relatively large and 
accessible pool of FPP and earlier MEP intermediates are available for diversion to the 
biosynthesis of desired sesquiterpenes or other terpene classes. The new yeast line 
ZX178-08 line, which co-expresses a tHMGR in combination with the sesquiterpene 
synthase gene, HPS, accumulated 170.23±30.44mg of premnaspirodiene/L, in 
comparison to EPY225 from Keasling lab, which has the equivalent modification but 
methonine supreesion strategy to inhibit squalene synthase instead of complete knock 
out, produced only 44 mg amorphadiene/L. Although the specific catalytic activities of 
sesquiterpene synthase will effct the sesquiterpene production, our newly develpded 
yeast lines also show much higher FPP baseline levels than EPY225, which suggests 
that with additional efforts as described in Fig2.7A our newly developed yeast terpene 
production platform has the potential to produce more terpene compounds and further 
improve the state of art of metabolic engineering of terpene production in yeast. 
All the genes engineered into the ZX yeast lines are driven by a strong constitute 
promoter, the pGPD promoter, which natively controls expression of the glyceraldehyde-
3-phosphate dehydrogenase gene (Janke et al., 2004). This contrasts with the galactose 
inducible promoter used in constructing the yeast lines illustrated in Figure 2.7 A, which 
requires the addition of a relatively expensive inducer (galactose) at the right stage of 
culture development in order to affect the appropriate timing of expression of the 
downstream genes. Efficiency of the pGal promoters is also strongly suppressed by the 
glucose in the culture medium. Hence, one must wait for all the glucose to be utilized by 
the culture before inducing the cultures with galactose. This becomes even more 
demanding because the depletion of glucose results in metabolic shifts in the cultures, 
the so-call Pasteur effect, wherein the cells go into a state of anaerobic catabolism, a 
state that is not necessarily conducive to anabolic biosynthetic reactions. The ZX178-08 
line would not suffer such a shift because they can be grown in fed-batch conditions to 
 
 
46 
 
maintain a constant glucose supply that supports the highest rates of cell proliferation 
and aerobic metabolism.  
In summary, new yeast strains have been developed using novel selection mechanisms 
for genetic and molecular genetic mutants engineered for a dispensable pathway that 
can be partitioned to the biosynthesis of terpenes of choice. 
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Figure 2.7. The mevalonate (MVA) pathway in yeast and the efforts made for utilizing 
this pathway for sesquiterpene production by the Keasling group (A) and those 
developed in the current work (B).  
Genes directly over expressed by extra copies intergrated into yeast chromosome or on 
plasmid are in purple letters; genes up-regulated by over expression of the transcript 
factor upc2-1 are highlighted by green boxes; terpene production in blue bars and 
orange bars represent culture growth in selection media or rich non-selection media, 
respectively. All terpene production titers presented here were in shake flask scale 
culture. The greatest advantage of the work reported here in terms of sesquiterpene 
production is the complete knockout of squalene synthase, which necessarily stops 
carbon flux to sterol biosynthesis, yet avails the accumulation of FPP to sesquiterpene 
biosynthesis (B). 
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2.5. Materials and Methods 
2.5.1. Chemical and media preparations 
All chemical reagents were purchased from Sigma-Aldrich (St. Louis, MO), BD 
Bioscience (Franklin Lakes, NJ), or Fisher Scientific (Chicago, IL), while reagents for 
molecular manipulations were purchased from Stratagene (San Diego, CA), Takara 
(Shiga, Japan), Invitrogen (San Diego, CA), and New England Biolab (Ipswich, MA). 
Bacteria and yeast were grown using standard culture practices. YPD media for growing 
yeast without selection consisted of 1% Bactoyeast extract, 2% Bacto-peptone, and 2% 
glucose. YPDE media was YPD media supplemented with ergosterol (40 mg/L) for 
ergosterol dependent lines. YPDNCS media for the SUE mutation screening was YPD 
media supplement with 40 mg/L Nystatin, 40 mg/L cholesterol and 40 mg/L squalestatin. 
YPDSE media was YPD media supplement with 40 mg/L squalestatin and 40 mg/L 
ergosterol. Minimal media, SCE (pH 5.3), contained 0.67% Bacto-yeast nitrogen base 
(without amino acids), 2% dextrose, 0.6% succinic acid, 0.14% Sigma yeast dropout 
solution (-his,-leu,-ura,-trp), uracil (300 mg/L), L-tryptophan (150 mg/L), L-histidine (250 
mg/L), L-methionine (200 mg/L), L-leucine (1g/L) and 40 mg/L ergosterol. Cholesterol 
and ergostrol stocks were 10 mg/mL in 50% Triton X-100, 50% ethanol and kept at -
20˚C.  Selection media was prepared similarly except without supplementing the media 
with the indicated reagent based on the yeast auxotrophic makers. All solid media plates 
were prepared with 2% Bacto-Agar.  
2.5.2. Ethyl methane sulfonate (EMS) mutagenesis 
Strain BY4741 (MATa;his31;leu20;met150;ura30) (Janke et al., 2004) was used as  
the parental yeast line. BY4741 cells were incubated overnight at 30C in 5 ml YPD 
medium with shaking at 200 rpm, and used to establish a 200 ml YPD shake flask 
culture. When the yeast culture OD600 reached approximately 1.0, the cells were spun 
down by centrifugation (10 min at 4,000 xg), and washed twice with 20 ml 0.1M sodium 
phosphate buffer, pH7.0. Cells were concentrated by centrifugation again, re-suspended 
in 1 ml 0.1M sodium phosphate buffer, transferred to a 14 ml FALCON culture tubes, 
treated with 300 l EMS (1.2g/ml, Sigma), followed by incubation at 30C for 1 hour with 
shaking. To stop the mutagenesis, 8 ml of sterile 5% sodium thiosulfate (Fisher) were 
added to yeast cells to inactive the EMS. Cells were pelleted, washed with 8 ml sterile 
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water, concentrated by centrifugation, re-suspended in 1 ml sterile water and 100 l 
aliquots plated onto YPD-NCS agar plate (YPD plus 50mg/L cholesterol, 50mg/L 
nystatin, 50 mg/L squalesatin, 2% Bacto-agar). In some experiments, the washed cells 
were resuspended in 1 ml YPDE liquid media for recovery overnight before plating on 
YPD-NCS agar medium. The cultures were incubated for up to 2 weeks at 30oC until 
distinct colonies became visible.  
2.5.3. Yeast transformation and culture performance  
Yeast strains were transformed with the respective vector constructs using the 
FROZEN-EZ Yeast Transformation II Kit (Zymo Research, Orange, CA) according to the 
manufacturer’s recommendations. About 1 µg of plasmid or about 5 µg of linearized 
DNA was used per transformation and followed by selection on agar plates of SCE 
medium lacking specified amino acids for the auxotrophic markers or YPDE containing 
300 mg/L hygromycin B for screening for erg9 knockout at 30°C. Variable numbers of 
independent colonies were subsequently picked and used to start 3 ml cultures in 
minimal media to characterize their terpene production capacities. Aliquots of these 
cultures were analyzed for terpene production after 6 days of incubation at 30°C with 
shaking by GC-MS. Cultures exhibiting the highest terpene production levels were 
chosen for further studies and archived as glycerol stocks at -80˚C. Selected lines were 
characterized for cell growth and terpene production using 30 mL shake flask cultures. 
Starter cultures grown to saturation in minimal media were inoculated into 30 ml SCE 
media and 1 mL aliquots withdrawn at every other day intervals for 10-15 days. Cell 
growth was monitored as the change in optical density at 600 nm every two days, using 
appropriate dilutions for cultures at later stages of growth. Terpene production was 
determined by GC-MS similar to the initial screening method.  
2.5.4. GC-MS detection and quantification of terpenes 
To determine terpene accumulation levels, aliquots of cultures grown for 6 to 12 days 
were extracted with hexane and aliquots evaluated by GC-MS. In general, to 1 volume of 
culture, 1 volume of acetone was added and mixed vigorously for 3 to 5 min to lyse the 
cells. The sample was then allowed to incubate at room temperature for 10 min before 
adding 1 volume of hexane containing a known amount of cedrene external standard. 
The mixture was again mixed vigorously, then centrifuged in a clinical centrifuge for 5 
min at maximum speed. The upper organic layer was collected and when necessary, 
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concentrated under a N2 stream to 1/10 the original volume. An aliquot of the organic 
phase (1 μl) was then analyzed by GC-MS with a Varian CP-3800 GC coupled to a 
Varian Saturn 2200 MS/MS (Varian Medical Systems) using a Supelco SLB-5ms fused 
silica capillary column (30 m x 0.25 mm x 0.25 μm film thickness, Supelco).  The initial 
oven temperature was set at 70 °C for 1 min, ramped to 200 °C at 8 °C/min, and then 
ramped to 300 °C at 20°C/min and held for 5 min more. Farnesol and premnaspirodiene 
levels were calculated relative to the cedrene external standard.  
2.5.5. Construction of the squalene synthase (ERG9) Knockout mutation 
The primers ERG9PS1 and ERG-250downS2 were used to amplify the hygromycin 
resistance gene, hphNT1, from the PFA6-hph-NT1 vector (Janke et al., 2004), and at the 
same time add DNA sequences homologous to regions surrounding the ERG9 gene in 
the yeast genome. These primers are flanked by 42 nucleotide sequences (underlined) 
homologous to DNA sequences found 250 base pairs 5’ (upstream) and 3’ 
(downstream), respectively, of the ERG9 gene found in the yeast genome. The purified 
PCR fragment was transformed into various yeast lines identified for their ability to 
accumulate farnesol (Figure 2.3) and grown in 2 ml of YPDE media for an additional 6 
hours before being plated on YPDE hygromycin (300mg/L) agar plates at 28˚C. 
Independent single colonies were picked for ergosterol dependent test, PCR 
confirmation of recombination with hphF and ERG9 450DWR primer, as well as farnesol 
production analysis. The recombination sequence was further confirmed by DNA 
sequencing of the corresponding PCR amplification product. 
2.5.6. Expression of the HPS and HMGR genes in yeast  
The yeast GPD promoter (Pgpd) was amplified from the PYM-N14 plasmid described by  
using the primers GPD-BamHIF and GPD-NotIR primers and inserted into the pESC-His 
vector digested with BamHI and NotI to replace the original GAL1/10 promoters. The 
resulting plasmid was named pESC-His-gpd. The HPS gene was cloned into NotI and 
SpeI sites of pESC-His-gpd to obtain the yeast expression vector pESC-His-gpd-HPS as 
previously by Takahashi et al. (2007). pESC-Leu-gpd vector was built as the same way 
as pESC-HIS-gpd vector. HMGR full and tHMGR were cloned into NotI and SpeI sites of 
pESC-LEU-gpd to obtain the yeast expression vector pESC-LEU-GPD-tHMGR and 
pESC-GPD-HMGRfull constructs. Yeast lines transformed with this construct were then 
evaluated for their production of the sesquiterpene premnaspirodiene as a measure of 
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the available of intermediates of the mevalonate biosynthetic pathway for the 
biosynthesis of new terpenes.   
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Figure 2.8. Constructs used for evaluate yeast sesquiterpene productions. 
Yeast expression vector designed for the strong, constitutive expression of the 
sesquiterpene synthase HPS, tHMGR, HMGR genes directed by the gpd promoter 
(Pgpd) and termination provided the ADH terminator sequence (T-ADH) with auxotrophic 
rmarker His or LEU. 
 
 
 
 
54 
 
Table 2.1. Primers used for the various molecular manipulations describe in materials 
and methods. 
 
 
 
 
 
 
Copyright © Xun Zhuang 2013  
Primer name Primer sequence 
ERG9pS1 
GTACATTTCATAGCCCATCTTCAACAACAATACCGACTTACCC
GTACGCTGCAGGTCGAC 
ERG9 
250dwS2 
CAGATTGACGGAGAGAGGGCCACATTGTTTGTCGGCAATAAA
TCGATGAATTCGAGCTCG 
Hph F ATGGGTAAAAAGCCTGAACTCA 
Hph R TTATTCCTTTGCCCTCGGACGAG 
ERG9 
450dwR AGATGCTAGTCAATGGCAGAAG 
ERG9p300u
pF TGCTTACACAGAGTGAACCTGC 
ERG9 300R CTCGTGGAAGTGACGCAAC 
HPS NotI F GGGGCGGCCGCAAAAACA ATGGCCCCAGCTATAGTGATGAG 
HPS SpeIR GACTAGT TCAAATATCAATAGAATCCACC 
pGPD-
BamHI F CGGGATCCAGTTTATCATTATCAATACTCGCC 
pGPD-NotIR GGGGCGGCCGCGAGCTCAGTTTATCATTATC 
tHMGR-
NotIF GGGGCGGCCGCAAAACAATGTTGTCACGACTTTTCCGTATGC 
tHMGR-
SpeIR GACTAGT TCAAGCTGACTTCTTGGTGCACGTTCCTTG 
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Chapter 3: Engineer diterpene production in yeast  
 
3.1. Summary 
To more fully demonstrate the utility of yeast line ZX178-08 as a general production 
platform for diverse terpenes, the ability of this line to generate diterpenes was next 
investigated. Diterpenes are used for a variety of industrial manufacturing needs, serve 
as hormones or growth regulators in plants, possess anti-oxidant activities, which lead to 
their use in human nutraceuticals, and have found significant applications in 
pharmaceutical drug development. The intent of engineering ZX 178-08 for diterpene 
biosynthesis was to document the easy of engineering this yeast for the efficient 
diversion of the isoprenoid pathway intermediates to the biosynthesis of another class of 
terpene compounds and to identify the molecular conditions for high-yield production of 
diterpene hydrocarbons and hydroxylated derivatives generating additional high-valued 
chemical entities. When expression of the diterpene synthase gene encoding for 
abietadiene synthase (ABS) was coupled with the co-expression of a mutant avian 
farnesyl diphosphate synthase (mFPS) that exhibits a preferred biosynthesis for 
geranylgeranyl diphosphate (GGPP) rather than FPP, a dramatic accumulation of 
abietadiene at the expense of farnesol accumulation was noted in comparison to just 
expression of the ABS gene by itself. A variety of gene expression promoter 
combinations were also examined. The strategy for this effort varied the gene promoter 
element driving expression of the mutant FPS gene on one plasmid construct in 
combination with the various promoters also directing expression of a fungal kaurene 
synthase (FKS, another diterpene synthase) gene. The best promoter combination set 
for diterpene hydrocarbon production was determined to be use of the glyceraldehyde-3-
phosphate dehydrogenase (GPD) promoter for both heterologous genes.  
Optimization of medium and growth conditions also was shown to dramatically influence 
overall diterpene accumulation. Using a 5.5 L fed bath fermentation system, about 569 
mg/L kaurene and approximately 207 mg/L abietadiene plus 136 mg/L additional 
diterpene isomers were achieved. To engineer more highly modified diterpenes and 
especially those molecules that might have greater industrial, agricultural or medicinal 
applications, co-expression of four genes, mutant FPS (FPP synthase), FKS (kaurene 
synthase), FKO (fungal kaurene oxidase) and CPR (Cytochrome p450 reducatse), all 
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driven by GPD promoters in various combinations with 3 plasmid vectors, kaurenoic acid 
production reached 514 mg/L and byproduct kaurene and kaurenal at 71.7mg/L and 
20.1mg/L, respectively, in fed batch fermentation conditions. 
3.2. Background 
3.2.1. Diterpene applications and uses 
Diterpenes are a class of compounds within the much larger terpene family of molecules 
(Fig. 3.1). Terpenes, in general, are built upon a 5 carbon-repeating unit giving rise to 
classes of compounds having 10 (monoterpenes), 15 (sesquiterpenes), 20 (diterpenes), 
and more carbons. Diterpenes are known to have diverse biological and practical 
applications. In plants, specific diterpenes serve as hormones or growth regulators (i.e. 
gibberellic acid derivatives) (Yamaguchi, 2008) while others serve as accessory photo-
pigments funneling energy from light capture to the light reactions of photosynthesis 
(Havaux et al., 2004). Other diterpenes provide protection against oxidative radicals 
(Grassmann, 2005). The anti-oxidant activity of diterpenes has also led to their use in 
human nutraceuticals and medical applications (Cardenas et al., 2011). Perhaps the 
most widely recognized diterpene is taxol, used very successfully and extensively for the 
treatment of a variety of cancers (Wall & Wani, 1995). Specific diterpenes have also 
found use in the control of dental caries providing antimicrobial activities (Porto et al., 
2009). Other diterpenes have found utility in chemical manufacturing (Bremser et al., 
2006). 
3.2.2. Diterpene engineering in microbial host cells  
Diterpenes are traditionally obtained from plant sources. However, they are often found 
in only small amounts and as components of complex mixtures that vary with growth and 
environmental conditions, making it difficult to obtain large amounts of any one diterpene 
constituent (Wu et al., 2006). Chemical synthesis of diterpenes is often costly and 
inefficient (Nicolaou et al., 1994). Chemical synthesis also suffers from generating 
enantiomeric mixtures, which adds other complications if one particular stereochemical 
form of a terpene are desired. Given such difficulties, there are many on-going efforts to 
create robust, reliable and efficient biological systems for the production of distinct 
diterpenes, and more so for the generation of stereochemically pure forms of diterpenes 
(Anterola et al., 2009, Engels et al., 2008, Kovacs et al., 2007, Roberts, 2007, Dejong et 
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al., 2006). Taxadiene, a diterpene derivative, is the key intermediate of paclitaxel, which 
is widely used in cancer chemotherapy. Metabolic engineering of taxadiene has resulted 
in 1.3 mg/L in E. coli (Huang et al., 2001) and 1 mg/L in yeast (Dejong et al., 2006). 
Recently, advanced improvements in taxadiene engineering achieved 1g/L in E. coli 
(Ajikumar et al., 2010) under fedbatch fermentation through a muiltivariate-modular 
approach for optimize balancing and channeling the overflow flux from IPP and DMAPP 
toward taxadiene biosynthesis. Recent approaches for improving diterpene production in 
heterologous hosts have included over-expression of fusion enzymes to increase the 
association of successively acting enzymes and thus channeling of intermediates 
towards the biosynthesis of desired end-products. One example of this strategy was the 
observation of 238.8 mg geranylgeraniol/L by yeast over-expressing several diterpene 
biosynthetic enzymes (Tokuhiro et al., 2009). Using a similar strategy for miltiradiene 
biosynthesis, the diterpene precursor to the Chinese herb medicine tanshionones, up to 
~480 mg/L were achieved in optimized yeast fermentation (Zhou et al., 2012, Dai et al., 
2012).  
3.2.3. Overall strategy of engineering diterpene in our yeast  
Figure 3.2 outlines the approach we used to generate yeast lines that provide for the 
robust biosynthesis of precursors that can be utilized for the production of many different 
classes of terpenes. The strategy takes advantage of the native mevalonate (MVA) 
pathway that operates normally in yeast for the biosynthesis of ergosterol, the dominant 
sterol found in yeast. Ergosterol is the main product of the yeast mevalonate pathway, is 
an important membrane component, and is essential for yeast growth. If the ergosterol 
biosynthetic pathway is blocked or inhibited, yeast die. In fact, this is the basis for many 
pharmacological drugs to control fungal infections in man (Maertens, 2004) and 
agricultural chemicals to control fungal infection in plants (Casida, 2009). To further 
complicate matters, wild type yeast can take up exogenously supplied sterol from their 
environment only under anaerobic conditions.  
In order to be able to efficiently channel terpene biosynthetic intermediates from the 
ergosterol biosynthetic pathway (Fig. 3.2A), a SUE (sterol uptake enhancement) 
mutation supporting the aerobic uptake and utilization of exogenous sterol was first 
created (Bourot & Karst, 1995, Shianna et al., 2001). A SUE mutant is thus a yeast line 
that can meet all its sterol needs by an exogenous source of sterol, and therefore 
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making the endogenous ergosterol biosynthetic pathway dispensable. The SUE 
mutation was then complemented by the introduction of a knockout mutation in the 
ERG9 gene (squalene synthase) (Zhang et al., 1993), resulting in a yeast line where the 
MVA pathway was still operational up to the biosynthesis of FPP and hence, 
intermediates in the pathway (DMAPP, IPP and FPP) could be diverted to the 
biosynthesis of other non-essential terpene components.  
The intent of the current study in Chapter 3 was to further this technology for the efficient 
diversion of isoprenoid pathway intermediates to the biosynthesis of diterpenes, to 
identify the molecular means for high-yielding conditions for the production of diterpene 
hydrocarbons and decorating the diterpene scaffolds to generate additional high-valued 
chemical entities.  
Yeast line ZX178-08 was previous developed (see Chapter 2), having a dispensable 
sterol biosynthetic pathway and accumulating high levels of FPP, but limited GGPP as 
indicated by no detectable accumulation of geranylgeraniol. The current chapter 
describes the generation of yeast lines that can be utilized for the production of diverse 
and high-valued diterpenes through heterologous expression of a novel GGPP synthase 
and diterpene synthases, along with diterpene oxidase for further decoration. 
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Figure 3.1. The representative compounds of each class terpenoids and the prenyl 
diphosphates they are derived from. 
All terpenes are derived from allylic diphosphates, which are polymers of repeating 
isopentyl units (IPP) put together by the action of prenyltransferases. Monoterpenes 
are derived from the C10 precursor geranyl diphosphate (GPP), sesquiterpenes from 
farnesyl diphosphate (FPP), and diterpenes from geranylgeranyldiphosphate (GGPP) 
by the action of terpene synthases. The terpene synthases impose unique regio- and 
stereo-chemical configurations onto the reaction intermediates during catalysis that 
impart novel characteristics to the reaction products. 
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Figure 3.2. The strategies for develop a yeast line suitable for engineering diterpene 
chemicals.  
Schematic diagram of the overall approach for generating a yeast line that would have a 
dispensable sterol biosynthetic pathway (panel A), which would provide opportunities for 
diverting intermediates (DMAPP, IPP and FPP) from the mevalonate (MVA) pathway for 
the biosynthesis of diterpene compounds (panel B).  
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3.2.4. Building a GGPP pool in yeast by overexpression of a mutant avian FPS 
synthase 
The limited accumulation of geranylgeraniol in our previous developed yeast line ZX178-
08 indicated the necessity of co-expression of a GGPP synthase (a prenyltransferase) to 
generate a GGPP pool sufficient for its diversion to diterpene biosynthesis. 
Prenyltransferases catalyze the condensation of allylic diphosphates to build increasing 
polymeric forms of allylic diphosphates. For example, trans-prenyltransferase synthesize 
products up to C50 in chain lengths and can be divided into short chain (C10-C25), 
medium chain (C30-C35), and long-chain (C40-C50) prenyltransferases (Chang et al., 
2006). GPS (gernayl diphosphate synthase C10), FPS (farnesyl diphosphate synthase, 
C15), GGPPS (Geranylgeranyl diphosphate synthase, C20) belong to the short chain 
trans-prenyltransferases, and they all share a significant level of amino acid sequence 
similarity. The sequence alignments include five highly conserved sequence domains, 
which include two important Asp-rich motifs, FARM (first Asp-Rich motif) and SARM 
(second Asp-rich motif), which share the consensus sequence DDX2-4D, X representing 
any amino acid (Bouvier et al., 2005). These two highly conserved Asp-rich motifs are 
important for catalytic function and substrate binding. For short-chain trans-
prenyltransferases, a bulky amino acid residue generally occupies the fourth or fifth 
position upstream from the FARM. FARM has been designated as the chain length 
determination region (Bouvier et al., 2005, Narita et al., 1999). SARM provides a Mg2+ 
binding site and is important for overall prenyl product formation (Bouvier et al., 2005). 
Both FARM and SARM are important for enzyme catalytic activity and product chain 
determination. Data based on the FPS 3D crystallographic structure and site direct 
mutagenesis, mutant forms of FPS showed that the amino residue at the fourth and fifth 
position before the FARM block the allylic substrate site and prevent further product 
chain elongation (Bouvier et al., 2005). Directed mutagenesis of FPP synthase can 
generate mutant enzymes capable of producing shorter chain product GPP or longer 
chain prenyl diphosphates. For example, mutant avian farnesyl diphosphate synthase 
(FPS) has the capability of producing geranyl diphosphate (A116W, N144W) (Fernandez 
et al., 2000), geranylgeranyl diphosphate (F112A), geranylfarnesyl (C25) diphosphate 
(F113S), and longer chain prenyl diphosphates (F112A/F113S) (Tarshis et al., 1996). 
Equally important is that the relatively activity of avian mutant enzymes, at least those 
that can produce longer prenyl diphosphate products than FPP, retain about the same 
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level of catalytic activity as the wide type avian FPS (Tarshis et al., 1996). Such mutants 
could give us additional tools for engineering diterpene metabolism in yeast.  
GGPP is precursor for diterpene, carotenoids, chlorophylls, geranylgeranylated proteins, 
which is an essential post-translational modification for signaling proteins such as Ras, 
Rho, Rab, and Rac (Takai et al., 2001). Neither native (BY4741) nor our modified yeast 
ZX series lines accumulate GGOH (geranylgeraniol), indicating the limited availability of 
GGPP in these lines. In other work from Wu et al. (2006), co-expression of a 
prenyltransferase, capable of supplying the appropriate allylic diphosphate substrate for 
terpene synthase, along with an appropriate terpene synthase was sufficient to enhance 
overall terpene accumulation more than 1,000 times higher than if only the synthase 
were expressed by itself. We therefore reasoned that expression of a mutant form of the 
avian FPS (substituting phenylalanine 112 for alanine) in yeast line ZX178-08 might 
result in the build-up of a GGPP pool. And, if we were to co-express a suitably robust 
diterpene synthase, then this pool of GGPP might be diverted to the biosynthesis and 
accumulation of a diterpene in the yeast culture. 
3.2.5. Kaurene and abietadiene synthase and the enzymes responsible for 
converting these hydrocarbons to oxidized forms  
Ent-kaurene is an important precursor to gibberellins (GAs), diterpene phytohormones 
which regulate various aspects of plant developments including shoot and stem 
enlongation, germination, dormancy, flowering, and leaf and fruit senescence (Hedden & 
Phillips, 2000). In higher plants, ent-kaurene is formed by the successive action of two 
cyclase enzymes, CPP synthase and ent-kaurene synthase, which catalyze the 
cyclization of GGPP to CPP (copalyl diphosphate), followed by the cyclization of CPP to 
kaurene as shown in Fig. 3.3 (Keeling et al., 2010). In contrast, fungal ent-kaurene 
synthase is a single bifunctional enzyme that catalyzes the two-step conversion of 
GGPP to ent-kaurene (Toyomasu et al., 2000). Gibberella fujikuroi is the rice pathogenic 
fungus causing lodging of field grown plants by producing large quantities of GAs, which 
result in abnormal growth characteristics of plants leading to the lodging phenotype. The 
fungal enzymes responsible for gibberellin biosynthesis have been extensively studied 
(Toyomasu et al., 2000). In considering engineering diterpene biosynthesis into yeast, 
the advantage of having a single, bifunctiional enzyme that can catalyze the two-step 
cyclization reactions represents a distinct advantage to attempting the co-expression of 
 
 
63 
 
two successively acting enzyme activities. In fact, an attempt to over-express a codon 
optimized form of the Gibberella fujikuroi kaurene synthase (FKS) in yeast was reported 
by Toyomasu et al. (2000). 
The Arabidopsis ent-kaurene oxidase gene (AtKO1), belonging to a cytochrome P450 
monooxygenase subfamily CYP701A, was first isolated by Helliwell et al. (Helliwell et al., 
1998), and found to catalyze the three step oxidation ent-kaurene to ent-kaurenoic acid 
when expressed in yeast (Helliwell et al., 1999). Ashman et al. (1990) characterized an 
ent-kaurene oxidase activity associated with the crude cell extracts from Gibberella 
fujikuro strains by estimating the conversion of ent-[3H] kaurene to ent-kaurenoids. They 
demonstrated the predominant product was ent-kaurenoic acid (> 90% of the total 
incorporation) in all incubations (Ashman et al., 1990), which indicated that the 
Gibberella fujikuro kaurene oxidase was a particularly efficient enzyme. The genes for 
gibberellin biosynthesis pathway in G. fujikuroi are clustered on chromosome 4, 
including the bifunctional ent-copalyl diphosphate synthase/ent-kaurene synthase, a GA- 
specific geranylgeranyl diphosphate synthase, and four cytochrome P450 
monooxygenases (Tudzynski et al., 2001). A knockout mutant of the P450-4 gene in G. 
fujikuroi resulted in the accumulation of ent-kaurene, while a GA-deficient mutant strain 
SG139, missing the entire 30-kb GA biosynthesis gene cluster, was able to convert ent-
kaurene to ent-kaurenoic acid only after it had been transformed with copy of the P450-4 
gene (Tudzynski et al., 2001, Malonek et al., 2005). These experiments thus confirmed 
the functional identity of kaurene oxidase genes from Arabidopsis and Gibberella 
fujikuroi kaurene oxidase, which could then be compared and evaluated for their utility 
for engineering kaurenoic acid production in yeast.  
Grand Fir, Abies grandis, is a coniferous tree that produces resin acids rich in abietic 
acid. Abietic acid, like kaurenoic acid, is a diterpene acid derived from a hydrocarbon 
precursor, abietadiene. Abietadiene is synthesized by abietadiene synthase, ABS, a 
bifunctional enzyme which catalyzes two sequential cyclization reactions (Class I and 
ClassII synthase reaction) in the formation of a mixture of abietadiene double bond 
isomers (Peters & Croteau, 2002a, Peters & Croteau, 2002b, Peters et al., 2000, Peters 
et al., 2001, Peters et al., 2003, Vogel et al., 1996). This reaction is analogous to that 
catalyzed by the Gibberella fujikuroi kaurene synthase of the gibberellin biosynthetic 
pathway. The first reaction converts GGPP to CPP via protonation-initiated cyclization, 
while the second reaction converts CPP to the abietadiene skeletons via ionization-
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initiated cyclization (Peters & Croteau, 2002a, Peters & Croteau, 2002b, Peters et al., 
2000, Peters et al., 2001, Peters et al., 2003). In A. grandis, abietadiene, like all 
diterpenes in plants, is biosynthesized in the plastid compartment, and thus abietadiene 
synthase contains a N-terminal plastidic targeting sequence, so-called targeting transit 
peptide, which is cleaved to form the mature protein when it is imported into the plastid 
compartment (Peters et al., 2000). Peters et al. generated a truncation series of the 
putative targeting sequence and evaluated “pseudomature” forms of the abietadiene 
synthase (Peters et al., 2000). Removal of 5’ DNA sequences encoding for the first 84 
amino acid residues resulted in a bacterial expressed form of the enzyme that behaved 
as a functionally soluble enzyme, exhibited good catalytic activity, and produced the 
same chemical profiles of abietadiene, levopimaradiene, and neoabietadiene, as the 
native abietadiene synthase (Peters et al., 2000). We, hence, choose to determine if 
over-expression of the Grand Fir ABS gene with the sequence corresponding to the 84 
N-terminal transit peptides deleted in yeast could result in abietadiene accumulation.  
Like the coversion of kaurene to its acid form, the diterpene resin acids found in Grand 
Fir (Abies grandis) and lodgepole pine (Pinus contorda) are derived from GGPP being 
converted first to diterpene hydrocarbons like abietadiene, which then are subject to 
successive oxidation of the C18-methyl to yield the acid forms (Funk & Croteau, 1994, 
Funk et al., 1994). Funk and Crouteau (1994) also demonstrated that there were three 
different enzymatic activities catalyzing the sequential oxidization of abietadiene to 
abietic acid, with the first two steps being catalyzed by cytochrome P450-dependent 
monooxygenases, abietadine and abietadienol hydroxylases, while the third step, the 
conversion of abietadienal to abietic acid, is catalyzed by a soluble aldehyde 
dehydrogenase. Equally interesting, the two P450-dependent monooxygenases 
activities are inducible and reach maximum levels within 10 day after wounding, while 
the soluble aldehyde dehydrogenase activity seems to be constitutive (Funk et al., 
1994). In fact, Ro et al. (2005) cloned and functionally identified a multi-functional and 
multi-substrate cytochrome P450 enzyme, CYP720B1, from Loblolly pine and classified 
this enzyme as abietadienol/abietadienal oxidase (PtAO) (Ro et al., 2005). When 
expressed in yeast, PtAO catalyzed a very low level of oxidation of abietadiene, but 
showed a clear preference for the oxidation of abietadienol or abietadienal (Ro et al., 
2005, Ro & Bohlmann, 2006). Hamberger et al. (2011) have cloned two other sequence 
related P450 enzymes CYP720B4 from white spruce (Picea glauca) and Sitka spruce 
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(Picea sitchensis) (Hamberger et al., 2009, Hamberger et al., 2011). CYP720B4 
(PsCYP720B4) was active with 24 different diterpene substrates, catalyzing consecutive 
C-18 oxidations in the biosynthesis of series diterpene alcohols, aldehydes, and acids. 
When co-expressed with a higher plant GGPP synthase, abietadiene synthase, and 
Cytochrome P450 reducatase (CPR), yeast were able to accumulate abietic acid up to 
0.2 mg/L (Hamberger et al., 2011). 
 
 
66 
 
 
Figure 3.3. Biosynthetic conversion of geranylgeranyl diphosphate (GGPP) via copalyl 
diphosphate (CPP) to kaurene, then kaurenoic acid, or the conversion abietadiene then 
abietic acid.  
The figure is also annotated to show how plants utilize the successive action of two 
enzyme for kaurene biosynthesis while fungi utilize a single multi-functional enzyme.  
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3.3. Results 
3.3.1. Co-expression of a mutant prenyltransferase 
Specific efforts were undertaken to generate yeast lines balanced for expressing high 
levels of heterologous proteins and in turn accumulating high levels of diterpenes. The 
first indication that the co-expression of a GGPP synthase might be needed along with a 
diterpene synthase was that neither the wide type yeast, nor our newly generated ZX 
yeast series with a sterol dispensable pathway and erg9 knock out accumulated any 
geranygeraniol (GGOH), which would be a sign that a GGPP pool exists in yeast. 
Another indication that GGPP was in short supply was our observation that only very low 
amounts of abietadiene accumulated in our ZX yeast line, which also over-expressed the 
ABS gene (Fig. 3.4). However, when expression of the ABS gene was coupled with the 
co-expression of a mutant avian farnesyl diphosphate synthase (mFPS F112A), those 
yeast lines demonstrated a dramatic improvement in their accumulation of abietadiene at 
the expense of farnesol accumulation (Fig. 3.5). The mutant FPP synthase, mFPS 
F112A, was previously characterized as exhibiting a preferential biosynthesis of GGPP, 
rather than FPP (Fernandez et al., 2000), and was additionally preferred because the 
encoded avian enzyme is relatively small, but particular active as a homodimeric protein, 
and because this foreign gene and protein would avoid any of feedback regulation that a 
native fungal GGPP synthase would be subject to. 
The benefit of co-expressing the mutant FPS gene with other diterpene synthases 
corroborated the generality of this observation. In Figure 3.6, co-expression of the mFPS 
gene along with a codon optimized fungal kaurene synthase gene (Toyomasu et al., 
2000) dramatically improved kaurene accumulation (lower panel) as observed for 
abietadiene biosynthesis (upper panel). Equally important to note, the enhanced 
diterpene accumulation due to the co-expression of the mFPS did not impose any 
obvious penalty in cell biomass accumulation (OD600 nm). Cell culture growth was, in 
fact, improved from 20 to 40% when the diterpene synthase genes were co-expressed 
with the mutant prenyltransferase.  
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Figure 3.4. Comparison of the terpene chemical profiles of yeast over-expressing the 
abietadiene synthase (ABS) gene versus control yeast not harboring the ABS gene.  
GC chromatographs of extracts prepared from yeast engineered for expression of the 
abietadiene synthase (ABS) gene (upper panel) versus control yeast (those engineered 
with an empty plasmid DNA, no ABS gene) (lower panel).  The yeast lines were grown 
for 5 days, aliquots of the culture were extracted into hexane, and the hexane extracts 
then profiled by GC-MS. Cedrene was added to cultures prior to extraction as an 
external standard to account for sample extraction efficiency (peak 1); farnesol (peak 3) 
was monitored as an estimation of how much carbon flux to FPP was occuring in the 
yeast cells; and abietadiene (peak 5) was monitored as a measure of how much terpene 
intermediates (IPP, DMAPP and FPP) were being diverted to diterpene biosynthesis.   
abietadiene 
 
Control yeast (no transgenes) 
Yeast expressing the ABS gene  
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Figure 3.5. Comparison of terpene chemical profiles from yeast co-expressing an 
alternative GGPP synthase (mFPS F112A) with abietadiene synthase versus only over-
expressing the abietadiene synthase.   
GC chromatograms of yeast co-expressing the abietadiene synthase (ABS) and a 
mutant avian farnesyl diphosphate synthase (mFPS) (upper panel) versus a yeast line 
only expressing the ABS gene (lower panel). The yeast lines were grown for 5 days, 
aliquots of the culture were extracted into hexane, and the hexane extracts then profiled 
by GC-MS. Cedrene was added to cultures prior to extraction as an external standard to 
account for sample extraction efficiency (peak 1); farnesol (peak 2) was monitored as an 
estimation of how much carbon flux to FPP was occurring in the yeast cells, thus 
estimating how much carbon was escaping channeling to diterpene biosynthesis; and 
abietadiene (peak 3) was monitored as a measure of how much isoprenoid 
intermediates (IPP, DMAPP and FPP) were being diverted to specialized diterpene 
biosynthesis.   
Yeast expressing ABS & mFPS genes 
Yeast expressing only the ABS gene 
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Figure 3.6. The co-expression of the mFPS gene with different diterpene synthases 
genes enhances diterpene accumulation.  
In the upper panel, yeast engineered for expression of the ABS gene or ABS gene plus 
mFPS gene were grown under standard conditions and aliquots of the cultures were 
monitored daily for growth (OD600 nm) and abietadiene accumulation (GC-MS 
determination). In the lower panel, yeast were engineered for expression of a second 
diterpene synthase gene, kaurene synthase, plus and minus co-expression of the mFPS 
gene. Cultures were monitored daily for growth (OD600 nm) and kaurene accumulation 
(GC-MS). 
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3.3.2. Identification of gene expression promoters and vector configurations to 
enhance kaurene diterpene accumulation 
The successful accumulation of diterpenes in cultures when the mutant FPS and 
diterpene synthases were co-expressed suggested that the expression level of each 
gene relative to one another (the stoichiometric relationship) might be an important for 
optimized diterpene production. A variety of gene promoter combinations were then 
examined with the notion that this would be the best means for regulating the level of the 
target enzymes in the cells. The strategy for this effort is outlined in Fig. 3.7. Varied gene 
promoter elements driving expression of the mutant FPS gene on one plasmid construct 
in combination with the same promoters directing expression of the fungal kaurene 
synthase (FKS) gene on an another plasmid construct were examined in yeast for 
kaurene production. The promoter elements included the actin (ACT1) promoter (Mateus 
& Avery, 2000), a copper inducible (CUP1) promoter (Tohoyama et al., 2001), 
glyceraldehyde phosphate dehydrogenase (GPD) promoter (Bitter & Egan, 1984), 
transcription elongation factor (TEF1) promoter (Mumberg et al., 1995), and the alcohol 
dehydrogenase (ADH1) promoter, which we previous described using for heterologous 
expression in yeast (Takahashi et al., 2007). ADH, TEF and GPD promoters are strong 
constitutive promoters and their relative strength arranged in ascending order, with 
ADH1 being the moderate strength, and the GPD promoter the strongest. The Act1 
promoter is a relatively lower constitutive promoter, and appeared as the strongest in 
cells growing actively with sucrose (Monfort et al., 1999). While the CUP1 promoter 
belongs to the class of promoters known for their inducibility, exhibits a rapid induction of 
approximately 20-fold and the maximal level of transcript detected 30 min after exposure 
to copper (Monfort et al., 1999, Romanos et al., 1992). These various strength and 
inducible promoters combination of co-expression of prenyltransferase and diterpene 
synthase helps to identify the best fine tuning association between these two enzymes 
for carbon flux to build the desired diterpene compound.  
Yeast strain ZX 2-2 was co-transformed with the various two plasmid construct 
combinations, then individual transformant lines were monitored for kaurene and 
farnesol accumulation (Fig. 3.8). While we were obviously screened these lines for the 
promoter combination giving the highest level of diterpene production, an equal 
important parameter was the farnesol levels. If a yeast line was efficiently diverting the 
earlier isoprenoid precursors to diterpene, their farnesol levels would be expected to be 
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equally low. By these criteria, having the GPD promoter direct expression of both the 
mutant prenyltransferase and the kaurene synthase genes yielded the highest level of 
kaurene with the greatest efficiency. The results of Figure 3.8 also demonstrate that the 
absolute level of gene expression and stoichiometry of the encoded enzymes can 
significantly influence overall diterpene production.  
We further assessed this by assembling the prenyltransferase and diterpene synthase 
genes into a single vector. In this way, we were evaluating whether variation in diterpene 
accumulation could be associated with possible variation in gene copy number as 
reflected by possible variation in plasmid copy number caused by different auxotrophic 
selection markers on vectors, or whether a one-to-one stoichiometry of prenyltransferase 
and diterpene synthase genes on a single plasmid vector were preferable. In the first 
examination of these possibilities, the constructs were substituted GPD, ACT, TEF, and 
ADH promoters to drive expression of the prenyltransferase and diterpene synthase 
genes in single vector. The constructs were then introduced into yeast and multiple, 
independent transformants selected for monitoring diterpene (kaurene) production and 
farnesol accumulation (Fig. 3.9). Farnesol accumulation was monitored as a measure of 
how much carbon was not efficiently being converted to diterpene. Once again, the 
combination of the dual combination of the GPD promoters proved superior to any other 
promoter combination with respect to kaurene yield and efficiency, as noted by the 
limited amount of farnesol accumulating. But no significant improvement of production 
was noted in comparison with two genes on separated vectors. At this point, the most 
optimal vector design suggested by the experimental findings recommends that having 
both the prenyltransferase and diterpene synthase genes driven by the GPD promoter 
was the preferred structural organization. 
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Figure 3.7. Construct design for testing the importance of specific gene promoters for 
diterpene (kaurene) production in yeast. 
 A variety of promoter elements were inserted independently upfront of the mFPS gene 
and the fungal kaurene synthase gene, then yeast were transformed with all possible 
combinations of each construct. The different transgenic yeast lines were then evaluated 
for kaurene production levels. Pact = the actin gene promoter (Mateus & Avery, 2000); 
Pcup = the copper inducible promoter (Tohoyama et al., 2001); Pgpd = the 
glyceraldehyde phosphate dehydrogenase promoter (Bitter & Egan, 1984); Ptef = the 
transcription elongation factor (tef1) promoter (Mumberg et al., 1995);Padh = the alcohol 
dehydrogenase promoter (Takahashi et al., 2007). 
 
 
 
74 
 
 
Figure 3.8. Kaurene and farnesol (FOH) accumulation in yeast engineered for 
expression of the kaurene synthase and mutant avian FPP synthase driven by different 
gene promoters.  
Yeast strain ZX 2-2 were transformed with the various plasmids noted in Fig. 3.7, 
selected for prototrophic growth without leucine or histidine added to the culture media 
(standard recipe), then grown for 10 days before extracting and chemically profiling 
aliquots of the cultures by GC-MS. For the line harboring the CUP promoter construct, 
the cultures were grown for 2 days, then 1 mM copper sulfate was added to the growth 
media.  
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Figure 3.9. Kaurene, farnesol (FOH), and geranylgeraniol accumulation in yeast 
engineered for expression of the kaurene synthase and mutant avian FPP synthase 
driven by different gene promoters combinations on a single expression vector. 
Evaluating the efficiency of he ACT, ADH, TEF or GPD promoters to direct expression of 
both the mutant prenyltransferase and kaurene synthase genes on a single plasmid 
vector for the diterpene kaurene production. Yeast line ZX 2-2 was transformed with the 
indicated plasmid vector (i.e. 2act = the actin promoter driving expression of both the 
kaurene synthase gene and the mutant FPP synthase gene arrayed on a single 
expression vector harbor the Leu2 auxotrophic selection marker) and a resulting 
transformant line chemically profiled by GC-MS after 10 days of growth in standard 
section media.  
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3.3.3. Optimization of culture conditions to enhance kaurene diterpene 
accumulation 
Throughout our testing of genes and genetic elements for enhancing diterpene 
accumulation, we noted some variation in diterpene yields with the culture conditions.  
The yield of diterpene compounds depend primarily on maximizing and balancing 
expression levels of the heterologous proteins, and the cell concentration which is 
directly related to biomass accumulation. Thus the medium composition and culture 
condition can affect cell growth and protein yield and thereby affect the target compound 
yield. We therefore examined these parameters more systematically and found that for 
each diterpene target, specific culture conditions could dramatically influence overall 
diterpene accumulation. Complex complete medium usually supports higher cell growth 
rates in comparison with minimal media because it provides an excess of essential 
nutrients and provides an exogenous source of some factors which the cells do not need 
to synthesize. There are also two kinds of selection markers used in the molecular 
manipulations of yeast. Antibiotic resistant genes provide for selection against antibiotic 
addition to the cultures, and auxotrophic gene markers provide for a trans-
complementation for knockout mutation in key enzymes of primary metabolism. The 
relatively high price for antibiotic compounds precludes their use in large-scale 
fermentations, hence auxotrophic markers are the preferred selection markers used for 
molecular manipulations in yeast. However, when using yeast strains harboring 
numerous auxotrophic mutations, only some of which are complemented by introduced 
gene constructs, the concentrations of essential nutrients to be added to the growth 
medium for optimal culture growth and heterologous expression of engineered genes 
must be empirically determined. Pronk et al. (2002) demonstrated that the auxotrophic 
amino acid concentrations are limited in many standard synthetic medium recipes for 
cultivation of S. cerevisiae (Pronk, 2002). In such cases, yeast growth is limited by the 
concentration of the auxotrophically required nutrient in the medium. Pronk 
recommended much higher concentrations of commonly applied auxotrophy 
complementing compounds than the standard recipes based on calculations of the 
required compound content in 0.5 g biomass per gram glucose during aerobic growth 
condition (Pronk, 2002). We presumed doubling the auxotrophical amino acids 
concentrations recommended by Pronk would avoid nutrient limitation conditions. To test 
the yeast performance in different nutrients media, yeast ZX 2-2 strain were cultured in 
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three kinds of media, standard selection media, YPDE rich media and the optimized 
selection media. Yeast culture samples were collected after 6 days and 12 days of 
growth and evaluated for the amount of farnesol they had accumulated. Both rich media 
and optimized media dramatically enhance farnesol level two folds compared with the 
standard selection media (Fig. 3.10 A). To further corroborate these observations, a 
yeast line expressing both the mutant FPP synthase and kaurene synthase genes (both 
driven by the GPD promoters, on two separate vectors were inoculated into YPDE 
nutrient rich media and the optimized selection media in shake flask. As shown in Fig. 3. 
10 B, cell growth and terpene accumulation were determined by spectrophotometer or 
GC-MS every two days. The kaurene producing yeast line grew better in the rich 
complete media than in optimized selection media with150% higher OD600 reading. 
Kaurene accumulation level was also slightly higher in rich nutrient media than optimized 
selection media. The more interesting result was that the farnesol levels were extremely 
low, less than 2mg/L, and no significant level of geranygeraniol was detected under 
these growth conditions, which suggested that sufficient conversion of FPP to GGPP 
and then to diterpene hydrocarbon had occurred. When the engineered yeast were 
cultivated in a 7.5 L bioreactor, 569 mg/L kaurene accumulated with only 41 mg/L of 
GGOH and 25.8 mg/L of FOH accumulating (Fig. 3.11).  
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Figure 3.10. Optimizing medium conditions to enhance terpene production by yeast 
strain ZX 2-2 
A) Yeast ZX 2-2 line was cultured in three medium for the indicated time periods 
indicated, and the amount of farnesol accumulating in these cultures determined by GC-
MS. B) Yeast 2-2 transformed with the plasmids containing the kaurene synthase and 
prenyltransferase genes under GPD promoter on two separate expression vector 
plasmids were cultured under optimized selection media or complete media, and 
monitored for growth (OD 600) and terpene levels by GC-MS.  
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Figure 3.11. Growth and chemical profiles of yeast line ZX 2-2 harboring genes 
encoding for GGPP synthase and kaurene synthase grown under optimized 
fermentation conditions.  
Yeast 2-2 transformed with plasmids containing the kaurene synthase and 
prenyltransferase genes under the control of the GPD promoters on two separate 
vectors were cultured in complete rich media at 30°C in a 7.5 L stirred-tank bioreactor. 
Culture growth was measured at OD600 nm and terpene accumulation was determined 
by GC-MS.  
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3.3.4. Screening yeast strains for optimal accumulation of a second diterpene, 
abietadiene  
To determine if we could extend our findings with kaurene biosynthesis and 
accumulation to a second diterpene, we mimicked many of the engineering and culture 
conditions for abietadiene biosynthesis. Yeast ZX 2-2 strain was transformed with 
constructs for the prenyltransferase and abietadiene synthase genes on one plasmid 
vector, or on separate vectors with all genes driven by GPD promoter, then cultivated in 
optimized selection media monitoring growth and diterpene accumulation. Surprisingly, 
those transgenic lines with the multiple plasmid constructs exhibited relatively minor 
variation in the level of diterpene and farnesol accumulated, while the lines transformed 
with the single vector harboring both the prenyltransferase and diterpene synthase 
genes showed more than 50% variation in the absolute levels of farnesol and 
abietadiene (Fig. 3.12). Nonetheless, independent transgenic lines containing the 
targeted genes on a single plasmid vector also demonstrated greater than 30% more 
abietadiene and farnesol than when the transgenes were introduced on separate 
plasmid vectors. When combined with the information for kaurene production in Figs. 3.8 
and 3.9, the most optimal vector design suggested that having both the 
prenyltransferase and diterpene synthase genes on one plasmid vector and having 
expression of both genes driven by the GPD promoter was the preferred structural 
organization. However, the abietadiene accumulation in yeast was still relatively low 
relative that observed for kaurene production earlier, and the large amount of FOH 
accumulated in these lines would suggest that the conversion of GGPP to abietadiene 
was limiting. That may be caused by the Garnd Fir abietadiene synthase specific activity 
being relatively low in comparison to the fungal kaurene synthase, or it might arise from 
some sort of feedback regulatory mechanism by GGPP. 
Ten additional ZX yeast lines plus ZX 2-2 expressing the mFPS and abietadine synthase 
under the direction of the GPD promoter on a single plasmid construct were thus 
quantified for GGOH, abietadiene, and FOH accumulation. Three independent 
transformants of each strain were cultivated in test tube scale at 23°C. Although there is 
some variability between independent transgenic lines, reduction of the culture 
temperature from 30°C to 23°C significantly enhanced the abietadiene yield and 
efficiency as noted by the limited about of farnesol and geranylgeraniol accumulating 
(Fig. 3.13). Because line #31 of strain ZX178-08 accumulated the highest levels 
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abietdiene and lowest levels of FOH and GGOH, this line was chosen for further 
characterization and optimization for abietadiene production.  
In Fig. 3.14, the accumulation of abietadiene, farnesol and geranylgeraniol by the 
ZX178-08 line over-expressing the mutant prenyltransferase and abietadiene synthase 
genes grown under 4 conditions (2 temperatures and 2 media) was examined. Not 
unexpectedly, when grown in nutrient rich media (YPDE), the yeast grew approximately 
2-fold greater than when cultured in selection media (SCE) for 10 days. However, growth 
of the cultures at 23°C versus 30°C had relatively little influence over this 10-day period 
in terms of overall biomass accumulation. However, a dramatic effect on abietadiene 
accumulation was noted when the cultures were grown at 23°C in selection media. 
Abietadiene accumulation was 2-fold greater under these conditions than when grown at 
the higher temperature or in the nutrient rich media. The latter observation might be 
explained by the loss of the recombinant expression plasmid from the yeast grown in the 
absence of selection pressure provided by the selection media. In contrast, kaurene 
accumulation by yeast co-expressing the fungal kaurene synthase and mutant 
prenyltransferase also under the control of GPD promoters was highest in yeast grown 
in nutrient rich media rather than selection media, even if the cultures were grown for 10 
or more days (see Figs. 3.10 and 3.11). But cooler culture temperatures appear to 
improve diterpene accumulation regardless of the diterpene synthase gene used.  
There are two major types of plasmid instability associated with yeast as we have 
prepared and grown segregation and structural instability. Segregation instability is due 
to the failure to distribute plasmids evenly between daughter cells during cell division 
resulting in reduction of copy number and loss of plasmid. Structure instability is due to 
the mutation or changes in the structure of the plasmid such that rearrangements or loss 
of plasmid DNA sequences through recombination might occur. Plasmid instability in the 
yeast strains might also be caused by the toxicity of the high level constitutive 
expression of ABS gene and accumulation abietadiene products resulting in poor cell 
growth, and plasmid segregation instability. The repeat DNA sequences of GPD 
promoter and ADH terminator on the single plasmid, might also improve the probability 
of homologous recombination resulting in gene sequence loss. Nonetheless, the 
experimental evidence up to this point for the most optimal vector design suggested that 
having both the prenyltransferase and diterpene synthase genes on one plasmid vector 
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and having expression of both genes driven by the GPD promoter was the preferred 
structural organization.  
When the ZX178-08 yeast were grown in a 7.5 L bioreactor, 207 mg/L abietadiene, 20 
mg/L palustradiene, 58 mg/L levopimaradiene, 58 mg/L neoabietadiene accumulated 
with only 0.8mg/L and 3.6 mg/L GGOH and FOH, respectively (Fig 3.15). These 
additional diterpene products were identified by careful GC analysis and identification by 
comparison of retention time and mass spectrum to those of authentic standards as well 
as reference to literature documentation (Lee et al., 2001). These abietadiene isomers 
were previously identified in in vitro assay using recombinant ABS protein or ABS protein 
extracted from Grand Fir as described by Peters et al. (2000).  
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Figure 3.12. Comparison of the vector configuration effects on abietadine production in 
ZX 2-2 yeast line. 
To test for how the molecular configuration of the mutant prenyltransferase (mFPS, 
geranylgeranyl diphosphate synthase) relative to the diterpene synthase (ABS, 
abietadiene synthase) might influence diterpene production, the indicated plasmid 
vectors were introduced into yeast ZX 2-2 and 4 independent transgenic lines grown for 
10 days at 30°C in 30 ml optimized selection media prior to extracting and chemically 
profiling by GC-MS for abietadiene and farnesol (FOH) accumulation. 
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Figure 3.13. Quantitation of abietadiene production levels in the ZX yeast series lines.  
The indicated yeast lines were engineered with both the mutant prenyltransferase and 
abietadiene synthase genes, and 3 independent transformants for each strain were 
grown as test tube shake cultures at 30°C with 3 ml of optimized selection medium 
containing 40 µg/ml of ergosterol for 6 days prior to sampling the cultures. One ml 
aliquots of cultures were extracted with n-hexane, then subjected to GC-MS. 
Abietadiene, GGOH, and FOH levels were quantified relative to an external standard. * 
indicates lines selected for further evaluations. 
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Figure 3.14. Culture medium and temperature influences on abietadiene accumulation.  
Yeast strain ZX178-08 co-expressing abietadiene synthase and mutant 
prenyltransferase under the control of the GPD promoter on one vector was grown in 
nutrient rich media (YPDE) or optimized selection media (SCE) at 23°C or 30°C for 10 
days. Culture growth was measured at OD600 nm and terpene accumulation was 
determined by GC-MS.  
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Figure 3.15. Terpene chemical profiles of yeast strain ZX178-08 co-expressing 
abietadiene synthase and mutant prenyltransferase grown under fermentation 
conditions. 
Yeast ZX178-08 transformed with a single plasmid containing the abietadiene synthase 
and prenyltransferase genes under the control of the GPD promoters was cultured in 
optimized selection media at 23°C in a 7.5 L stirred-tank bioreactor. Culture growth was 
measured at OD600 nm and terpene accumulation profiles were determined by GC-MS.  
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Figure 3.16. GC-MS assessment of the diterpene hydrocarbons accumulating in yeast 
co-expressing the genes encoding for abietadiene synthase and a mutant 
prenyltransferase.  
When co-expressing the mFPS F112A gene and the abietadiene synthase gene under 
the regulation of the GPD promoter in ZX1708-08 lines, several abietadiene isomers 
accumulate, as shown in the GC chromatogram of an extract prepared from a culture 
grown for X days in selection medium at 23oC as a shake flask culture (A). The identities 
of the compounds in the various peaks were determined by matches of their mass 
spectra data to diterpenes reported in the NIST library (B). 
A 
B 
 
 
88 
 
3.3.5. Decorating diterpene hydrocarbon scaffolds 
Having achieved the production of diterpene hydrocarbon production in yeast, the next 
objective sought the biosynthesis of more highly modified forms of diterpenes and 
especially those molecules that might have industrial, agricultural or medicinal 
applications. For this purpose, we have utilized a 3 plasmid construct design (Fig. 3.17). 
Plasmids 1 and 2 are those described above and whose expression in yeast yields 
robust levels of diterpenes such as kaurene. The third plasmid construct was similarly 
designed to constructs 1 and 2, but contained a gene encoding for kaurene oxidase, a 
fungal P450 enzyme (Tudzynski et al., 2001) or Arabidopsis kaurene synthase, both 
which require reducing equivalents from a cytochrome P450 reductase (CPR) 
(Takahashi et al., 2007) for activity as shown in Fig. 3.17A. Three vector constructs 
coding mfps, FKS, along with GFKO plus CPR or AtKAO plus CPR were transformed 
into yeast line ZX2-2 and confirmed transformants evaluated for their efficiency of 
converting kaurene to its oxidized form, kaurenoic acid. Fig 3.17 B shows GC 
chromatograms of yeast culture extracts prepared from transgenic yeast and derivatized 
to assure volatility for detection by gas chromatography. Apparently, the over-expression 
of the fungal kaurene oxidase gene results in a more efficient oxidization of the C18 
methyl on kaurene scaffold. When transgenic yeast from test tube culture were 
quantified, the kaurene scaffold chemicals composition percentage distribution were 
61.4% kaurene, 28.5%, kaurenal, 5% kaurenol, 5.3% kaurenoic acid from AtKAO 
transgenic yeast lines, versus 21% kaurene, 13.1% kaurenal, 6% kaurenol, 53% 
kaurenoic acid from the GFKO transgenic yeast line. Hence, over-expression of the 
fungal kaurene oxidase gene appears to result in more enzyme activity that catalyzes 
the successive three-step oxidation of kaurene. 
This obtained kaurenoic acid producing line was evaluated for diterpene production at 
23°C and 30°C in nutrient rich media and optimized selection media as described 
previously for simply hydrocarbon production (compare Fig. 3.19 to Fig. 3.14). The yeast 
were grown for 10 days before the accumulation of kaurene and its specific oxidation 
products kaurenal and kaurenoic acid were measured by GC-MS. Consistent with the 
earlier observations for only kaurene production, maximal production of approximately 
200 mg/l of kaurenoic acid was observed for the culture grown in nutrient rich media at 
the reduced temperature. The diterpene productivity was about 2-fold greater than the 
any of the other conditions tested. These growth conditions were corroborated when this 
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yeast line was cultivated in a 7.5 L bioreactor. Under these conditions, 514 mg/L 
kaurenoic acid accumulated with levels of kaurene and kaurenal reaching 71.7 mg/L and 
20.1 mg/L, respectively (Fig. 3.20). 
Because the kaurenoic acid accumulating yeast requires an exogenous source of sterol 
for growth, as do all the third generation ZX strains, we next examined the optimal sterol 
source and concentration on the overall diterpene production of the yeast. Ergosterol 
and cholesterol were tested for their effects on kaurenoic acid and other terpene 
production at different concentrations and at 2 stages of culture development in shake 
flask cultures (Fig. 3.21). Too low or too high a concentration of ergosterol or cholesterol 
suppressed diterpene production, yet total amount of kaurene and its oxidized products 
and specifically kaurenoic acid production reached 660 mg/L and 470 mg/L, respectively 
in medium containing 10 mg/L ergosterol in shake flask culture. Additional improvement 
in diterpene productivity might be possible if the sterol requirement were met with a fed-
batch application. Bulk addition of the sterol at the start of the a culture necessitates its 
addition with large amounts of detergent, which could have adverse effects on overall 
culture physiology and productivity, and a more regulated and titratable addition of the 
required sterol might alleviate some of these effects. 
Efforts to generate yeast lines accumulating oxidized forms of abietadiene were less 
successful. Two cytochrome P450 genes noted in the literature for their ability to code 
for enzymes hydroxylating abietadiene are CYP720B1 from Loblolly pine described as 
an abietadienol/abietadienal oxidase (PtAO) (Ro et al., 2005) and that from white 
spruce, CYP720B4, (Hamberger et al., 2009, Hamberger et al., 2011) were evaluated. 
When PtAO was co-expressed in abietadiene accumulating yeast, no oxidized products 
were observed, nor when co-expressed along with GFKO assuming that this enzyme 
might initiate the first oxidation at C18 to yield abietadienol (data not shown). When the 
white spruce CYP720B4 gene was co-expressed in abietdiene producing line, 
approximately 5 mg/L abietic acid accumulated. Whether this inefficient conversion could 
be due to low expression levels of the corresponding P450 genes, inadequate balancing 
of the various enzymes involved, or simply low catalytic efficiency of the cytochrome 
P450 enzymes themselves remains to be determined.   
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Figure 3.17. Test for the specificity and efficiency of kaurene oxidation by the co-
expression of an Arabidopsis kaurene oxidase gene or the Gibberella fujikuroi kaurene 
oxidase gene in yeast optimized for kaurene production.  
In panel A, the indicated plasmid vectors containing a P450 reductase gene (CPR) along 
with either the Arabidopsis kaurene oxidase gene under the transcriptional control of a 
cup promoters, or a fungal kaurene  oxidase gene under transcriptional control of the 
GPD promoter were transformed into the highest kaurene  accumulating lines of yeast 
ZX 2-2. In panel B, the chemical profiles of the respective yeast lines co-expressing the 
mutant prenyltransferase gene, the kaurene synthase gene and either of the kaurene 
oxidase genes shown in panel A were determined by GC-MS. The mass spectra data for 
the kaurenoic acid and other oxidized species are also shown.  
A 
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Figure 3.18. Expression constructs designed for producing diterpene acids in yeast. 
The mutant prenyltransferase (mFPS) and kaurene synthase (FKS) constructs were 
described above and the new construct consists of a gene encoding for a fungal P450 
enzyme catalyzing the oxidation of kaurene to it acidic form (kaurene oxidase, GFKO), 
plus a cytochrome P450 reductase (CPR) that provides reducing equivalents to the 
kaurene oxidase. Expression of these genes, like the prenyltransferase and kaurene 
synthase genes, is controlled by the GPD promoter.   
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Figure 3.19.  Culture medium and temperature influence kaurenoic acid accumulation.  
In panel A, yeast strain ZX178-08 co-expressing the mutant prenyltransferase, kaurene 
synthase, CPR and kaurene oxidase genes under the direction of the GPD promoters as 
illustrated in Fig. 18, were grown in nutrient rich media (YPDE) or optimized selection 
media (SCE) at 23°C or 30°C for 10 days. Culture growth was then measured at OD600 
nm and kaurene, kaurenal, kaurenoic acid accumulation was determined by GC-MS 
after derivatization treatment. In panel B, the distribution of the various diterpenes 
between the culture medium and the cell pellet are presented.  
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Figure 3.20. Terpene chemical profiles of yeast strain ZX178-08 engineered for 
kaurenoic acid biosynthesis as shown in Fig. 3.18 grown under fermentation conditions.  
Yeast strain ZX178-08 harboring all the vectors shown in Fig. 3.18 was grown in nutrient 
rich media at 23°C in a 7.5 L stirred-tank bioreactor. At the indicated time points, culture 
growth (OD600 nm) and terpene accumulation (determined by GC-MS) were measured.  
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Figure 3.21. Sterol dependence of engineered yeast cultures to accumulate kaurene, 
kaurenal and kaurenoic acid.   
Yeast strain ZX178-08 harboring all the vectors shown in Fig. 3.18 was grown in 30 ml 
nutrient rich medium at 23°C in shake flasks containing the indicated concentrations of 
cholesterol or ergosterol. At the indicated time points, culture growth was measured as 
OD600 nm and terpene accumulation determined by GC-MS.  
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3.4. Discussion 
Impressive progress in diterpene engineering in microbes has been achieved over the 
last decade or so. Taxadiene production started at 1.3 mg/L in E. coli (Huang et al., 
2001) and 1 mg/L in yeast (Dejong et al., 2006), and recent advances reported 1 g/L in 
E. coli (Ajikumar et al., 2010) under fed-batch fermentation with a muiltivariate-modular 
approach for optimizing, balancing and channeling the overflow flux from IPP and 
DMAPP toward diterpene biosynthesis. Tokuhiro et al. (2009) overexpressed fusion 
enzymes to increase the association of successive acting enzymes and channel of 
intermediates to desired products, yielding about 238.8 mg/L geranylgeraniol in yeast 
shake flask cultures. Using similar strategies, miltiradiene, the diterpene precursor to the 
Chinese herb medicine tanshionone, was produced up to ~480 mg/L in optimized yeast 
fermentation (Zhou et al., 2012, Dai et al., 2012). 
These developments have built on important observations that have been reported to 
influence terpene metabolism in yeast. First, it has been recognized for quite some time 
that carbon flux through the mevalonate pathway is highly regulated. HMGR, for 
instance, is considered to be a rate-limiting step in this pathway (Gardner and Hampton 
2009, Liscum et al., 1985). Over-expression of truncated, heterologous forms of this 
enzyme along with changes in the transcriptional promoter driving expression of this 
engineered gene to overcome native regulatory mechanisms can dramatically increase 
the amount of squalene accumulation (Dai et al., 2012, Polakowski et al., 1998). An up-
regulation mutation in the general transcription factor gene upc2 also increased the 
uptake of exogenous sterol from the medium five fold, paving the way for using this 
mutation to creating sterol auxotrophic mutants in yeast (Crowley et al., 1998). Over-
expression of other genes within the mevalonate pathway (ERG 13, 12, 8, 1, 11, 24, 25, 
6, 2, 3 and IDI) also dramatically improved sesquiterpene production in yeast harboring 
the upc2 mutation and truncated HMGR gene cassette (Westfall et al., 2012).  
In the current work, a novel yeast line was developed with the intent that this strain could 
be utilized for the production of all classes of terpene compounds. The aim of the work 
reported in this chapter was to optimize these yeast strains for diterpene production and 
more specific for kaurene, kaurenoic acid and abietadiene. The strategy employed was 
first to assume that the substrate, GGPP, for diterpene biosynthesis would be limiting in 
the yeast, and this necessitated the incorporation of a GGPP synthase into our yeast 
strains in order to divert the available IPP, DMAPP and FPP for GGPP biosynthesis. 
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While others have utilized functionally characterized GGPP synthase genes to effect 
such a change in metabolism (Dai et al., 2012, Tokuhiro et al., 2009, Zhou et al., 2012), 
we instead chose to mutate the avian FPP synthase into a GGPP synthase for this 
purpose. Our reasoning was that the avian FPP synthase is a superior prenyltransferase 
exhibiting higher catalytic turnover rates and lower Kms for its substrates than other 
prenyltransferase (Tarshis et al., 1996), and because the extensive biochemical and 
structural characterization of this enzyme readily facilitated its conversion into a potent 
GGPP synthase (Tarshis et al., 1996). We also assumed that the conversion of GGPP to 
diterpenes would be subject to the same enzymological concerns. That is, higher plant 
diterpene synthases are known to have low catalytic efficiencies (Keeling et al., 2010). 
Hence, we screened both plant and fungal sources for appropriate diterpene synthases. 
The same screening effort was directed to the enzymes that can decorate the diterpene 
scaffolds, and in particular the diterpene hydroxylases. This was followed by screening 
for the best expression vectors for the transgenes introduced into our yeast strains and 
lead to the identification of the GPD promoter as the best promoter leading to the highest 
levels of the desired diterpenes. Further enhancement of diterpene production by our 
yeast strains was provided by documentation of specific culture medium and 
temperature conditions, which varied depending on the desired diterpene product. 
We fully recognize that additional efforts can improve the diterpene yield in our yeast 
lines. For example, recent precedent for improving chemical yields by focusing on the 
association between enzymes catalyzing sequential reactions is an avenue worth 
considering. Dueber et al. (2009) built synthetic protein scaffolds bearing interaction 
domains allowing the assembly of heterologous proteins in prescribed stoichiometries for 
three mevalonate biosynthetic enzymes and achieved a 77-fold improvement in terpene 
product accumulation. Leonard et al. (2010) demonstrated that they were able to use a 
combinatorial mutation library of geranylgeranyl diphosphate synthase and 
levopimaradiene synthase to assemble enzyme complexes yielding increased 
production of levopimaradiene. Wild type levopimaradiene synthase, like many other 
terpene synthase catalyzes the production of several other diterpene products in 
addition to lelopiraradiene. The key mutants selected by Leonard et al. (2010) not only 
increased diterpenoid production, but also tuned the overall product selectivity towards 
levopimaradiene. These two studies offer additional approaches for how we might 
further enhance kaurene and abietadiene diterpene production in our yeast platform.  
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A second research area warranting further investigation based on our results relates to 
plasmid stability and copy number. We observed that the greatest yield of kaurene and 
its oxidation products was in fermentation conditions using a nutrient rich cultivation 
medium. This is in contrast to cultures for abietadiene production, which were grown in 
selection medium, medium that uses auxotrophic selection markers for the maintenance 
of the engineered plasmid vectors. We do not know why in one case (abietadiene 
production) selection pressure for plasmid maintenance is required, but not in the other 
(kaurene production). However, the level of plasmid retention in a culture is known to be 
affect by both genetic and physiological factors. Plasmid instability has been divided in 
two cases, segregation instability and structure instability, and both cause loss of 
recombinant genes in host cells. When yeast cells are grown under non-selective 
conditions, even the most stable 2µ-based chimeric plasmids undergo significant 
segregational instability (Romanos et al., 1992, Mendoza-Vega et al., 1994). Leu2d and 
Ura3d are two frequently used defective variant of LEU2 and URA3 genes, having 
mutations within their promoter regions that dampen the expression level of the 
corresponding selection marker genes. Selection of yeast transformants harboring these 
mutant selection markers can result in very high copy numbers of the respective 
plasmids, such as plasmids containing the Leu2d mutant results in 200 copies per 
haploid genome, which is 5 to 10 higher than for the conventional LEU2 marker 
(Mendoza-Vega et al., 1994). However, Ro et al. (2008) observed that using the Leu2d 
selection marker for introducing the amorphadiene (a sesquiterpene) biosynthetic gene 
only increased production 1.3-fold in selection medium, yet production was 5.9-fold in to 
non-selective, rich medium. While these defective auxotrophic selection markers 
increase plasmid copy numbers, it remains to be determined if this amplification actually 
translates to increase gene expression of genes carried on the respective plasmid 
vector. Our screen here of the various promoters driving expression of the diterpene 
biosynthetic genes would suggest that a similar screen with the defective selection 
marker vectors may be helpful in this regard.  
The third area of potential further optimization is in the culture medium and growth 
conditions. While we observed distinct differences in diterpene production based on 
nutrient rich versus selection medium, growth at 23oC versus 30oC, and exogenous 
sterol type and concentration, we are confident that many other growth condition 
parameters remain to be optimized. The efficiency of biomass accumulation by yeast is 
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dependent on the cells glucose consumption rate, which supports aerobic respiration 
and biomass accumulation, while anaerobic respiration encourages ethanol 
accumulation that inhibits cell growth. Thus, precise control of glucose addition to 
fermenting yeast can have a dramatic effect on secondary metabolism and the cultures 
abilities to accumulate diterpenes. In fact, it is more complicated than this simple model 
might suggest. Westfall et al. (2012) demonstrated using an ethanol and glucose pulse 
feeding strategy they could significantly boost amorphadiene production in fed-bath 
cultures. Since our yeast line is dependent upon an exogenous sterol supply, which is 
readily taken up under aerobic conditions, a multi-factorial screen of nutrients supplied 
by cultures grown under standard fermentation conditions (dissolved oxygen levels, pH 
control and impeller rpm) has the potential to also improve diterpene production levels. 
The yeast strains used for our studies are haploid and there is evidence to suggest their 
conversion to the diploid state could also improve diterpene yield. Prototrophic diploid 
cells generally exhibit more tolerance to environmental stresses, for instance, osmotic 
pressure, generally exhibit good growth kinetics, and accumulate more biomass in a low 
cost medium. Zhou et al. (2012) recently demonstrated that converting a haploid yeast 
strain to their corresponding prototrophic diploid form improved the accumulation of the 
diterpene miltiradiene 2.5 folds. Efforts to convert the ZX series yeast to their diploid 
form are a clear priority objective for the future.   
3.5. Materials and Methods 
3.5.1. Chemical and media preparations 
All chemical reagents were obtained from Sigma-Aldrich (St. Louis, MO), BD Bioscience 
(Franklin Lakes, NJ), or Fisher Scientific (Chicago, IL), while reagents for molecular 
manipulations were from Stratagene (San Diego, CA), Takara (Shiga, Japan), Invitrogen 
(San Diego, CA), and New England Biolab (Ipswich, MA). 
Bacteria and yeast were grown using standard culture practices. YPD media for growing 
yeast without selection consisted of 1% Bactoyeast extract, 2% Bacto-peptone, and 2% 
glucose (or 0.5% glucose for select experiments). YPDE media was YPD media 
supplemented with ergosterol (40 mg/L) for ergosterol dependent lines. 
Standard minimal selection media, SCE (pH 5.3), contained 0.67% Bacto-yeast nitrogen 
base (without amino acids), 2% dextrose, 0.6% succinic acid, 0.14% Sigma yeast 
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dropout solution (-his,-leu,-ura,-trp), uracil (20 mg/L), L-tryptophan (20 mg/L), L-histidine 
(20 mg/L), L-leucine (20 mg/L) and 40 mg/L ergosterol. The optimized selection meida is 
similar as the standard selection media but the supplement amino acid concentration 
used to complement auxotrophic genes are higher at uracil (300 mg/L), L-tryptophan 
(150 mg/L), L-histidine (250 mg/L), L-methionine (200 mg/L), L-leucine (1 g/L). 
Cholesterol and ergosterol stocks were 10 mg/mL in 50% Triton X-100, 50% ethanol, 
consideration sterilized and kept at -20˚C. Selection media was prepared similarly 
except without supplementing the media with the indicated reagent based on the yeast 
auxotrophic makers. All solid media plates were prepared with 2% Bacto-Agar.  
3.5.2. Yeast strains 
The ZX yeast lines used in these studies were described in Chapter 2. Essentially, these 
strains were selected for their ability to utilize exogenous sterol sources under aerobic 
conditions and were engineered with a knockout mutation in their squalene synthase 
(ERG9) gene such that the basic mevalonate biosynthetic pathway is operative up to 
FPP biosynthesis. 
3.5.3. Yeast transformation and culture performance  
Yeast strains were transformed with the respective vector constructs using the 
FROZEN-EZ Yeast Transformation II Kit (Zymo Research, Irvine, CA) according to the 
manufacturer’s recommendations. About 1 µg of plasmid DNA was used per 
transformation, followed by selection on agar plates of SCE medium lacking specified 
amino acids for the auxotrophic markers (selection media) or YPDE (rich media) at 30oC. 
Variable numbers of independent colonies were subsequently picked and used to start 3 
mL cultures in minimal media to characterize their terpene production capacities. 
Aliquots of these cultures were analyzed for terpene production after 3-6 days of 
incubation at 30oC with shaking by GC-MS. Cultures exhibiting the highest terpene 
production levels were chosen for further studies and archived as glycerol stocks at -
80˚C. Selected lines were characterized for cell growth and terpene production using 30 
mL shake flask cultures. Starter cultures grown to saturation in minimal media were 
inoculated into 30 mL SCE or YPDE media and 1 mL aliquots withdrawn at indicated 
intervals for up to 15 days. Cell growth was monitored as the change in optical density at 
600 nm, using appropriate dilutions for cultures at later stages of growth. Terpene 
production was determined by GC-MS similar to the initial screening method.  
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3.5.4. GC-MS detection and quantification of terpenes 
To determine terpene accumulation levels, aliquots of cultures grown for 3 to 12 days 
were extracted with hexane and aliquots evaluated by GC-MS. In general, to 1 volume of 
culture, 1 volume of acetone was added and mixed vigorously for 3 to 5 min to lyse the 
cells. The sample was then allowed to incubate at room temperature for 10 min before 
adding 1 volume of hexane containing a known amount of cedrene external standard. 
The mixture was again mixed vigorously, then centrifuged in a clinical centrifuge for 5 
min at maximum speed. The upper organic layer was collected and when necessary, 
concentrated under a N2 stream to 1/10 the original volume. An aliquot of the organic 
phase (1 μL) was then analyzed by GC-MS with a Varian CP-3800 GC coupled to a 
Varian Saturn 2200 MS/MS (Varian Medical Systems) using a Supelco SLB-5ms fused 
silica capillary column (30 m x 0.25 mm x 0.25 μm film thickness, Supelco).  The initial 
oven temperature was set at 70 °C for 1 min, ramped to 200 °C at 8 °C/min, and then 
ramped to 300 °C at 20°C/in and held for 5 min more. Farnesol and diterpene levels 
were calculated relative to the cedrene external standard.   
To determine kaurenoic acid accumulation level, yeast sample were collected and 
treated with acetone but extracted with 80% n-hexane and 20% ethyl acetate spiked with 
4-octyl benzoic acid (20 µg/mL). The extracts were completely dried under a N2 stream, 
resuspended in 100 µL methanol, and then derivatized with 60 µL of trimethylsilyl-
diazomethane (Aldrich 527254) for 20 minutes at room temperature. Sample were 
completely dried under N2 stream and resuspended in 100 µL hexane, 1 µL sample was 
subjected to quantitative and qualitative analysis by GC–MS. 
3.5.5. Expression vector construction  
The yeast GPD promoter (Pgpd) was amplified from the PYM-N14 plasmid described by 
Janke et al. (2004) using the primers GPD-BamHIF and GPD-NotIR primers and 
inserted into the pESC-His vector digested with BamHI and NotI to replace the original 
GAL1/10 promoters. The resulting plasmid was named pESC-His-gpd. The other 
promoter elements were obtained similarly.  Act promoter was amplified from the yeast 
genomic DNA described by Mateus et al. (2000). ADH1 promoter was amplified from 
Yep352 plasmid (Takahashi et al., 2007). Tef1, Cup1 promoters were amplified from the 
plasmids PYM-N18, PYM-N1 respectively (Janke et al., 2004). Those promoter elements 
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were then inserted into the pESC-His, pESC-leu, or pESC-ura with BamhI and NotI 
sites.  
pET28A-FPS was built by Wu et al. (2006). pET28A-mFPSF112A was constructed by 
site directed mutagenesis with primers mFPS F112A F/R following the manufacture’s 
instructions (Stratagene, San Diego, CA). Then mFPS gene was amplified and inserted 
into NotI and SpeI sites on pESC-His-GPD vector and similar vectors but the GPD 
promoter is replaced with other listed promoter elements.  
The fungal kaurene synthase, truncated grand fir abietadiene synthase, fungal kaurene 
oxidase, Arabidopsis kaurene oxidase, ABO and CYPB4, were synthesized with 
optimized codons for expression in yeast (Genescript, Piscataway, NJ), and inserted into 
pESC-Leu-GPD, or pESC-Ura-GPD as indicated in Figs. 3.7, 3.12, and 3.17. For mFPS 
and diterpene synthase inserted into one vector construct, pESC-HIs-GPD-mFPS was 
used as template to amplify with primers GPD-NheI and TADH-SalI, then inserted into 
pESC-leu-GPD-ABS vector with NheI and SalI sites. All other constructs with genes 
inserted into a single vector were built similarly. 
3.5.6. Yeast fed-bath fermentation   
Yeast diterpene producing strains were used for production of kaurene, abietadiene and 
kaurenoic acid by fed-batch fermentation. Yeast pre-cultures were prepared in 
Erlenmeyer flasks with optimized selection media at 23°C or 30°C as indicated with 
rotary shaking (180 rpm) for 2 days. The main culture medium (initial volume, 5.5 liters) 
in a 7.5-liter jar fermentor (New Brunswick Bioflo115) was seeded with a 200-ml aliquot 
of the pre-cultures. The temperature, agitation speed, flow rate of germ free air, 
dissolved oxygen, and pH were controlled at 23°C or 30°C as indicated, 600 rpm, 1 
volume of air per volume of culture per minute, >40% saturation and pH controlled to 5.3 
with 20% NaOH and 5% H2SO4. A total 1L 40% (w/v) glucose was fed at 15 g/h, once 
the initial starter culture glucose was depleted. Glucose was monitored using urinary 
glucose test strips available from common drug stores. During the fermentation, 2ml 
aliquots of culture were collected periodically to determine the amounts of terpene 
production and cell growth. 
Kaurene and kaurenoic acid fermentation media contained 10 g Bacto yeast extract, 20 
g Bacto peptone, 20 g glucose, 10 g KH2PO4, 0.5 g CaCl2, 2 g NaCl, 3 g MgSO4 per liter. 
 
 
102 
 
Abietadiene fermentation media contained 6 g Bacto-yeast nitrogen base (without amino 
acids), 1.4 g sigma yeast dropout solution (-his,-leu,-ura,-trp), 300 mg uracil, 150 mg L-
tryptophan, 250 mg L-histidine, 20 g glucose, 10 g KH2PO4, 0.5 g CaCl2, 2 g NaCl, 3 g 
MgSO4 per liter.  
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Table 3.1. Primers used for the various molecular manipulations describe in materials 
and methods 
Primer name Primer sequence 
mFPS 
F112A F 
GTGCATCGAGCTCTTCCAGGCCGCCTTCCTGGTG 
mFPS 
 F112A R 
CACCAGGAAGGCGGCCTGGAAGAGCTCGATGCAC 
FPS-NotIF 
GGGGCGGCCGCAAAAACAATGCAGCCCCATCATCATCATAA
AGAG 
FPS-SpeIR GGGACTAGTTCATTTCTGGCGTTTGTAGATCTTCTG 
FKS-NotIF 
GGGGCGGCCGCAAAAACAATGGGCGGCCGCTACCAGGTAA
AATTG 
FKS-SpeIR GGGACTAGTTTATTTCATACTTGAAGACAAATC 
ABS-NotIF 
GGGGCGGCCGCAAAAACAATGGTGAAAAGGGAGTTTCCAC
CTGG 
ABS-SpeIR GGGACTAGTTTATGCAACAGGTTGGAACAAAC 
CPR-NotIF 
GGGGCGGCCGCAAAAACAATGCAATCAACAACTTCCGTTAA
G 
CPR-SpeIR GGGACTAGTTTACCATACATCACGGAGATATCTTC 
AtKAO-NotIF 
GGGGCGGCCGCAAAAACAATGGCCTTCTTCTCCATGATCTC
C 
AtKAO-SpeIR GGGACTAGTTTAAGAACGCCTTGGATTGATAATAG 
GFKO-NotIF 
GGGGCGGCCGCAAAAACAATGAGTAAGAGTAACAGTATGA
AC 
GFKO-SpeIR GGGACTAGTTCATTCGTCTCTCAAACTTCTTTTTC 
PtAO-NotIF 
GGGGCGGCCGCAAAAACAATGGCAGACCAGATCAGTCTGC
TGC 
PtAO-SpeIR GGGACTAGTTTATTCACGGTTATACAGACGCATTG 
CYP720B4 
NotIF 
GGGGCGGCCGCAAAAACAATGGCTCCTATGGCTGACCAAA
TC 
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CYP720B4 
SpeIR 
GGGACTAGTTCATTCATTTTCAACTCTACCGTG 
 
Act BamHIF CGGGATCCTCAAAACCCTTAAAAACATATGCC 
Act-NotIR GGGGCGGCCGCAAAAGCTGATGTAGTAGAAGATC 
Adh-BamHIF CGGGATCC GTGGAATATTTCGGATATCCTTTTG 
Adh-NotIR GGGGCGGCCGCAGCTTAGCTTAGTTGATTGTATGCTTG 
Gpd-BamHIF CGGGATCCAGTTTATCATTATCAATACTCG 
Gpd-NotIR GGGGCGGCCGCCGTCGAAACTAAGTTCTGGTG 
Tef-BamHIF CGGGATCC ATAGCTTCAAAATGTTTCTACTCC 
Tef-NotIR GGGGCGGCCGCAAAACTTAGATTAGATTGCTATGC 
Cup-BamHIF CGGGATCCTAGTAAGCCGATCCCATTACCGAC 
Cup-NotIR GGGGCGGCCGC CTCTGTCGTCCGGATTTATGTGATG 
Gpd-NheIF GGGGCTAGCAGTTTATCATTATCAATACTCG 
Tadh-SalIR GGGGTCGACGAGCGACCTCATGCTATACCTGAG 
Act-NheIF GGGGTCGACTCAAAACCCTTAAAAACATATGCC 
Adh-NheI GGGGTCGACGTGGAATATTTCGGATATCCTTTTG 
Tef-NheI GGGGTCGACATAGCTTCAAAATGTTTCTACTCC 
Table 3.1 (continued) 
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Chapter 4: Engineer Monoterpene Production in Yeast  
 
4.1. Summary 
Yeast do not harbor a specific GPP synthase (GPS), only a FPP synthase, encoded by 
the ERG20 gene, which catalyzes conversion of IPP and DMAPP to FPP without 
releasing GPP. Knockout mutations of the Erg20 gene in genetic backrounds of yeast 
able to meet their sterol requirement from exogenous sources (sue mutants – sterol 
uptake enhancement mutants) are lethal, probably because FPP is involved in protein 
prenylation and the formation of GGPP, necessary for dolichol and ubiquinone 
biosynthesis. To advance the ZX178-08 yeast line capacity for monoterpene production, 
two avian mutant FPSs, mFPSA116W and mFPSN144W, having significantly more GPS 
like activity than FPS activity, were integrated into yeast genome to replace the native 
ERG20 gene to create the new yeast lines ZXM116 and ZXM144, respectively. The 
most promising results were observed when a bifunctional strawberry linalool 
(monoterpene)/nerolidol (sesquiterpene) synthase gene, FaNES, was coexpressed in 
ZXM144 line on a plasmid vector, yielding 84.76±13.2 mg/L linalool, 20.54±3.8 mg/L 
nerolidol and no detectable farneol. In contrast, only nerolidol and farnesol, without any 
geraniol or linalool, accumulated when FaNES was expressed alone or co-expressed 
with mutant FPS having GPS activity in ZX178-08. These results indicate the successful 
shift in yeast metabolism from the biosynthesis of the 15 carbon intermediate FPP to its 
10 carbon precursor, GPP. 
 
4.2. Background 
4.2.1. Monoterpene applications and uses 
Monoterpenes consist of two isoprene units, hence consist of 10 carbon atoms, and are 
derived from GPP. Monoterpenes are found predominantly in plants where they are 
thought to function as defense agents (Hick et al., 1999), attractants for pollinators 
(Kessler et al., 2008), and may mediate plant-to-plant communication (Barkovich & Liao, 
2001). More than 500 natural occurring monoterpenes have been identified, and many of 
these have commercial value as flavors, fragrances, pharmaceuticals, insect and 
antimicrobial control agents (Loza-Tavera, 1999). For instance, D-Limonene, which 
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possesses a strong smell of oranges, is commonly used in cosmetic products, such as 
hand cleansers, perfume, and shampoo (Bedoukian, 1983). Limonene is also widely 
used in food manufacturing, medicines, in cleaning solvents to remove oil from machine 
parts, and in some model airplane glues. Recently, limonene has also been suggested 
as a biofuel (Lohrasbi et al., 2010, Martín et al., 2010, Pourbafrani et al., 2010). Linalool, 
another common monoterpene, is widely used as a scent in perfumed hygiene products 
and cleaning agents, such as soaps, detergents, and shampoos (Bedoukian, 1983). 
Linalool is also used as a flea and cockroach insecticide, and is the sole active 
ingredient in some mosquito repellent products. Nakmura et al. (2009) have also 
reported that aroma therapy with linalool can reduce stress in lab rats. 
4.2.2 Conceptual framework for generating a GPP pool in yeast 
Geranyl diphosphate, GPP, is the essential allylic precursor for all monoterpene 
biosynthesis, and is not produced or produced in only very limited amounts in animals 
and microorganisms, including yeast cells. In fact, the yeast genome does not contain a 
geranyl diphosphate synthase (GPS) gene homolog. Instead, yeast harbors the gene 
ERG20, which encodes for a farnesyl diphosphate synthase, a multifunctional enzyme 
responsible for FPP biosynthesis from DMAP and IPP. Because of the apparent tight 
binding of GPP to the FPP synthase catalytic site, all the GPP generated from IPP and 
DMAPP by ERG20 is directly converted to FPP. Hence, the endogenous ERG20 
enzyme in yeast is considered to be solely an FPP synthase. More specifically, if the 
intent is to generate monoterpene products in yeast, the internal metabolism of yeast 
needs to be modified by building a GPP pool, and introducing an external appropriate 
monoterpene synthase that can efficiently divert this GPP to monoterpene biosynthesis 
as shown in Fig. 4.1.  
There are many ways to build a GPP pool in yeast, at least conceptualy. One would be 
to express a native plant specific GPP synthase enzyme in yeast with hopes a second 
enzyme, a monoterpene synthase also introduced into the yeast, would be efficient 
enough to divert the GPP so produced to monoterpene biosynthesis. A second means 
would be to mutate a robust FPS into a GPS-like enzyme and to introduce this into the 
yeast in a way that this prenyltransferase would yield sufficient amounts of FPP to meet 
this metabolic need in yeast, yet produce an excess of GPP. GPS belongs to the short 
chain prenyltransferase family of enzymes. This protein family includes GPS, FPS 
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(farnesyl diphosphate synthase), and GGPS (geranylgeranyl diphosphate synthase), 
and they all share a significant level of amino acid sequence similarity. Sequence 
alignment of various example sequences for these prenyltransferases has revealed five 
conserved amino acid sequence domains (Bouvier et al., 2005). Two important Asp-rich 
Motifs, FARM (First Asp-Rich Motif) and SARM (Second Asp-Rich Motif), both of which 
share the consensus sequence DDX2-4D, X representing any amino acid (Bouvier et al., 
2005). These two highly conserved Asp-rich motifs are important for catalytic function by 
supporting substrate binding. FARM has also been designated as the chain length 
determination region (Bouvier et al., 2005, Narita et al., 1999). A simple model for 
consecutive condensations of IPP by FPP synthase was illustrated by Ohnuma et al. 
(1996) and is shown in Figure 4.2. First, FPP synthase accepts IPP and DMAPP as 
substrates. After two consecutive condensations of IPP, the ω-terminus of the formed 
FPP reaches the amino acid at the fifth amino acid of the FARM domain (Ohnuma et al., 
1996). If the side chain of this amino acid is large, further condensation is inhibited, 
resulting in formation of only FPP. On the other hand, when the side chain is smaller, the 
condensation continues to give longer products such as GGPP and HPP (Tarshis et al., 
1996). Using the 3D crystallographic structure and site direct mutagenesis, mutant forms 
of FPS showed that the amino residue at the fourth and fifth position of the FARM block 
can serve as a steric hinderance to the allylic substrate binding site and prevent further 
product chain elongation (Bouvier et al., 2005). Directed mutagenesis of FPP synthase 
also generated mutant enzymes capable of further elongating the FPP as well. For 
example, mutation of phenylalanine at position 112 to alanine (F112A) of the avian 
farnesyl diphosphate synthase (FPS) results in a enzyme capable of producing 
geranylgeranyl diphosphate, while a F113S mutant yields geranylfarnesyl (C25) 
diphosphate as its dominant product, and even longer chain prenyl diphosphates when 
the double mutation F112A/F113S) was constructed (Tarshis et al., 1996).  
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Figure 4.1. Overall design for generating a yeast strain, ZXM144, capable of producing 
monoterpenes.  
The new generated yeast line would have a dispensable sterol biosynthetic pathway, 
and include the substitution of the native FPP synthase ERG20 with a mutant avian 
prenyltransferase selected for its ability to catalyze the robust generation of GPP. The 
build-up of a GPP pool would provide the necessary precursor for the biosynthesis of 
monoterpene compounds.  
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Figure 4.2. A schematic diagram of how the avian farnesyl diphosphate synthase is 
converted to a geranyl diphosphate synthase-like enzyme.  
The simple model for consecutive condensations of IPP by FPP synthase was adapted 
from the models of Ohnuma et al. (1996) and Fernandez et al. (2000). FPP synthase 
first accepts IPP and DMAPP, then condenses these two intermediated to GPP. In the 
mutant FPS model, the chain length determining region is occluded by a larger size 
amino residue, making the binding pocket shallower and prohibiting the further 
elongation of GPP to FPP, resulting in the release of GPP as the dominant product. In 
the wide type FPS model, a second consecutive condensation with IPP could happen 
and form the FPP as product. Kinetic parameters were determined by Fernandez et al. 
(2000): Wt FPS: Km=0.87 µM for IPP, Km=1.10 µM for DMAPP, Km=0.37 µM for GPP; 
mFPS A116W: Km=8.4 µM for IPP, Km=44 µM for DMAPP, Km=440 µM for GPP; mFPS 
N144W: Km=6 µM for IPP, Km=100 µM for DMAPP, Km=260 µM for GPP. 
  
 
 
110 
 
The distribution of GPSs (GPP syntheses) is limited in nature with some functioning as 
homodimers, like the Arabidopsis GPS (Bouvier et al., 2005), tomato GPS (Van Schie et 
al., 2007), three Grand Fir GPSs (Burke & Croteau, 2002) and an orchid GPS (Hsiao et 
al., 2008). Others function as heterodimers, which requires interaction between two 
separate and distinct subunits for enzyme activity. Examples of the heterodimeric GPSs 
include that from Clarkia, snapdragon, and mint (Burke et al., 2004). The large subunits 
of heterodimeric GPS share high amino acid sequence identity (50%-75%) with other 
prenyltransferases, while the heterodimer small subunits share much lower sequence 
identity with other prenyl diphosphate synthases (22-38%) and lack any Asp-rich motif. 
Interestingly, it has been found that the interaction of a small subunit of GPS with a 
homodimeric GGPPS from Taxus canadensis and Abies grandis can functionally convert 
these enzymes into GPS like enzymes (Burke et al., 2004), suggesting that the 
heterodimeric small subunit plays an important role in controlling prenyl chain length.  
Because hetrodimeric GPSs function as a pair of proteins with different amino acid 
sequences, balanced and coordinated expression of the two different genes to obtain 
the final functional protein is necessary. For this reason, given our aim to engineer 
monoterpene biosynthesis, it appeared that engineering of a homodimeric GPS would 
be a better choice than trying to engineer a heterodimeric GPS. All the homodimeric 
GPS protein sequences currently described from Chlamydomonas (Chlamydomonas 
reinhardtii XM001691017 (GeneBank accession number)), Grand Fir (Burke & Croteau, 
2002), grape (Vitis vinifera AY351862), sweet orange (citrus sinensis AJ243739), tomato 
(Solanum lycopersicum DQ286930), and Arabidopsis (Y17376, Bouvier et al., 2000) 
share high sequence similarity and contain the two asp-rich motifs. Exceptions to the 
sequence conservation within the homodimer group of GPS include the GPS from 
soybean (Glycine max EU399509), orchid (Hsiao et al., 2008) and a bark beetle Ips pini 
(Gilg et al., 2005), which lacks the conserved Asp-rich motif. The only homodimeric plant 
GPS without an Asp-rich motif is from Orchid and this enzyme exhibits dual 
prenyltransferase activity producing both GPP and FPP. It contains a putative active site 
EAEVE motif, which could provide a substitute binding site for Mg2+ and serve the 
reaction in a manner similar to the SARM (Hsiao et al., 2008).  
Considering the low GPS enzyme activity observed in preliminary experiments with an 
Arabidopsis homodimeric GPS, we instead began work on evolving a GPS from FPS as 
described by Fernandez et al. (2000) for the avian FPS. The mutations of A116W and 
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N144W of avian FPS putatively reduce the size of the binding pocket, which was 
identified by molecular modeling (Fernandez et al., 2000). The depth of the pocket that 
binds the hydrocarbon chain of the allylic substrate determines the number of isoprene 
residues (IPP) that could be added to the growing chain. The mutants N144W and 
A116W, which have bigger amino acid side chains, would tend to narrow or constrict the 
substrate binding pocket, stopping chain elongation from GPP to FPP, thus converting 
FPS into a selective GPS. These two mutant A116W and N144W exhibit GPP: FPP 
selectivity of about 35 and 185 to 1 respectively, but they only have approximately 35% 
of the activity of wild type FPP in terms of DMAPP utilization (Fernandez et al., 2000).  
Wu et al. (2006) reported that coupled over-expression of the avian FPS with 
sesquiterpene synthases in transgenic tobacco plants yielded about 30 µg/g FW 
sesquiterpene product, more than 1,000 times higher levels of sesquiterpene than in 
plants harboring only the synthase transgene. But, in constrast, over-expression of the 
Arabidopsis homodimeric GPS and a monoterpene synthase only yielded monoterpene 
accumulation about 1/100th that for sesquiterpenes. This information too suggested that 
the Arabidopsis homodimeric GPS could be limiting for GPP production in those 
transgenic plants. 
Altogether, the existing information pointed to the need for a more robust GPS sufficient 
to build up a GPP pool in yeast. And although the relative activity for the N144W and 
A116W mutants of the avian enzyme were slightly compromised, we considered the 
heterologous over-expression of these mutants in yeast as a viable means for building 
up the endogenous GPP pool and still providing the necessary FPP for viability. 
However, we also consider the buildup of a GPP pool in yeast as problematic without 
some means for down-regulating ERG20 and the conversion of any GPP to FPP that 
would be catalyzed by this enzyme. Moreover, because FPP is utilized in several 
biosynthetic processes, a direct knockout of ERG20 would be a lethal mutation. FPP is 
used in protein prenylation, and the formation of GGPP is necessary for dolichol 
(important for glycosylation reactions) and ubiquinone (important for electron transport) 
biosynthesis. Since the mutant avian FPS A116W and N144W mutants still maintained 
some FPP biosynthetic activity, we assumed that a direct replacement of ERG20 with 
either of the mutant avian enzymes could provide sufficient amounts of FPP for normal 
growth requirements, and could provide the necessary flux of carbon to GPP 
biosynthesis to support further monoterpene biosynthetic engineering. 
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4.2.3 Enzymatic active monoterpene synthase 
Monoterpene, the volatile compounds contained in essential oils, are widely applied in 
flavors or pharmacological agents. Interestingly, monoterpene synthesis can be carried 
out by colorless plastids, leucoplasts found in specialized secretary gland cells 
associated with leaves and stem trichomes or with the secretary cavities of citrus peel, 
as well as in the normal chloroplasts found throughout plants (Buchanan et al., 2002). 
Monoterpene synthase are responsible for the specific diversion of GPP to 
monoterpenes. Many monoterpene synthases have been isolated from essential oil 
producing species. Three monoterpene synthases (terpinene synthase, pinene synthase 
and limonene synthase) from lemon have been metabolic engineering into tobacco to 
increase fragrance, which produced limonene as levels as high as 1.2 µg/g fresh weight 
sample every 24 hours (Lücker et al., 2001). Transgenic tobacco plants engineered by 
(Wu et al., 2006) for over-expression of an Arabidopsis GPS and a lemon limonene 
synthase accumulated upwards of 500 ng/g FW. Aharoni et al. (2003) observed that 
constitutively expressing a strawberry dual linalool/nerolidol synthase (FaNES1) in 
Arabidopsis resulted in linalool and its glycosylated and hydroxylated derivatives 
accumulating up to 13 µg linalool per day. FaNES1 is a multi-functional terpene 
synthase that can synthesize a monoterpene, linalool, from GPP and a sesquiterpene, 
nerolidiol, from FPP (Aharoni et al., 2004). Over-expression FaNES1 in yeast could thus 
serve as a measurement of the endogenous pools of GPP and FPP, and monitoring the 
endogenous shift from FPP to GPP accumulation in erg20 defective lines. Hence, we 
decided to use FaNES1 as a means for monitoring the success of our strategy to 
metabolic engineer yeast for monoterpene biosynthesis.  
4.3. Results 
4.3.1. Mutating a FPS into a GPS  
Our attempts to engineer elevated GPP levels in yeast using known plant geranyl 
diphosphate synthases were unsuccessful. In fact, all the known GPS enzymes appear 
to possess poor catalytic efficiencies for GPP biosynthesis. We therefore decided to 
evolve GPS activity from the very robust avian FPS according to (Fernandez et al., 
2000). The mutants A116W and N144W of the avian FPS are predicted to restrict the 
size of the active site pocket, stopping chain elongation from GPP to FPP, and thus 
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converting FPS into a more selective GPS while maintaining relatively good catalytic 
efficiencies, up to 35% of the wild type enzyme. 
Wide type avian FPS was subcloned from a construct built by Wu et al. (2006) into 
Pet28a vector under the control of an IPTG inducible T7 promoter. The mutant FPSs 
were generated with the primers described by Fernandez et al. (2000) via sited directed 
mutagenesis with pET28a-FPS serving as the template. Then the constructs were 
transformed into E. coli BL21. After induction by IPTG, the mutant FPS lines gave similar 
protein levels to the wide type FPS as shown by Coomassie Blue stained SDS- PAGE 
gels of total protein extracts from the transformed lines of E. coli (Fig. 4.3A).   
The prenyltransferase selective enzymatic activities of mutants FPS toward synthesis 
GPP relative to wild type FPS were identified by the assay with DMAPP and IPP as 
substrate and cell-free extract lysate to produce GPP or FPP. When radioactive 
substrates were used, the reaction solution was extracted by butanol and aliquots of the 
extract counted in a liquid scintillation counter to gain a measure for the total 
prenyltransferase (GPP and FPP) activity. The mutant enzymes possess approximately 
70% or better of the catalytic activity as the wild type enzyme. When non-radioactive 
substrates were used, after the reactions were incubated, alkaline phosphatase was 
added to hydrolyze the prenyl diphosphates (GPP and FPP) to the corresponding 
alcohols GOH and FOH, and then the products could be separated and quantified by 
GC-MS as described in Fig.4.3B & C. For wild type FPS when supplied with IPP and 
DMAPP as substrates, it produced both GPP and FPP, while the two mutants 
mFPSA116W and mFPS-N144W only produce GPP in our cell-free cold assay system. 
mFPSA 116W gave about 80% product yield and mFPSN144W gave 67% product yield 
relative to the wild type enzyme. Based on the studies of Fernandez et al. (2000), these 
two mutant A116W and N144W should exhibit GPP: FPP selectivity of about 35 and 185 
to 1 respectively. We were not able to confirm these selectivity ratios in part because of 
the sensitivity of our instrumentation. Nonetheless, we decided to test both of these two 
mutants in our yeast system. 
4.3.2. Replacement of yeast FPP synthase gene, ERG20, with the avian mFPS 
A116W and N144W through homologous recombination 
Because we did not know if the residual FPS activity for either of the two mFPS would 
be sufficient to complement an erg20 knock out in terms of supplying FPP, we designed 
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a two-step replacement strategy (Fig. 4.4). First, an algal, Botryococcus braunii, FPS 
(bFPS) was inserted into a URA3 expression vector and introduced into the yeast 
ZX178-08 line. This was done to assure that a knockout mutation in the ERG20 gene 
would not be lethal. Then we went about the process of designing and constructing site-
specific recombination cassettes bearing the mutant avian FPSs between 5’ and 3’ 
sequences of the ERG20 locus. Integration of these cassettes into the yeast genome 
would remove the intact ERG20 gene and replace it with the various mutant FPS genes. 
To monitor these integration events, yeast were grown in complete medium for 48hr, 
then plated onto selection medium minus Leu. About twenty single independent yeast 
transformants grew and were picked for further confirmation of recombination. Genomic 
DNA isolated from the tranformants and control yeast line ZX178-08 were used as 
template for PCR reactions with four sets of primers to verify the correct gene 
replacement of the target ERG20 as described in Fig 4.5. Transformant #4 was negative 
in PCR reactions A, which is specific for the ERG20 gene, yet positive in PCR reactions 
B, a reaction specific for the avian mFPS gene. Transformant #4 was also gave positive 
and correct sized DNA fragments in PCR reactions C and D, also consistent with the 
proper integration of the mFPS-LEU2 constructs into the ERG20 locus.  
The next step was to evict the plasmid vector harboring the bFPS gene. If the mFPS 
genes integrated into the genome were sufficient in meeting the cell’s demands for FPP, 
then the yeast lines without the bFPS construct would be viable and afford the yeast 
lines with a pool of GPP for monoterpene biosynthesis. When positive yeast 
transformant # 4 was replica plated onto minimal medium containing 5FOA (5-
fluoroorotic acid) to counter-select for lose of lthe Ura3 containing episomal vector, yeast 
line ZXM116 was obtained. 5-FOA is nontoxic to yeast, but in strains expressing a 
functional URA3 gene, 5-FOA is converted to the toxin 5-flurouracil. In an identical 
manner, yeast strain ZXM144 was development by replacement of the ERG20 gene with 
the mFPS N144W gene. Both of these yeast lines produced a significant amount of 
geraniol as determined by GC-MS, and had a distinctive rose-like scent which differed 
from the common scent of yeast.  
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Figure 4.3. Characterization of prenyltransferase activities.   
A) FPS and mutant FPS genes were expressed in E. coli BL21 (DE3) cells, total proteins 
extracted, size separated by SDS-PAGE and the gel stained with the general protein 
stain Coomassie Blue. Total proteins from E. coli  harboring the expression vector only 
(no foreign gene inserts) (lane 2), or the total proteins from E. coli expressing wild type 
FPS gene, the FPS A116W mutant or the FPS N116W mutant genes (lanes 3, 4, and 5 
respectively). B) A cartoon depiction of the assay used to qualify the reaction products of 
the different prenyltransferases as measured in the GC-MS assays. C) Actual GC-MS 
assessment of the reaction products generated by the indicated bacterial extracts 
incubated with IPP and DMAPP as substrates. While wild type FPS generated both GPP 
and FPP in these in vitro assay conditions, both mutants appear to only produce GPP.   
Mutant FPS A116W gave approximate 80% product yield relative to the wild type 
enzyme, while mFPSN144W gave approximately 67% product yield. The retention times 
and mass spectra for the indicated GOH and FOH peaks matched authentic standards. 
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Figure 4.4. A schematic diagram of the overall approach to generate new yeast strains 
with the ability to accumulate high levels of GPP, a key precursor for monoterpene 
biosynthesis.  
ZX178-08 is a yeast line that accumulates high levels of FPP and has a dispensable 
sterol biosynthetic pathway because of a knockout mutation in its squalene synthase 
gene, ERG9. ZX178-08 hence served as the initial parental line for generating a strain 
that accumulates GPP, a key intermediate in monoterpene metabolism, rather than FPP. 
To limit FPP biosynthesis in ZX178-08, a knockout mutation in the native FPS gene, 
ERG20 was desired. However, because a complete knockout and elimination of all FPP 
would be a lethal mutation, we sought to replace the ERG20 gene with a 
prenyltransferase yielding some FPP, but mostly GPP when expressed. Two mutant 
FPS genes, referred to as A116W and N144W for the particular amino acid modification 
in each, encode for prenyltransferases that have robust GPP biosynthetic activity, but 
still have some capacity for FPP biosynthesis. To replace the native FPP synthase gene 
ERG20 with these mutant forms required a two-step process. First, to assure a supply of 
FPP, the yeast were engineered with an algal FPP synthase on an episomal vector.  
Then the mFPS genes were flanked by 5’ and 3’ sequence surround the ERG20 gene, 
which facilitates the replacement of the ERG20 gene by homologous recombination. 
After selection for independent recombinant colonies each of the transformants can be 
PCR screened for replacement of the ERG20 gene.  The positive ERG20 replacement 
lines can then be replica plated onto medium containing 5-FOA to select for lose of the 
bFPS plasmid. The resulting yeast lines are named ZXM116 or ZXM144. Finally, a 
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bifunctional monoterpene/sesquiterpene synthase gene, FaNES1, can be introduced 
into the new ZXM yeast series to divert any excess GPP and FPP to monoterpene and 
sesquiterpene biosynthesis, respectively. To further enhance monoterpene biosynthesis, 
the introduction of an extra copy of the mFPS can also be added to the episomal vector.  
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4.3.3. Measuring the GPP and FPP pools in yeast by over-espression of the 
FaNES1 gene 
To evaluate the utility of the new yeast lines ZXM116 and ZXM144 for monoterpene 
production, we first examined their accumulation of geraniol, the dephosphorylated 
product from GPP while harboring an expression vector, Xhis, without any inserted 
monoterpene synthase gene. The rationale for this was that we would ultimately want to 
introduce a monoterpene synthase into these lines and hence wanted to establish the 
background levels for their substrate, GPP. While no geraniol was detectable in cultures 
of the parental yeast line BY4741 or ZX178-08, ZXM116 containing the Xhis vector 
accumulated 1.33±0.57 mg/L geraniol and 34.66±5.66 mg/L farnesol, and ZXM144-Xhis 
accumulated 2±1.1mg/L geraniol but no farnesol. The accumulation of both geraniol and 
farnesol in the yeast line harboring the A116W mutant FPS and essentially only geraniol 
accumulation in the yeast line containing the N144W mutant FPS is consistent with the 
observations of Fernandez et al. (2000), who noted that the N144W mutant exhibited a 
much greater GPP synthase activity relative to FPP synthase activity than the A116W 
mutant.  
We next sought to determine how available the accumulating GPP pool might be for 
monoterpene synthase. For this purpose, we chose to over-express the strawberry 
FaNES gene, which encodes for a bifunctional terpene synthase (Fig. 4.6). If provided 
with GPP, the enzyme would convert this substrate to linalool. If provided with FPP, the 
NES enzyme catalyzes its conversion to nerolidol. Thus, over-expression of the NES 
enzyme activity could be used to measure, simultaneously, the available GPP and FPP 
pools. When the FaNES gene was expressed in the parental yeast line ZX178-08, 
nerolidol accumulated up to 140 mg/L over a 10 day culture period, but no linalool was 
detected (Fig. 4.7). Even when the avian A116W mutant FPS was included with the 
FaNES gene on the expression vector, no linalool was detected.  
The FaNES gene was then introduced into the ZXM116 and ZXM144 yeast lines in 
combination with extra copies of the mutant FPS also included on the expression vector 
(Fig. 4.8). Small-scale cultures of transformants harboring the various plasmid constructs 
were then propagated for 6 days prior to examining the cultures for their terpene profiles. 
ZXM116 with just the expression vector (empty vector control) accumulated 1 to 2 mg/L 
of geraniol and in excess of 35 mg/L of farnesol. When the FaNES gene was introduced 
into this line, a slight decline in the amount farnesol accumulation was noted with only a 
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very modest accumulation of linalool and nerolidol. When an extra copy of the mutant 
avian FPS was included, either the A116W mutant or the N144W mutant, linalool and 
nerolidol levels increased 10- to 20-fold. A somewhat similar trend was noted for the 
ZXM144 line, except that the level of farnesol and nerolidol were substantially lower. 
Similar trends in chemical accumulation were also observed when the ZXM lines were 
grown in shake flask cultures and when harboring extra copies of the avian mutant FPS 
gene (Fig. 4.9). That is the greatest level of monoterpene (linalool) accumulation was 
observed with the ZXM144 line co-expressing the FaNES gene and extra copies of 
mFPSN144W gene on episomal plasmid, with 84.76 ±13.2 mg/L linalool, 20.54±3.8 
mg/L nerolidol, less than 1mg/L geraniol and no detectable farnesol observed over the 
14 days of culturing. 
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Figure 4.5. PCR screening for replacement of the ERG20 gene with mutant FPS-LEU2 
constructs.  
DNA isolated from 6 independent colonies was used as PCR template with four sets of 
specific primers as illustrated in panel A. If the ERG20 gene (1059bp) was replaced by a 
mutant FPS, the amplification products expected in PCR reactions B, C, D are 1137bp, 
2304bp, and 5580bp size fragments, respectively, but no amplification product is 
expected from the A reactions. With ZX178-08 genomic DNA as control template, only 
amplification products from PCR reactions A & D are expected, and no product is 
expected from amplification reactions B or C.  
 
A 
 
B 
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Figure 4.6. The strawberry FaNES1 gene encodes for a bifunctional enzyme that can 
use either GPP or FPP as its substrate, and can hence serve to measure the available 
GPP and FPP levels in vivo. 
Strawberry FaNES1 is a bifunctional terpene synthase involved in monoterpene (C10) 
and sesquiterpene (C15) biosynthesis (Aharoni et al., 2004). FaNES catalyzes the 
conversion of geranyl diphosphate (GPP) into S-linalool and farnesyl diphosphate (FPP) 
into (3S)-E-nerolidol. The kinetic parameters for both activities are: Km=8.1 µM for FPP; 
Km=29.0 µM for GPP; Vmax=2.3 nmol/h/µg enzyme toward GPP; Vmax=3.0 nmol/h/µg 
enzyme toward farnesyl diphosphate (UniProtKB/Swiss-Prot: P0CV94.1). The 
bifunctional character of FaNES1 suggests that is can be used to measure GPP and 
FPP pools when expressed in yeast. 
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Figure 4.7. Expression of the strawberry FaNES gene in the parental yeast strain 
ZX178-08 only yields sesquiterpene products. 
 
Previously developed ZX178-08 line has the dispensable sterol biosynthesis pathway 
and yeast squalene synthase (ERG9) knock out, accumulated high level of FPP, which 
can be utilized as the precursor for engineering sesquiterpene and triterpene. To test the 
capability of engineering monoterpene biosynthesis into ZX178-08, yeast expression 
vectors harboring FaNES alone or plus mutant FPS gene having GPS activity 
(Fernandez et al., 2000) were transformed into ZX178-08 yeast line, and then grown for 
10 days prior to chemically profiling them for their chemical constituents by GC-FID and 
quantifying the levels of terpene accumulation in transgenic yeast. Terpene production 
and cell growth over 10-day shake flask culture are shown in panel A. No detectable 
geraniol or monoterpene related compounds accumulated, only farnesol and nerolidol 
were readily detected. GC was used to identify geraniol, linalool, farnesol, nerolidol and 
external standard cedrene from yeast extracts in comparison to authentic standards (B).  
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Figure 4.8. The expression of the strawberry FaNES gene alone and in combination 
with the avian mutant FPS in the ZXM yeast lines. 
Yeast strains ZXM116 (A) and ZXM144 (B) were transformed with a vector control 
plasmid Xhis, this same vector with the FaNES1 only (Xhis-tFaNES), or the FaNES1 
gene plus an extra copy of the mutant FPS as Xhis-116-tFaNES or Xhis-144-tFaNES. 
Yeast lines were grown as test tube shake cultures in 3 mL of SCE- Leu-His media 
containing 40 µg/ml of ergosterol for 6 days prior to sampling the cultures. Hexane 
extracts were concentrated and aliquots subjected to GC-FID to quantify linalool, 
geraniol, nerolidol and farnesol compound levels, relative to the external standard 
cedrene. The production level represents the average production from five independent 
single colonies.  
A 
 
ZXM116 
 
B 
 
ZXM144 
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Figure 4.9. Terpene accumulation in ZXM series yeast cultures over a 14 day period   in 
shake flask cultures with selection medium. 
Terpene accumulation and cell growth in yeast transformant lines ZXMO116 expressing 
Xhis-116-tFanes (A) or Xhis-144-tFaNES (B) and ZXMO144 expressing Xhis116-tFanes 
(C) or Xhis-144-tFaNES (D) were quantified and documented over 14 day culture. 
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Aliquots of hexane extracts prepared from the culture samples at the indicated time 
periods were subjected to GC-FID analysis and the linalool, geraniol, nerolidol and 
farnesol levels quantified relative to the external standard cedrene. Data points 
represent the average for 3 independent cultures. Panel E is an example GC 
chromatography of an extraction prepared from ZXM144 line expressing mutant mFPS 
N144W along with FaNES. Compounds were identified on the basis of their mass 
spectrum and retention time in comparison to authentic standards. 
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4.4. Discussion 
Compared with engineering sesquiterpene biosynthesis and accumulation in E. coli or S. 
cerevisiae, much less progress in the metabolic engineering of monoterpene metabolism 
has been achieved. There are probably many reasons for this, including less necessity 
for alternative production platforms when there are convenient natural sources already. 
Nonetheless, one of the other reasons monoterpene engineering has lagged behind 
other classes of terpene is because most microbial platforms do not readily produce the 
key intermediate GPP, which is essential to build monoterpenes, and there is relatively 
little in depth information available about the GPP synthase enzymes and the means for 
engineering these enzymes for high level GPP production are rare.  
Oswald et al. (2007) worked on evolving a GPS from FPS. The erg20-2 mutant yeast 
line is a leaky mutant which contains a K → E mutation at 197, leading to a 14-fold 
decrease in FPS activity (Blanchard & Karst, 1993). The erg20-2 strain also had the 
unusual property of accumulating geraniol. When in vitro enzyme assessments were 
done, the wide type ERG20 enzyme was shown to produce about 75% FPP and 25% 
GPP, while the erg20-2 mutant produced only 25% FPP, but 75% GPP (Oswald et al., 
2007). Using 3D structure model for the yeast FPS, the K197E mutation could be 
rationalized as causing a reduction in the binding pocket size, which in turn could 
prevent the successive elongation of the bound GPP with a second condensation with 
IPP. In the wild type FPS, lysine 197 would bind tightly with GPP and allow the next 
head to tail condensation with IPP to form FPP (C15), while glutamic acid at position 197 
of the mutant yeast FPS narrows the reaction pocket of yeast enzyme, preventing the 
next elongation to FPP. Overexpression of a sweet basil GES (geraniol synthase) in the 
erg20-2 mutant yeast line lead to the monoterpenol geraniol being excreted into the 
growth medium (500 µg/L). Fischer et al. (2011) went on to further improve the erg20-2 
mutant by subjecting the K197 position to other amino acid substitutions. The major 
improvement achieved was 5 mg/L of geraniol when GES was over-expressed in this 
yeast line (Fischer et al., 2011). 
Similar work has been carried out with a bacterial FPP synthase, IspA, and attempts to 
convert this enzyme into a GPP-like synthase. A mutation in Bacillus IspA, S82F, 
resulted in a distribution of GPP/FPP of 27:1, clearly indicating the importance of this site 
in the product specificity of the enzyme (Bouvier et al., 2005, Koyama et al., 1995). An 
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analogous mutation of E. coli IspA enzyme, S81F, was also used to engineer 
monoterpene production to 0.42 µg/OD600/L/h (Reiling et al., 2004).  
Overall, the monoterpene yeast lines developed here with co-expression of the bi-
functional enzyme FaNES along with mutant prenyl transferase, have resulted in the 
highest levels of monoterpenes produced in microbes yet reported. This was created in 
large part by the generation of mutant FPS enzymes that afford sufficient amount of FPP 
to be produced to meet the physiological needs of the cell, plus diversion of excess 
carbon to the biosynthesis of GPP. The mFPS N144W mutant, for example, exhibited 
greater GPP selectivity than mutant mFPS A116W in vivo, consistent with the in vitro 
findings of Fernandez et al. (2000). In contrast, when the ZXM144 line harbored the 
FaNES gene plus extra copies of mFPS N144W gene on a plasmid vector, linalool levels 
in excess of 80 mg/L in shake flask culture was achieved, nearly 25 to 50% the level 
sesquiterpene accumulation observed earlier in Chapter 2. Our newly generated yeast 
lines cultures also have a very prominent rose-like scent coming from volatile 
monoterpenes. These indicate a continuous loss during cultivation, and the productivity 
we measure as the monoterpene content in the cultures is certainly an under-estimation 
of the real productivity. Additional efforts to account for head gas losses will be 
necessary to fully appreciate the productivity of our metabolic engineered yeast lines.  
4.5. Materials and method 
4.5.1. Chemical and media preparations 
All chemical reagents were obtained from Sigma-Aldrich (St. Louis, MO), BD Bioscience 
(Franklin Lakes, NJ), or Fisher Scientific (Chicago, IL), while reagents for molecular 
manipulations were from Stratagene (San Diego, CA), Takara (Shiga, Japan), Invitrogen 
(San Diego, CA), and New England Biolab (Ipswich, MA). 
Bacteria and yeast were grown using standard culture practices. YPD media for growing 
yeast without selection consisted of 1% Bactoyeast extract, 2% Bacto-peptone, and 2% 
glucose. YPDE media was YPD media supplemented with ergosterol (40 mg/L) for 
ergosterol dependent lines. Ergosterol. Ergostrol stocks were 10 mg/mL in 50% Triton X-
100, 50% ethanol and kept at -20˚C.  Minimal media, SCE (pH 5.3), contained 0.67% 
Bacto-yeast nitrogen base (without amino acids), 2% dextrose, 0.6% succinic acid, 
0.14% Sigma yeast dropout solution (-his,-leu,-ura,-trp), uracil (300 mg/L), L-tryptophan 
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(150 mg/L), L-histidine (250 mg/L), L-methionine (200 mg/L), L-leucine (1g/L) and 40 
mg/L. Selection media was prepared similarly except without supplementing the media 
with the indicated reagent based on the yeast auxotrophic makers. All solid media plates 
were prepared with 2% Bacto-Agar.  
4.5.2. Yeast transformation and culture performance  
Yeast strains were transformed with the respective vector constructs using the 
FROZEN-EZ Yeast Transformation II Kit (Zymo Research, Orange, CA) according to the 
manufacturer’s recommendations. About 1 µg of plasmid or about 5 µg of linearized 
DNA was used per transformation and followed by selection on agar plates of SCE 
medium lacking specified amino acids for the auxotrophic markers at 30°C. Variable 
numbers of independent colonies were subsequently picked and used to start 3ml 
cultures in minimal media for isolating genomic DNA or characterize their terpene 
production capacities. To verify the correct homologous recombination of replacement of 
ERG20 more than 20 independent colonies were picked, cultured and prepared for 
genomic DNA by using YeaStar™ Genomic DNA Kit (Zymo Research, Orange, CA). 
Four sets of primers PA (ERG20F, ERG20R), PB (FPSF, FPSR), PC (LEU2 NotIF, 
Yeast X106918R), PD (Yeast X104229F, Yeast X106918R) as listed in table 4.1 were 
used to screen the positive replacement of ERG20. For terpene production 
quantification, aliquots of yeast cultures were analyzed by GC-MS after 6 days of 
incubation at 23°C with shaking. Cultures exhibiting the highest terpene production 
levels were chosen for further time course studies and archived as glycerol stocks at -
80˚C. Selected lines were characterized for cell growth and terpene production using 30 
mL shake flask cultures. Starter cultures grown to saturation in minimal media were 
inoculated into 30 mL SCE media and 1 mL aliquots withdrawn at every other day 
intervals for 10–15 days. Cell growth was monitored as the change in optical density at 
600 nm every two days, using appropriate dilutions for cultures at later stages of growth. 
Terpene production was determined by GC-MS similar to the initial screening method.  
4.5.3. GC-MS detection and quantification of terpenes 
To determine terpene accumulation levels, aliquots of cultures grown for 6 to 12 days 
were extracted with hexane and aliquots evaluated by GC-MS. In general, to 1 volume of 
culture, 1 volume of acetone was added and mixed vigorously and left on bench for 
15min to lyse the cells. The sample was then allowed to incubate at room temperature 
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for 10 min before adding 1 volume of hexane containing a known amount of cedrene 
external standard. The mixture was again mixed vigorously, then centrifuged in a clinical 
centrifuge for 5 min at maximum speed. The upper organic layer was collected and 
when necessary, concentrated under a N2 stream to 100 µl. An aliquot of the organic 
phase (1 μl) was then analyzed by GC-MS with a Varian CP-3800 GC coupled to a 
Varian Saturn 2200 MS/MS (Varian Medical Systems) using a Supelco SLB-5ms fused 
silica capillary column (30 m x 0.25 mm x 0.25 μm film thickness, Supelco).  The initial 
oven temperature was set at 60 °C for 2 min, ramped to 200 °C at 8 °C/min, and then 
ramped to 300 °C at 20°C/min and held for 1 min more. Linalool, geraniol, nerolidiol and 
farnesol levels were calculated relative to the cedrene external standard.  
4.5.4. Construction of the farnesyl diphosphate synthase erg20 Knockout 
mutation 
Figure 4.10 illustrates the general strategies used to construct the various expression 
vectors. The yeast GPD promoter (Pgpd) was amplified from the PYM-N14 plasmid 
described by (Janke et al., 2004) using the primers PTEF-PGDF and PGPD-EcoRIR. 
The yeast TEF1 promoter (Ptef1) was amplified from the PYM-N18 with PTEF-PGDPR 
and PTEF-BamHIR primers (Janke et al., 2004). After purification 200 ng Pgpd and Ptef 
was mixed and used as template to run second PCR with primers PGPD-EcoRIR and 
PTEF-BamHIR to assembly these two promoters together for building the pesc-X series 
vectors containing two strong constitutive divergent promoters for expression two genes 
in one single vector. The obtained two GPD and TEF promoter fusion product was 
inserted into the pESC vector series digested with EcoRI and BamHI to replace the 
original GAL1/10 promoters to construct the new X series vector. The resulting plasmids 
were named Xhis, XUra, XLeu.  
The LEU2 and bFPS gene were cloned into NotI and SpeI sites of XUra to obtain the 
yeast expression vector XUra-Leu and XUra-bFPS. Then the mutant FPS genes were 
amplified from pet28A-mFPS116 or Pet28A-mFPS144 with primers (FPS BamHIF and 
FPS XmaIR), and inseted into XUra-Leu multiple cloning sites digested with BamHI and 
XmaI. The resulting vector was used as template to amplify the fragment A harboring 
mFPS gene and Leu2 selection marker with primers ERG20L-TCYC2F and TADH-
ERG20R2 having homologous sequences to Erg20 with TCYC or TADH as illustrated in 
Fig4.8. 
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Figure 4.11 illustrates the vectors and experimental strategy for replacing the ERG20 
gene with the different mutant FPS genes. The primers (Yeast X-104429Fand Yeast X-
106818R) as list in Table 4.1 were used to amplify the farnesyl diphosphate synthase 
ERG20 (on chromosome X from coordinates 105014 to 106072) along with the 
surrounding 612 bp up and 746 downstream regions in the yeast genome from the yeast 
ZX178-08 genomic DNA by using Takara high fidelity Primestar taq polymerase. The 
obtained PCR fragment was gel purified, A tailed and ligated into the pGEM-Teasy 
vector (Promega, WI) by following the manual. The obtained vector was used as 
template to run second PCR with primers Erg20L-TCYC2R and ADH-Erg20RF2 to 
obtain PCR fragment B containing 30bp homologous region to ERG20 surrounding 
region plus flanking with 30bp homologous to TCYC and TADH as illustrated in Fig 4.8.  
To build the ERG20 replacement construct, PCR fragment A and B were treated with 
DpnI to digest the template plasmid, and then assembled together with Gibson 
Assembly Kit (New England Biolab, Ipswich, MA). The resulting construct was used as 
template to amplify fragment C as shown in Fig. 4.11 which contained the homologous 
sequence to ERG20 surrounding regions, mFPS and Leu2 selection marker. These PCR 
fragments were than transformed to the ZX178-08 yeast line harboring XUra-bFPS 
vector following the standard protocol but without growth in YPDE rich medium for 48 hr 
before selected on minus Leucine plates. Over twenty independent single colonies were 
picked for PCR confirmation of recombination with four primer sets listed above, as well 
as geranyl and farnesol production analysis. 
Yeast lines with correct recombination were replica plated on SCE-Leu plates containing 
5-FOA to select for loss of the XUra-bFPS vector, and the resulting yeast lines named 
ZXM116 (ERG20 replaced by mFPSA116W) or ZXM144 (ERG20 replaced by mFPS 
N144W). 
4.5.5. Expression of the FaNES and extra copy mFPS in yeast  
Total strawberry total RNA wes extracted from mature strawberry with QIAGEN RNeasy 
plant mini kit (QIAGEN, Valencia, CA), and double strand cDNA was synthesized 
according to the method described in Stratagene. Twenty nanogram of double-strand 
cDNA was used as template for PCR with primers tFaNES NotIF, and tFaNES SpeIR.  
The PCR fragment was inserted into Xhis-Leu-mFPS116 and Xhis-Leu-mFPS144 
vectors digested with NotI and SpeI to replace the Leu2 selection marker. The resulting 
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vectors were named Xhis116tFaNES and Xhis-144-tFanes. Xhis-tFaNES construct was 
built similarly, but the tFaNES fragment was inserted into Xhis vector digested with NotI 
and SpeI. Yeast lines transformed with these constructs plus Xhis control were then 
evaluated for their production of the linalool, geraniol, nerolidol and farnesol as a 
measure of the available of intermediates of the mevalonate biosynthetic pathway for the 
biosynthesis of monoterpene and susquiterpene.   
4.5.6. Characterization of prenyltransferase activities. 
4.5.6.1 Functional protein expression in E.coli 
Pet28A-FPS was built by Wu et al. (2006). Pet28A-FPS116 and Pet28A-FPS144 were 
constructed by site directed mutagenesis with primers mFPS A116WF/R and 
mFPSN144WF/R following the manufacture instruction described by stratagene. E. coli 
BL21(DE3) cells are transformed with the resulting recombinant plasmids, as well as an 
empty pET vector for use as control. Single positive bacteria colonies, confirmed by DNA 
sequence, were used to inoculate 10 mL LB medium with 100 µg/ml of kanamycin, and 
cultured overnight at 37°C. One mL of these cultures was then inoculated into 100 ml LB 
medium containing 100 µg/ml of kanamycin to grow continuously at 37°C until OD 
reached 0.5-1.0. Transcriptional expression of the recombinant genes downstream of 
the T7 promoters in the pET vectors were then induced by the addition of 1mM 
isopropyl-1-thio-b-D-galactopyranoside (IPTG), and the cultures grown at room 
temperature overnight. 
4.5.6.2. Preparation of E. coli lysates and purification of recombinant proteins with 
Ni column 
One hundred mL of overnight IPTG-induced cultures were harvested by centrifugation at 
4°C and resuspended in 4 mL of lysis buffer (80 mM postassium phosphate buffer, 
Ph7.0, 10mM Meta-bisulfate, 15mM MgCl2, β-mercaptoethanol,). Cells were disrupted 
by sonication using a microprobe operated at 60% power with 20s treatments followed 
by cooling for 1 min for a total of 8 treatments in a cold room. Cell debris was cleared by 
centrifugation at 13,000g for 30 min at 4°C. The resulting supernatants were used for 
enzyme assays as well as protein purification. For purification, the cleared lysates were 
diluted to 8 ml with 2X binding buffer then run through a nickel-activated His-tag column.  
The column was washed with 6 mL of binding buffer containing 20mM Tris-HCl, pH 7.9, 
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500 mM NaCl, 5mM imidazole, followed by increasing concentrations of imidazole in the 
same buffer up to a 500 mM imidazole concentration. One ml fractions were collected 
and used for enzyme assays.  
4.5.6.3. Detection of prenyltransferase activity 
Prenyltransferase assays were performed in a final volume of 50 µl containing 20 µM [1-
14C]-IPP (55 mCi/mmol), 20 µM cold IPP and 40 µM DMAPP in assay buffer (50 mM 
Tris-Hcl, pH 7.0, 10 mM MgCl2) with crude or purified proteins and incubated for 1 hr at 
30°C. After the reaction is over, 200 μl of saturated NaCl was added to the reaction 
solution and 1 ml of water-saturated 1-butanol was added, vigorous mixed for 15 sec, 
and after a short spin, 250 µL of the 1-butanol phase was counted in a liquid scintillation 
counter as a measure of GPP plus FPP biosynthesis. 
To evaluate the specific activity of GPP vs FPP, after the reaction is inactivated by 
chilling on ice, 6 µl of 10X alkaline phosphate buffer and 4 µl of Promega alkaline 
phosphatase (1uinit/ ul) were added. After an incubation at 37oC for 2hr, 60 µl of 
saturated NaCl and 200 µl hexane were added, vigorous mixed mixed for 15 sec, and 
after a short spin, 100 µl of hexane were collected and mixed with 5ul of 100 ng/ul of 
cold geraniol and farnesol as carrier. After concentration under nitrogen gas to 30 µl, 
samples were separated on reverse phase TLC plate developed with acetone/H2O (9:1) 
and visualized by iodine vapor; the zones corresponding to those of GOH and FOH were 
scraped separately and counted by liquid scintillation counter. 
4.5.6.4. Prenyltransferase product analysis  
For product analysis, one mL reactions were performed under the same conditions as 
the enzyme assays, except 40µM cold IPP but no radioactive IPP was used. After an 
overnight incubation at 30oC, 110µl of 10x alkaline phosphate buffer and 10 units of 
Promega alkaline phosphatase were added to hydrolyze the prenyl diphosphates to their 
corresponding alcohols. The reaction mixture were incubated at 37°C for 3hr, and then 
extracted with 3ml of hexane with vigorous shaking for 15s. After a brief centrifugation, 
the hexane extract was concentrated under nitrogen gas and then analyzed by GC-MS.  
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Figure 4.10. Schematic depiction of the constructs assembled to replace the ERG20 
gene (A and B) and to engineer monoterpene metabolism (C and D) in yeast.  
Yeast expression vectors designed for the strong, constitutive expression of the bFPS, 
mFPS-A116W, mFPS-N144W, FaNES1, and LEU2 selection genes directed by the GPD 
promoter (Pgpd) or the TEF1 promoter (pTEF), and termination provided the ADH 
terminator sequence (T-ADH) or CYC terminator sequence (T-CYC) along with His and 
Ura3  auxotrophic markers. 
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Figure 4.11. A schematic diagram of the steps required to build the various expression 
plasmids, their use in replacing the ERG20 gene, and identification of the primer sets 
(PA, PB, PC, and PD) used to verify homologous recombination at the target locus.  
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Table 4.1. Primers used for the various molecular manipulations describe in materials 
and methods. 
Primer name Primer sequence 
PTEF-PGDPF 
AAAAAAGGAGTAGAAACATTTTGAAGCTATAGTTTATCATTA
TCAATACTCGCCATTTCA 
PTEF-PGDPR 
TGAAATGGCGAGTATTGATAATGATAAACTATAGCTTCAAAA
TGTTTCTACTCCTTTTTT 
PGPD-
EcoRIR 
GGAATTC CGTCGAAACTAAGTTCTGGTG 
PTEF-
BamHIR 
CGGGATCCAAAACTTAGATTAGATTGCTATGC 
bFPS NotIF 
GGGGCGGCCGCAAAACAATGGCTGCTCTAGCTGCACCTGC
C 
bFPS SpeIR  GGGACTAGTCTATTTAGAGCGCTTGTAGATC 
Leu2-NotIF GGGGCGGCCGCAAAACAATGTCTGCCCCTATGTCTGCCCC 
Leu2-SpeIR GGGACTAGTTTAAGCAAGGATTTTCTTAACTTCTTCGGCG 
Erg20L-HRSF GATCACGTAAAACAACAACCAGG  
Erg20L-
TCYC2F 
GCACAATAAACTCAAAAATATTACGTAGAACTTCGAGCGTCC
CAAAACCTTCTCAAGCAA 
Erg20L-
TCYC2R 
TTGCTTGAGAAGGTTTTGGGACGCTCGAAGTTCTACGTAAT
ATTTTTG AGTTTATTGTGC 
TADH-
Erg20RF2 
TGCTTTCTCAGGTATAGCATGAGGTCGCTCGAACTAACGCT
AATCGATAAAACATTAGAT 
TADH-
Erg20RR2 
ATCTAATGTTTTATCGATTAGCGTTAGTTCGAGCGACCTCAT
GCTATACCTGAGAAAGCA 
Erg20R-
HRSR 
TTAAACATTAACTCTTTCCAGCTC 
 
Yeast X-
104429F 
GATCACGTAAAACAACAACCAGGAAAGG 
 
Yeast X-
106818R 
AATATATGGGGGTTATTTGCTCTTG 
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Yeast X 
104229F 
TCCATGAAATCATTATTCTTAAATGTTCCG 
 
Yeast X 
106918R 
CTTACATACCAAGGTTAGTAAATAAAGATA 
 
FPS F ATGCAGCCCCATCATCATCATAAAGAG 
FPS R TCATTTCTGGCGTTTGTAGATCTTCTG 
ERG20 F ATGGCTTCAGAAAAAGAAATTAGG 
ERG20R CTATTTGCTTCTCTTGTAAACTTTG 
FPS-BamHIF CGGGATCCAAAACAATGCAGCCCCATCATCATCATAAAG  
FPS-XmaIR GGGCCCGGGTCATTTCTGGCGTTTGTAGATC 
tFaNES NotIF GGGGCGGCCGCAAAACAATGAACGTTGAAACCAAGCATAC 
tFaNES 
SpeIR 
GGGACTAGTTTACATTGATACAGTCTCATACAAC 
 
mFPS-
A116WF 
GCCTTCTTCCTGGTGTGGGATGACATCATGGATCAGTCC 
 
mFPS-
A116WR 
GGACTGATCCATGATGTCATCCCACACCAGGAAGAAGGC 
 
mFPS-
N144WF 
GGTTTGGATGCCATCTGGGACTCCTTCCTCCTGGAATCCTC
TGTGTAC 
mFPS-
N144WR 
GTACACAGAGGATTCCAGGAGGAAGGAGTCCCAGATGGCA
TCCAAACC 
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Chapter 5: Engineer triterpenes metabolism in yeast  
 
5.1. Summary 
To eliminate the native squalene catabolism in yeast and to extend the application of our 
novel yeast line for triterpene production, insertional mutants into ERG1 gene (coding 
squalene epoxidase) were generated. When BSS (squalene synthase) was introduced 
into ZXB line, having an extra copy of tHMGR integrated into the ERG1 deletion region, 
the resulting yeast transformant accumulated production of 297.7 mg/L squalene and 
70.24 mg/L farnesol in shake flask conditions.  
5.2. Introduction 
Triterpenes are compounds containing 30 carbon atoms synthesized from isoprene units 
assembled in the cytoplasmic compartment by the mevalonate biosynthetic pathway. 
Three isoprene units are polymerized into 15 carbon units referred to as farnesyl 
diphosphate, FPP, and two FPP molecules are condensed in head-to-head reactions to 
form squalene. Squalene is then converted to 2,3-oxidosqualene by squalene 
epoxidase, and various oxidosqualene cyclases catalyze the cyclization of 2,3-
oxidosqualene to produce a wide variety of four and five ring structures that can be 
further decorated by hydroxylation, acylation, aroylation, methylation, and glycosylation.  
Triterpenoids play diverse functional roles in all eukaryotes. In plants, when triterpenes 
are directed towards 4-ring structures and particularly sterols, these compounds play 
essential roles in plant growth by serving as structural components in cell membranes, 
influence the lipid bilayer fluidity, as in regulatory roles serving as growth regulators or 
hormones. Brassinolides represent a particular important class of growth regulators in 
plants. Other triterpenoids fall into the classification of specialized metabolites, 
compounds that serve in plant specific manners to mediate interactions between plants 
and their environment. Avicins are triterpenes produced in the roots of oat species that 
provide protection against microbial pathogens (Haridas et al., 2001a, Haridas et al., 
2001b). In some solanaceous plants, specific triterpenes accumulate in aerial parts of 
the plants and serve as feeding deterrents to insect pests (Itoh et al., 1977). More 
recently, triterpenoids have been advanced for their utility as high quality biofuels. 
Botryococcene, a triterpene hydrocarbon oil, is the major oil constituent of Botryococcus 
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braunii, a colony-forming green algae, that accumulates up to 30-80% of this algae’s dry 
weight. The botryococcene oils have also attracted significant research interest because 
these triterpene oils from a single organism have been claimed to contribute up to 1.4% 
of the total hydrocarbon content in oil and coal shale deposits (Moldowan & Seifert, 
1980, Okada et al., 1997, Derenne et al., 1997, Glikson et al., 1989), and can be readily 
converted to high quality combustible fuels such as gasoline, jet fuel and diesel, under 
standard hydrocracking/distillations procedures. Niehaus et al. (2011) recently identified 
the unique mechanisms for botryococcene biosynthesis in Botryococcus braunii and 
functional characterized the SSL1 (squalene synthase-like protein 1) and SSL3 
(squalene synthase-like protein 3) enzymes as those responsible for catalyzing the two 
separate step reactions converting two FPPs to botryococcene. Another common 
eukaryotic triterpene, squalene, obtained from various plant sources and the livers of 
deep sea sharks, has utility as a nutraceutical product, is used extensively in many types 
of cosmetics with claims for its antioxidant properties preventing skin damage, has 
special utility as a lubricant for high performance machinery, and is used as an adjuvant 
in many pharmaceutical formulations, enhancing the immune system response and 
promoting cardiac health (Bhilwade et al., 2010, Huang et al., 2009, Reddy & Couvreur, 
2009). Metabolic engineering triterpene production in Saccharomyces cerevisiae could 
provide an alternative supply source for these valuable terpene compounds. The 
precursors of all classes of terpenes are natively synthesized in yeast via their sterol 
biosynthesis pathway, which offers unique opportunities to divert these intermediates for 
the production of high-value terpenes, and triterpenes in particular.  
5.3. Results 
5.3.1. Metabolic engineering botryococcene biosynthesis in yeast  
Taking advantage of the native mevalonate (MVA) pathway that normally operates in 
yeast, and introducing a SUE (sterol uptake enhancement) mutation by EMS 
mutagenesis, and deletion of the squalene synthase gene (ERG9 locus), our yeast strain 
ZX178-08 generates a high level of FPP as indicated by the accumulation of its 
dephosphorylated product farnesol. Since botryococcene would be a novel compound 
for yeast and not likely catabolized, engineering botryococenne biosynthesis into strain 
ZX178-08 was considered an important challenge. We hence introduced a chimeric 
construct fusing genes SSL-1 and 3 into ZX178-08. SSL1-3M consists of the SSL1 and 
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SSL3 genes fused with a triplet repeat linker of GGSG in between the two genes, plus a 
71 amino acid, membrane-spanning domain of the carboxyl terminus of the 
Botryococcus braunii squalene synthase. The yeast vector pESC-Adh-Ura-SSL1-3M 
assembled by Niehaus et al. (2011) was transformed into yeast ZX178-08 line to 
evaluate triterpene production capability for botryococcene as shown in Fig. 5.2. After 10 
days, shake flask cultures accumulated 60.37 mg/L of botryococcene and 20.66 mg/L 
farnesol.  
5.3.2. Metabolic engineering squalene production in yeast 
5.3.2.1 Knocking out the ERG1 gene   
In contrast to botryococcene production in our yeast line, production of squalene would 
be subject to utilization by the innate sterol biochemical pathway. Hence, we sought to 
inactivate squalene epoxidase, the key enzymatic step committing squalene to sterol 
biosynthesis. A second reason for wanting to inactive the squalene epoxidase enzyme 
relates to another interesting observation. That is, while our yeast squalene synthase 
knock out line (erg9) can be transformed with the homologous yeast gene and thus 
complement the erg9 mutation, we have not been able to obtain yeast transformants 
harboring other plant or animal squalene synthase genes under transcriptional control of 
a constitutive promoter. However, when those plant or animal squalene synthase genes 
are under the control of inducible inducible promoters, like the Gal10 promoter, then 
transformant of ZX178-08 could be obtained and squalene accumulation could be 
induced upon addition of galactose. We have simply assumed that when squalene is 
constitutively produced by the foreign plant and animal squalene synthases, the resulting 
squalene can be convert to 2-3’ epoxidosqualene in manner that it is was toxic to the 
cells. Based on these two reasons, we sought to delete the squalene epoxidase gene, of 
ERG1 to enhance the prospects of triterpene engieering.  
Our strategies for development of erg1 knockout yeast lines are outlined in Fig. 5.3. 
Insertional inactivation of the ERG1 gene was created by introducing a fragment 
containing the G418 resistance gene KanmX4 flanked by 30 bp fragments of the LoxP 
recombinase system plus everything sandwiched between 400 bp DNA sequences of 
the 5’ and 3’ ERG1 gene. Introduction of this sequence into ZX178-08 line and 
subsequent selection yielded many G418 resistant colonies. Yeast having correct 
homologous recombination between the transformed fragment and desired regions of 
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ERG1 coding sequence was further confirmed by PCR amplification with primers outside 
the recombination region as shown in Fig. 5.4 and this series of yeast were named ZXA.  
The G418 resistance gene Kanmx4 gene cassette can be rescued by loxp and Cre 
recombination to obtain the ZXC line as shown in Fig. 5.6. A truncated catalytic active 
HMGR (HMG-CoA reductase), the rate limited enzyme of MVA pathway, was also 
integrated into ERG1 gene region along with Kanmx4 selection cassette, and the 
obtained positive yeast line was named ZXB. ZXD line is ZXB line after the Kanmx4 
selection cassette was removed by the loxp and Cre recombination reaction. PCR 
confirmation of insertional knockout of erg1 gene and the successful antibiotic marker 
rescue of ZXC and ZXD lines are shown in Fig. 5.6. 
5.3.2.2. Squalene accumulation in new generated yeast lines ZXA and ZXB 
Yeast expression construct with BSS driven by strong constitutive promoter GPD was 
transformed into ZXA and ZXB lines. Terpene production was quantified by GC-FID 
analysis and cell growth measured as changes in the OD600 nm. After 12 days of 
cultivatation, ZXA and ZXB control lines accumulated farnesol to 125.26 mg/L with no 
squalene detected. When the BSS gene was over-expressed in the ZXA line, 17.35 
mg/L FOH and 87.18mg/L squalene accumulated. More encouraging, the ZXB yeast line 
accumulated 70.24 mg/L FOH and almost 300 mg/L squalene.  
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Figure 5.1. Overall approach for generating yeast lines ZXB and ZXD based on 
previously generated yeast line ZX178-08 (see Chapter 2).  
The newly generated yeast lines have a dispensable sterol biosynthetic pathway 
because of erg9 (squalene synthase gene) and erg1 (squalene epoxidase) knockout 
mutations, plus introduction of an N-terminus membrane spanning domain truncation, 
catalytic HMG-CoA reductase gene (tHMGR), a rate-limited enzyme of MVA pathway, 
inserted into the ERG1 gene of strain ZX178-08. The newly generated yeast line should 
be capable of accumulating high levels of FPP but not metabolizing squalene, and 
hence would provide opportunities for diverting the FPP from the mevalonate (MVA) 
pathway for the biosynthesis of desired triterpene compounds. 
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Figure 5.2. Expression of the Botryococcus braunii SSL1-3M gene, a SSL1 and SSL3 
fusion plus a membrane-spanning domain at the carboxyl terminal, in the ZX178-08 
yeast strain monitored by chemical profiling of the culture’s terpene compounds. 
The previously developed yeast ZX178-08 strain, which has a dispensable sterol 
biosynthetic pathway and a squalene synthase (erg9) knock out mutation as illustrated in 
Fig. 5.1, accumulates high level of FPP that can be diverted to the biosynthesis of 
triterpenes. A yeast expression vector harboring the B. braunii SSL1-3M gene fusion 
was transformed into ZX178-08 yeast line, and a transformant grown for 10 days in a 
shake flask culture with periodic chemically profiling by GC-MS for the levels of 
botryococcene and farnesol accumulation as illustrated in panel B. The terpene levels 
and cell growth over 10 days in a shake flask culture are shown in panel A.  
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Figure 5.3. A schematic diagram of the approach to generate yeast strains ZXA-D.  
The ZX178-08 yeast strain (described in Chapter 2) was engineered for insertional 
inactivation of the ERG1 gene by introducing the G418 resistance gene (KanmX4 
flanked by 30 bp of the LoxP sequence (indicated by red triangles)), with a truncated 
HMGR (tHMGR) gene (ZXB line) or without the tHMGR gene (ZXA line), and with each 
cassette flanked by 200 bp of DNA sequences for the 5’ and 3’ region of the ERG1 gene 
(not shown) and subsequent selection for resistance to G418. To recover the antibiotic 
resistance marker (KAnmX4) for future uses, the ZXA and ZXB lines were transformed 
with a Ura3 vector containing the Cre recombinase gene under the transcriptional control 
of a galactose inducible promoter, and the obtained transformants cultured in liquid 
medium with glucose as initial sugar carbon source, and then induced with 2% galactose 
to express the Cre recombinase and induce the specific LoxP-Cre recombination to 
release KanmX4 gene.  Two days later, the yeast were replicate plated on complete 
medium with and without G418 to select for lines that had lost the resistance trait. Loss 
of the KAnmX4 gene from the erg1 locus was confirmed by follow-up PCR reactions. 
These latter developed yeast strains were designated as ZXC (without tHMGR insertion) 
and ZXD (with tHMGR insertion).   
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Figure 5.4. PCR confirmation for the erg1 knockout mutation.  
A 
B 
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A) The strategy for insertional knockout of the erg1 gene in the yeast genome through 
homologous recombination with a G418 resistance gene cassette is illustrated in upper 
part of panel A, along with identification of the primers uses to verify the various 
recombination events (P1 and P2). DNA isolated from 16 independent colonies selected 
for substitution of the G418 resistance gene for the ERG1 gene and the genomic DNA 
from control ZX178-08 line were used as templates to perform PCR reactions with the 
primers P1 (ERG1-90upF) and P2 (ERG1-100dwR) specific for the genomic DNA 
surrounding the ERG1 locus and outside the homologous recombination region. If the 
KanmX4 gene cassette did insert and replace the ERG1 gene, the expected 
amplification product would be 2,596 bp versus 1,681 bp as shown for the wild type 
ZX178-08 control in the agarose gel picture. All 16 of the G418 resistant colonies gave 
the expected PCR fragment size of 2,596 bp and were designated as the ZXA series.  
B) The strategy of insertional knock out ERG1 gene in yeast genome through 
homologous recombination with a G418 resistance gene cassette plus an extra copy of 
truncated HMGR gene is illustrated in the upper part of panel B, along with identification 
of the primers uses to verify the various recombination events (P1 – P5). DNA isolated 
from 5 independent colonies selected for substitution of the G418 resistance gene for 
the ERG1 gene and the genomic DNA from the control ZX178-08 were used as 
templates to perform PCR reactions with primer pair combinations P1-P2, P1-P3, and 
P4-P5. If the KanmX4 gene cassette plus tHMGR gene did insert and replace the ERG1 
gene, the expected amplification product with primers P1 and P2 would be 5,286 bp 
versus 1,681 bp as shown for the wild type DNA from ZX178-08. Two more primer sets, 
P1 plus P3 and P4 plus P5, were used to do PCR amplification for further confirming the 
intact integration. For P1 plus P3 primer set, the expected amplification product is 
1130bp versus no amplification in control ZX178-08. For P4 plus P5 primer set, the 
expected amplification product is 1,668 bp versus no amplification in control ZX178-08.  
Colonies 1, 2, 4, and 5 provided all the expected PCR verifications with correct fragment 
sizes from all three primer set test, and were hence designated as the ZXB series. 
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Figure 5.5. Terpene chemical profiles for yeast strains ZXA and ZXB over-expressing 
the Botryococcus braunii squalene synthase (BSS) gene. 
A yeast expression vector harboring the B. braunii squalene synthase gene under the 
control of the GPD promoter was transformed into the yeast strains ZXA or ZXB to 
compare terpene accumulation levels.  Yeast transformed with the expression vector (in 
red) are compared to control yeast (in black) in terms of their terpene chemical profiles 
determined by GC-MS. Aliquots of the cultures were chemically profiled at the indicated 
times by GC-MS and cell culture growth measured as their change in OD600nm over a 
12 day period for the ZXA strain (panel A) and ZXB strain (panel B). The GC 
chromatograph of BSS expressed in ZXB is also shown in panel C along with its mass 
spectrum, which is identical to an authentic standard. 
C 
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Figure 5.6. PCR confirmation of the selection marker rescue in new strains ZXC and 
ZXD lines.  
A 
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The strategy for rescuing the G418 resistance gene cassette is illustrated in the upper 
sections of panels A and B. Cre recombinase driven by a galactose inducible promoter 
on a yeast expression vector was transformed into ZXA and ZXB lines, and 
transformants selected by plating on SCE-Ura plates. Several single independent 
colonies were picked and cultivated in SCE-Ura liquid media before inducing expression 
of the Cre recombinase by 1.8% galactose to the culture. After two more days, the yeast 
cultures were diluted and plated onto selectable YPDE plates. Forty single independent 
colonies were then replica plated onto YPDE plates containing G418 to screen for loss 
of G418 resistance. Six independent clones of each strain (ZXA and ZXB) having lost 
the G418 resistance ability were cultivated and their genomic DNA isolated for PCR 
screens using two primers P1 (ERG1-90upF) and P2 (ERG1-100dwR) that are specific 
for the genomic DNA surrounding the ERG1 locus and outside the homologous 
recombination region. If the KanmX4 gene cassettes were lost as a consequence of the 
Cre- LoxP recombination reaction, the expected amplification product would be 825 bp 
versus 2,596 bp from ZXA, 3,515 bp versus 5,286 bp for ZXB, and 1,681 bp for the 
ZX178-08 control as shown in agarose gel pictures in panels A and B. A. All 6 colonies 
for each strain gave the expected PCR fragment sizes, the resulting yeast lines were 
then screen on plates containing 5FOA evict the Cre plasmid. The resulting yeast lines 
were designate as ZXC (derived from ZXA) and ZXD (derived from ZXB).  
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5.4. Discussion 
The previously generated yeast line ZX178-08 was further modified and advanced for 
triterpene engineering with the additional knockout of the ERG1 gene and addition of an 
extra copy of the catalytically active truncated hamster HMGR (Chappell et al., 1995) 
integrated into yeast genome. Chappell et al. (1995) previously demonstrated that 
constitutively expression this truncated hamster HMGR in tobacco led to a 3- to 6-fold 
increase in the total HMGR enzyme activity and a 3- to 10 -fold increase in the total 
sterol accumulation. HGMR is a rate-limiting enzyme in sterol biosynthesis, catalyzing 
the formation of mevalonic acid from HMG-CoA, and is highly regulated by downstream 
intermediates, which feedback control HMGR degradation (Gardner & Hampton, 1999). 
Overexpression a truncated version of HMGR by removing a post-transcriptional 
regulation region at N terminal, only expressing the catalytically active C-terminal region, 
has been shown to dramatically increase squalene accumulation in yeast (Dai et al., 
2012, Polakowski et al., 1998). Confirming those observations again, squalene 
accumulation level was increased 3.4 times and reaches 297.7mg/L in ZXB line, having 
one extra copy of tHMGR, and growing the cultures in shake flasks under selection 
media growth condition.  
5.5. Materials and methods 
5.5.1. Chemical and media preparations 
All chemical reagents were obtained from Sigma-Aldrich (St. Louis, MO), BD Bioscience 
(Franklin Lakes, NJ), or Fisher Scientific (Chicago, IL), while reagents for molecular 
manipulations were from Stratagene (San Diego, CA), Takara (Shiga, Japan), Invitrogen 
(San Diego, CA), and New England Biolab (Ipswich, MA). 
Bacteria and yeast were grown using standard culture practices. YPD media for growing 
yeast without selection consisted of 1% Bactoyeast extract, 2% Bacto-peptone, and 2% 
glucose. YPDE media was YPD media supplemented with ergosterol (40 mg/L) for 
ergosterol dependent lines. Ergosterol. Ergostrol stocks were 10 mg/mL in 50% Triton X-
100, 50% ethanol and kept at -20˚C.  Minimal media, SCE (pH 5.3), contained 0.67% 
Bacto-yeast nitrogen base (without amino acids), 2% dextrose, 0.6% succinic acid, 
0.14% Sigma yeast dropout solution (-his,-leu,-ura,-trp), uracil (300 mg/L), L-tryptophan 
(150 mg/L), L-histidine (250 mg/L), L-methionine (200 mg/L), L-leucine (1g/L) and 40 
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mg/L. Selection media was prepared similarly except without supplementing the media 
with the indicated reagent based on the yeast auxotrophic makers. All solid media plates 
were prepared with 2% Bacto-Agar.  
5.5.2. Yeast transformation and culture performance  
Yeast strains were transformed with the respective vector constructs using the 
FROZEN-EZ Yeast Transformation II Kit (Zymo Research, Orange, CA) according to the 
manufacturer’s recommendations. About 1 µg of plasmid or about 5 µg of linearized 
DNA was used per transformation and followed by selection on agar plates of SCE 
medium lacking specified amino acids for the auxotrophic markers at 30°C. Variable 
numbers of independent colonies were subsequently picked and used to start 3ml 
cultures in minimal media for isolating genomic DNA or characterize their terpene 
production capacities. To verify the correct homologous recombination of knockout 
ERG1 gene more than 20 independent colonies were picked, cultured and prepared for 
genomic DNA by using YeaStar™ Genomic DNA Kit (Zymo Research, Orange, CA).  
Primers ERG1-90upF and ERG1-100dwR outside the desired homologous 
recombination region as listed in table 1 were used to screen the positive replacement of 
ERG1 gene.   The PCR amplification fragment from PCR wide type genomic DNA is 
1681bp. With positive Adh-Kanmx4-loxp replaced Erg1 yeast genomic DNA as template, 
the PCR amplification fragment is 2596bp, and the obtained yeast line named ZXA. With 
Adh-Kanmx4-loxp-tHMGR replaced Erg1 yeast genomic DNA as template, the PCR 
amplification fragment is 5286 bp, and the obtained yeast line named ZXB. To rescue 
the selection marker kanmx4, the construct Pesc-URA-Cre, having Cre recombinase 
driven by gal inducible promoter, was introduced into ZXA and ZXB lines. Positive 
transformants containing Pesc-URA-Cre were cultivated in SCE-Ura liquid media for 3 
days, then the Cre recombinase gene expression were induced by 2% galactose when 
glucose was depleted from the initial start culture. After two more days, the yeast culture 
was serial diluted and plated on YPDE plates. Forty independent single colonies from 
each transformation (ZXA line, and ZXB line) were replica on YPDE and YPDE+G418 
plates, such that only the positive lines having lost Kanx4 through loxp-Cre 
recombination could not grow on plate containing G418. Over 40% of the colonies were 
positive for loss of the Kanmx4 selection lines, those positive yeast colonies were 
cultivated and extracted genomic DNA for PCR amplification to confirm the loss of 
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selection marker with primers ERG1-90upF and ERG1-100dwR. The expected PCR 
fragments size would change from 2596 bp to 825bp for ZXA line and from 5286bp to 
3515bp for ZXB line. Those obtained yeast were re-streaked on minimal medium plus 5-
FOA to selectively screen for loss of plasmid pEsc-URA-Cre, resulting in yeast lines 
designated ZXC and ZXD. The whole procedure of generating ZXA, ZXB, ZXC, ZXD 
lines are shown in Fig. 5.2. 
For terpene production quantification, aliquots of yeast cultures were analyzed by GC-
MS after 6 days of incubation at 23°C with shaking. Cultures exhibiting the highest 
terpene production levels were chosen for further time course studies and archived as 
glycerol stocks at -80˚C. Selected lines were characterized for cell growth and terpene 
production using 30 mL shake flask cultures. Starter cultures grown to saturation in 
minimal media were inoculated into 30 ml SCE media and 1 mL aliquots withdrawn at 
every other day intervals for 10–15 days. Cell growth was monitored as the change in 
optical density at 600 nm every two days, using appropriate dilutions for cultures at later 
stages of growth. Terpene production was determined by GC-MS.  
5.5.3. GC-MS detection and quantification of terpenes 
To determine terpene accumulation levels, aliquots of cultures grown for 6 to 12 days 
were lysised by acetone and then extracted with hexane and aliquots evaluated by GC-
MS. In general, to 1 volume of culture, 1 volume of acetone was added and mixed 
vigorously and left on bench for 15min to lyse the cells. The sample was then allowed to 
incubate at room temperature for 10 min before adding 1 volume of hexane containing a 
known amount of cedrene external standard. The mixture was again mixed vigorously, 
then centrifuged in a clinical centrifuge for 5 min at maximum speed. The upper organic 
layer was collected and when necessary, concentrated under a N2 stream to 100 µl. An 
aliquot of the organic phase (1 μl) was then analyzed by GC-MS with a Varian CP-3800 
GC coupled to a Varian Saturn 2200 MS/MS (Varian Medical Systems) using a Supelco 
SLB-5ms fused silica capillary column (30 m x 0.25 mm x 0.25 μm film thickness. The 
initial oven temperature was set at 100 °C for 1 min, ramped to 250 °C at 15 °C/min, and 
then ramped to 300 °C at 5°C/min and held for 1 min more. Relative terpenoid levels 
were calculated relative to the cedrene external standard. 
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5.5.4. Construction of the squalene epoxidase synthase ERG1 Knockout mutation 
Yeast vector pESC-ADA-URA-SSL1-3M for botryococcene production was assembled 
by Tom Niehaus (Niehaus et al., 2011) and pESC-GPD-LEU-tHMGR was built as 
described in Chapter 2. The Botryococcus SQS gene was cloned into the NotI and SpeI 
sites of pESC-GPD-Ura vector, and the resulting construct was named pESC-Gpd-Ura-
bSQS in Fig. 5.7. Cre recombinase gene was cloned into NotI and SpeI sites of pESC-
URA vector (Stratagene), and the resulting vector was named pESC-URA-Cre in Fig. 
5.7. 
The primers ERG1F and ERG1R as list in table 5.1 were used to amplify the squalene 
epoxidase synthase ERG1 gene from the yeast BY4741 genomic DNA by using Takara 
high fidelity Primestar taq polymerase. The obtained PCR fragment was gel purified, A 
tailed and ligated into the pGEM-Teasy vector (Promega, WI) by following the 
manufacture manual. The obtained vector was used as template to run second PCR with 
primers Erg1-splitF and ERG1-splitR to obtain PCR fragment with deletion of 891bp 
CDS in the middle and remaining 310bp at 5’ end region and 291bp at 3’ end region of 
ERG1 gene, which are the target homologous recombination sequences for the ERG1 
knock out. After digested with BamHI and self ligation, and transformation to DH5α 
competent cell, the resulting vector containing left and right arms of homologous 
recombination region and four restriction enzyme cloning sites in the middle of these two 
homologous sequences, which can be utilized for sub-cloning selection marker and 
other genes of interest. The resulting construct was named pGEM-ERG1-split as shown 
in Fig. 5.8. 
The Padh-Kanmx4-Tcyc-LoxP antibiotic selection marker cassette was constructed by 
assembly from three PCR fragments. Padh promoter was PCR amplified with Padh-
loxP-BamHIF and Padh-Kanmx4R primers by using Yep352 vector as template. Kanmx4 
selection gene was PCR amplified with Padh-kanmx4F and Tcyc-kanmx4R primers by 
using PYM-N14 plasmid described by (Janke et al., 2004) as template. Tcyc terminator 
was PCR amplified with Padh-loxP-BamHIF and Padh-Kanmx4R primers by using the 
pESC vector as the template. Thus, the resulting three PCR fragments containing 
homologous regions within each other were gel purified and 250ng of each fragment 
were mixed together to serve as the template for the secondary assembly PCR reaction 
to fuse them together to obtain the pAdh-Kanmx4-Tcyc-LoxP cassette, which was then 
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digested and inserted into pGEM-ERG1-split vector. The resulting construct was used as 
template to run PCR with ERG1F and ERG1R to obtain PCR fragment for generate ZXA 
lines. Pgpd-tHMGR-Tadh fragment was amplified from pESC-gpd-LEU-tHMGR vector 
with primers GPD-BamHIF and Tadh-XhoIR, and then inserted into the pGEM-ERG1-
split vector containing the Kanmx4 cassette. The resulting construct was used as a 
template to amplify a fragment with the ERG1F and ERG1R primers for building ZXB 
line, which has a erg1 knock out plus one copy of tHMGR integrated into genome. 
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Figure 5.7. Constructs used for engineering botryococcene production in yeast, the 
vector for introducing the ERG1 knockout mutation, the vector for directing squalene 
accumulation, and the Cre-Lox vector used to create the antibiotic selection marker 
rescue phenotype in the ZXA and B yeast strains. 
Yeast expression vectors were designed for the strong, constitutive expression of the 
SSL1-3M, bSQS, tHMGR, KanmX4 genes driven by the GPD promoter (Pgpd) or the 
ADH promoter (Padh) and termination sequences provided by the ADH terminator 
sequence (T-ADH) or CYC terminator sequence (T-CYC) with auxotrophic marker Ura3 
as indicated. 
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Figure 5.8. A Schematic depiction of the steps used in building the ERG1 knockout vector and the insertional mutation of ERG1 
through homologous recombination.  
The primers used for construction and screening the homologous recombinants and the successfully rescue of antibiotic selection 
markers are indicated as colored arrows.  
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Table 5.1. Primers used for the various molecular manipulations describe in materials 
Primer name Primer sequence 
tHMGR-NotIF 
GGGGCGGCCGCAAAACAATGTTGTCACGACTTTTCCGTATG
C 
tHMGR-SpeIR GACTAGT TCAAGCTGACTTCTTGGTGCACGTTCCTTG 
ERG1F ATGTCTGCTGTTAACGTTGCACCTG 
ERG1R TTAACCAATCAACTCACCAAAC 
ERG1-split F CGGGATCCCTCGAG TTGTTCGCTGCTGACAGCGATAAC 
ERG1-splitR 
CGGGATCCGCTAGCGGTACCACATGGGTCCTTTATATTGAC
ACG 
ERG1 90up F ATCAGAACAATTGTCCAGTATTG 
ERG1100dwR AATGTACTATACAAGCCTTCC 
bSQS-NotIF GGGGCGGCCGCAAAACAATGGGGATGCTTCGCTGGGGAGT 
bSQS-SpeIR GACTAGTTTAGCTCCTCAATTCGTCAAAGGT 
Cre-NotIF 
GGGGCGGCCGCAAAACAATGGACATGTTCAGGGATCGCCA
GG 
Cre-SpeIR GACTAGTCTAATCGCCATCTTCCAGCAGGCG 
Padh-Loxp-
BamHIF 
CGGGATCCATAACTTCGTATAGCATACATTATACGAAGTTAT
GTGGAATATTTCGGATAT   
Padh-
Kanmx4F 
GCATACAATCAACTAAGCTAAGCTAAAACAATGGGTAAGGA
AAAGACTCACGTTTC 
Padh-
Kanmx4R 
GAAACGTGAGTCTTTTCCTTACCCATTGTTTTAGCTTAGCTT
AGTTGATTGTATGC 
Kanmx4-
TcycF 
CATTTGATGCTCGATGAGTTTTTCTAAATCCGCTCTAACCGA
AAAGGAAGGAG 
Kanmx4-
TcycR 
CTCCTTCCTTTTCGGTTAGAGCGGATTTAGAAAAACTCATCG
AGCATCAAATG 
Tcyc-LoxP-
NheIR 
GGGGCTAGCATAACTTCGTATAATGTATGCTATACGAAGTTA
TCTTCGAGCGTCCCAAAA 
Gpd-BamHIF CGGGATCCAGTTTATCATTATCAATACTCG 
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Tadh-XhoIR GGGCTCGAG GAGCGACCTCATGCTATACCTG 
Kanmx4R TTAGAAAAACTCATCGAGCATC 
Table 5.1 (continued) 
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Chapter 6: Concluding remarks 
 
The over-arching goal of this thesis was to develop yeast as a production platform for all 
classes of terpenes, classes of compounds that yeast do not accumulate or synthesize 
naturally. Our challenge was use the tools of genetics and molecular genetics to create a 
yeast line that contained a dispensable sterol biosynthetic pathway such that carbon flux 
down this pathway could be redirected to the synthesis and accumulation of mono-, 
sesqui-, di- or tri-terpene compounds. For this purpose, we first selected for yeast that 
could take up and utilized exogenous sterols in place of the ergosterol that the cells 
normally synthesize to meet their sterol needs. This left the native sterol biosynthetic 
pathway available for metabolic engineering efforts to redirect carbon flux to desired 
terpene end products. As illustrated in each of the chapters, specific manipulations were 
required to affect the biosynthesis of each class of terpenes which included the 
engineering of novel prenyltransferases and knocking out competing pathways that 
compete for available intermediates and/or catabolize the final, desired end-products.  
And while we appreciate that our efforts have been successful in developing production 
platforms for 100s of mg of terpenes per L of cultural broth, we are equally cognizant 
that these production levels represent a relative low efficiency of the theoretic maximum 
based on the percent of total feedstock carbon provided. Hence, we believe there are 
significant gains in efficiency yet to be realized.  
Budding yeast exhibit robust oscillations in oxygen consumption during continuous 
nutrient-limited conditions (Silverman et al., 2010, Tu & McKnight, 2007, Tu et al., 2007), 
and half of the genes in the yeast genome are expressed periodically during three 
oscillatory phases, Ox (oxidative), RB (reductive/building) and RC (reductive/charging) of 
yeast metabolic cycles (YMC) (Tu et al., 2007). These metabolic cycles drive many 
changes in intracellular metabolite concentrations. Numerous amino acid precursor, 
amino acids, nucleotide precursor and TCA (tricarboxylic acid cycle) intermediates 
increase significantly during the Ox phase (Tu et al., 2007). Acetyl-CoA, the initial 
precursor for MVA pathway, reaches it peak concentration during the Ox phase. Ideally if 
the yeast cell could be arrested in the Ox phase, then there might be a chance more 
acetyl-CoA would be available for terpene biosynthesis.  
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Yeast cells undergoing the YMC are also synchronized with respect to the cell cycle. 
Yeast mitotic cell cycle can be divided into the G1 (Gap1), S (synthesis), G2 (Gap2), and 
M (mitotic) phases as in Fig 6.6 (Fingar & Blenis, 2004). Under nutrient limited 
conditions, yeast cells typically arrest growth and enter into a quiescent state called G0 
(Cai & Tu, 2012). In G1 phase the cell increases in size until it reaches the G1 
checkpoint which promotes Start transition, thus, commitment to S phase and a new 
round of DNA synthesis and division. TOR (target of rapamycin) kinase cascades affect 
expression of the key regulatory G1 cyclin molecules, which, in turn, promote execution 
of START (Fingar & Blenis, 2004). In contrast, rapamycin inhibits cell cycle progression 
and proliferation by inducing an accumulation of cells in the G1 phase (Fingar & Blenis, 
2004). Interestingly, the G1 phase is related to the Ox phase in YMC, in which the 
concentration of acetyl-CoA reaches its peak. Rapamycin and other drugs known to 
down regulate sphingolipid synthesis also increase the chronologic lifespan (CLS) in 
yeast (Huang et al., 2012), which may correspond to another metablic state conducive to 
the biosynthesis and production of specialized compounds in yeast. Controlling the 
metabolic state and arresting yeast to specific cell cycle phases, in which there is more 
precursor feeding to MVA pathway, could represent another important means to further 
promote terpene production in yeast  
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Figure 6.1. The changes in yeast metabolites occur with respect to cell cycle stage (G0, 
G1, S, and M) and metabolic cycle phase, OX (growth), RB (division), and RC 
(survival/quiescence) of budding yeast. 
The YMC (yeast metabolic cycle) trace represents absolute dissolved oxygen 
concentrations in the growth medium. The drop in dO2 indicates oxygen consumption. 
Target of rapamycin (TOR) integrates with signals from nutrients and growth factors to 
regulate cell growth and cell cycle progression. Rapamycin or drugs down regulating 
sphingolipid synthesis increases the yeast chronologic lifespan (Huang et al., 2012). 
Adapted from (Cai & Tu, 2012, Huang et al., 2012). 
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